AU4356993A - Oxytocin antagonist - Google Patents
Oxytocin antagonistInfo
- Publication number
- AU4356993A AU4356993A AU43569/93A AU4356993A AU4356993A AU 4356993 A AU4356993 A AU 4356993A AU 43569/93 A AU43569/93 A AU 43569/93A AU 4356993 A AU4356993 A AU 4356993A AU 4356993 A AU4356993 A AU 4356993A
- Authority
- AU
- Australia
- Prior art keywords
- optionally
- substituted
- alkyl
- alkoxy
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Description
D E S C R I P T I O N
OXYTOCIN ANTAGONIST
Technical Field
This invention relates to a novel oxytocin antagonist, which has excellent pharmacological activities, for example, inhibitory effect on uterin smooth muscle constriction, inhibitory effect on milk secretion,
inhibitory effect on synthesis and secreation of
prostaglandin, and vasodilation activity, and hence, are useful in the protection or treatment of oxytocin relating diseases, e.g. premature delivery, dysmenorrhea,
endometr itis , or in stopping labour preparatory to Caesarian delivery.
Background Art
The carboxytril derivatives of the following formula (1) and the benzohetrocyclic compounds of the following formula (2), which are active ingredients of the present oxytocin antagonist, are known to have vasopressin antagonistic activity (cf. Japanese Patent First Publication (Kokai) No. 173870/1991, and European Patent No. 40097, respectively).
It is known that some heterocyclic compounds have oxytocin antagonistic activity. For example, EP-0421802-A2 discloses that 3-substituted-1,4-benzodiazepines of the following formula are antagonists of oxytocin and are useful in the treatment of preterm labour and dysmenorrhea and for
stoppage of labour preparatory to Caesarian delivery:
wherein R1 is H, C1-C 6 alkyl, lower alkenyl, lower alkynyl, -X12COOR6, -X11-cyclo(lower)alkyl, -X12NR4R5, -X12CONR4R5, -X12CN or -X11CX10; R2 is H, lower alkyl, substituted or unsubstituted phenyl, etc,; R3 is H, -X11NR18X11R7, etc.; R9 and R10 are each H, OH or CH3; R13 is H, lower alkyl, acyl, O, cyclo(lower)alkyl, -X11COX9X11R7 or -X11COX11R7; X1 is H, NO2, CF3, CN, OH, lower alkyl, halo, etc.; X7 is O, S, NH or NR15; X11 is C1-C 4 alkylidene; and X12 is C1-C 4 alkyl.
These compounds have a 1,4-benzodiazepine nucleus which is inclusive within the active compounds of the formula (2) of the present invention, but are different in the subs t i tuen t at 1-position.
Some other European patent applications disclose also various oxytocin antagonists, such as spiro(indenepiperidine) compounds and analogues thereof (cf. EP-0444945-A2, EP-0450761-A1, and EP-0486280-A2), but these compounds are different from the active compounds of the formulae (1) and (2) of the present invention in the chemical
structure.
Disclosure of the Invention
The present inventors have intensively studied the carbostyril derivatives of the formula (1) and the
benzohetrocyclic compounds of the formula (2), and have found that these compounds and pharmaceutically acceptable salts thereof have excellent oxytocin antagonistic activity and have accomplished the present invention.
The carbostyril derivatives, which are one of active ingredients of the oxytocin antagonist of the present invention, have the following formula (1):
wherein R1 is hydrogen atom; nitro; a lower alkoxy; a lower alkoxycarbonyl; a lower alkyl; a halogen atom; an amino having optionally one or two substituents selected from a lower alkanoyl, a lower alkyl, benozyl and a phenyl(lower)alkoxycarbonyl; hydroxy; cyano; carboxy; a lower alkanoyloxy; or hydrazinocarbonyl,
q is an integer of 1 to 3, and
R is a group of the formula: or
wherein R2 is hydrogen atom; a lower alkoxycarbonyl; a phenoxycarbonyl wherein the phenyl r ing may optionally be substituted by one to three substituents selected from nitro and an amino having optionally one or two substituents selected from a lower alkanoyl, a lower alkyl and benzoyl; a phenyl (lower)alkenylcarbonyl; a phenyl(lower)alkanoyl wherein the lower alkanoyl moiety may optionally be
substituted by an amino having optionally a lower
alkoxycarbonyl substituent; an alkanoyl; an alkenylcarbonyl; a phenylsulfonyl wherein the phenyl ring may optionally be substituted by a lower alkoxy; a group of the formula:
-CONR8R9 (wherein R8 and R9 are the same or different and are each hydrogen atom or a phenyl which may optionally have one to three substituents selected from a lower alkoxy, a lower alkyl, a halogen atom, an amino having optionally one or two substituents selected from a lower alkyl and a lower alkanoyl, and nitro); a heterocyclic group-substituted carbonyl wherein the heterocyclic group may optionally have one to three substituents selected from a phenyl(lower)alkoxycarbonyl, a phenyl(lower)alkoxy, oxo, a lower alkyl, and a lower alkylenedioxy; a group of the formula:
naphthylcarbonyl; a thienyl(lower)alkanoyl; a tricyclo- [3.3.1.1]decanyl(lower)alkanoyl; tricyclo[3.3.1.1]-decanylcarbonyl; or a group of the formula: (wherein p is 0 or an integer of 1 to 3, and
R13 is hydroxy; an alkoxy; an alkoxy which has one or two substituents selected from hydroxy, a lower alkanoyloxy, a tri(lower)alkylarnmonium, a lower alkoxy, and a group of the formula: -NR14R15 [wherein R14 and R15 are the same or different and are each hydrogen atom, a lower alkyl, a
hydroxy-substituted lower alkyl, a lower alkanoyl, a
tetrahydropyranyl(lower)alkyl, phenyl, a phenyl(lower)alkyl (wherein the alkyl moiety may optionally be substituted by hydroxy and the phenyl ring may optionally be substituted by a lower alkoxy), or a pyridyl(lower)alkyl; or R14 and R15 may bind with the nitrogen atom to which they bond to form a 5- or 6-membered, saturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom
(wherein the heterocyclic group may optionally be
substituted by a member selected from carbamoyl, a lower alkyl, a phenyl(lower)alkyl, phenyl and a hydroxy-substituted lower alkyl)]; a carboxy-substituted alkoxy; a halogen-substituted lower alkoxy; a lower alkoxycarbonyl-substituted alkoxy; a lower alkanoyloxy-substituted lower alkoxy; a lower alkenyloxy-substituted lower alkoxy; a lower alkoxy(lower)alkoxy; a lower alkylsulfonyloxy-substituted lower alkoxy; a benzoyloxy-substituted lower alkoxy;
tricyclo[3.3.1.1]decanyl-substituted lower alkoxy; a lower alkoxy(lower)alkoxy which is substituted by one or two substituents selected from hydroxy and an amino being optionally substituted by a lower alkyl; a morpholinyl-substituted lower alkoxy which may optionally be substituted by a lower alkyl or oxo; a benzimidazolylthio-substituted lower alkoxy; a benzimidazolylsulfinyl-substituted lower alkoxy; a group of the formula: -O-A-(E)ℓ-NR4R5 (wherein A is an alkylene, ℓ is an integer of 0 or 1, E is a group of the formula: -CO- or -OCO-, R4 and R5 are the same or different and are each hydrogen atom; a lower alkyl which
may optionally be substituted by hydroxy or cyano; a lower alkenyl; a lower alkynyl; a phenyl(lower)alkyl; a lower alkanoyl which may optionally have one to three substituents of a halogen atom; a benzoyl wherein the phenyl ring may optionally be substituted by a member selected from nitro and an amino having optionally one or two substituents selected from a lower alkyl, a lower alkanoyl and a
phenyl(lower)alkoxycarbonyl; phenyl; a lower alkoxycarbonyl; a lower alkoxycarbonyl(lower)alkyl wherein the lower alkyl moiety may optionally be substituted by hydroxy or an amino having optionally a phenyl(lower)alkoxycarbonyl substituent; an amido having optionally a lower alkyl substituent; a pyrrolidinyl-substituted carbonyl wherein the pyrrolidinyl ring may optionally be substituted by a phenyl(lower)alkoxycarbonyl; an amino-substituted lower alkanoyl wherein the lower alkanoyl moiety may optionally be subst i tuted by a member selected from phenyl(lower)alkoxycarbonylamino, hydroxy, a phenyl having optionally a hydroxy substitutent, carbamoyl, imidazolyl and a lower alkylthio, and the amino group may optionally have a substituent selected from a lower alkyl having optionally a hydroxy substitutent, a lower alkenyl, a phenyl(lower)alkyl having optionally a lower alkoxy substituent on the phenyl ring, a lower
alkylsulfonyl, a lower alkanoyl, and a phenyl(lower)alkoxycarbonyl; a hydroxy-substituted lower alkanoyl; a lower alkanoyloxy(lower)alkanoyl; a lower alkylsulfonyl; a
phenylsulfonyl wherein the phenyl ring may optionally be substituted by a lower alkyl, nitro or an amino having
optionally one or two substituents selected from a lower alkyl and a lower alkanoyl; an amido-substituted lower alkyl wherein the lower alkyl moiety have optionally a substituent selected from a phenyl having optionally a hydroxy substituent, imidazolyl, carbamoyl and a lower alkylthio, and the amido group may optionally have a lower alkyl substituent; an amino-substituted lower alkyl which may optionally substituted by a lower alkyl or a lower alkanoyl; anilinocarbonyl; a piperidinyl which may optionally be substituted by a phenyl(lower)alkyl; a cycloalkyl, a cycloalkenylcarbonyl; a cycloalkylcarbonyl which may optionally have one to three substituents selected from hydroxy and a lower alkanoyloxy ; a tetrahydropyranyl-substi tuted lower alkyl wherein the tetrahydropyranyl ring may optionally have one to four substituents selected from hydroxy and a lower alkoxy; a lower alkanoyl which is substituted by a 5- or 6-membered saturated heterocyclic group selected from
pyrrolidinyl, piperazinyl, piperidinyl and morpholinyl wherein the heterocyclic group have optionally a substituent selected from a lower alkyl and phenyl; a piperidinyl-substituted carbonyl which may optionally be substituted by a lower alkanoyl; a lower alkanoyloxy(lower)alkyl; a
pyridyl-substituted lower alkyl; or an amino acid residue which can form an amido group with its amino group, or R4 and R5 may bind together with the nitrogen atom to which they bond to form a 5- or 6-membered, saturated or
unsaturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom, wherein the
heterocyclic group may optionally be substituted by a member selected from a phenyl having optionally a subsituent selected from a lower alkoxy and a halogen atom, oxo, hydroxy, a lower alkenyl, carboxy, a phenyl(lower)alkyl having optionally a hydroxy substituent on the lower alkyl moiety, a lower alkanoyl, a lower alkyl having optionally a hydroxy substituent, benzoyl, an amido having optionally a lower alkyl substituent, anilinocarbonyl, a benzoyl(lower)alkyl, a lower alkylsulfonyl, piperidinyl, pyrimidinyl, pyridyl, and a lower alkoxycarbonyl); a carbamoyloxysubstituted lower alkoxy; a lower alkylthio-substituted lower alkoxy; a lower alkylsulfonyl-substituted lower alkoxy; a lower alkylsulfinyl-substituted lower alkoxy; an alkenyloxy; phenoxy; a lower alkanoyloxy; a lower alkylsulfonyloxy; a lower alkynyloxy; a phenyl(lower)alkoxy; a cycloalkyl; a cycloalkyloxy; a cycloalkenyloxy; imidazo[ 4,5-c]pyridyl-carbonyl(lower)alkoxy; a group of the
formula: -(B)ℓNR6R7 (wherein ℓ is as defined above, B is a lower alkylene or a group of -CO-, and R6 and R 7 are the same or different and are each hydrogen atom, a lower alkyl, a lower alkanoyl having optionally one to three halogen substituents, a carboxy(lower)alkyl, a lower alkoxycarbonyl, a lower alkoxycarbonyl(lower)alkyl, a lower alkenyl, an amido-substituted lower alkyl having optionally a lower alkyl substituent, or a phenyl(lower)alkoxycarbonyl, or R6 and R7 may bind together with nitrogen atom to which they bond to form a 5- or 6-membered, saturated or unsaturated heterocyclic group which may be intervened or not with
nitrogen, oxygen or sulfur atom, wherein the heterocyclic group may optionally have a substituent selected from a lower alkoxycarbonyl, a lower alkyl, a lower alkylthio, and oxo); nitro; a halogen atom; a lower alkylsulfonyl; a lower alkyl which may optionally have one to three substituents selected from a halogen atom, hydroxy, phenyl and a lower alkoxy; a cyano-substituted lower alkoxy; an oxiranyl-substituted lower alkoxy; a phthalimido-substituted alkoxy; an amidino-substituted lower alkoxy, a pyr rolyl-substituted lower alkoxy; cyano; a lower alkoxycarbonyl; amidino;
carbamoyl; carboxy; a lower alkanoyl; benzoyl; a lower alkoxycarbonyl(lower)alkyl; a carboxy(lower)alkyl; a lower alkoxy(lower)alkyl; a lower alkanoyloxy(lower)alkyl;
hydroxyimino-substituted lower alkyl; phenyl; a lower alkylthio; a lower alkylsulfinyl; a lower alkenyl having optionally a hydroxy substituent; a lower alkylenedioxy, a lower alkylsilyy; a pyrimidylthio-substituted lower alkoxy; a pyrimidylsulfinyl-substituted lower alkoxy; a pyrmidylsufonyl-substituted lower alkoxy; an imidazolylthio-substituted lower alkoxy which may optionally have a lower alkyl substituent; an imidazolylsulfonyl-substituted lower alkoxy which may optionally have a lower alkyl substituent; an ammonium-lower alkoxy having three substituents selected from lower alkyl, lower alkenyl and oxo; a phenylthio-substituted lower alkoxy wherein the phenyl ring may
optionally have a substituent selected from nitro and amino; a phenylsulfonyl-substituted lower alkoxy wherein the phenyl ring may optionally have a substituent selected from nitro
and an amino having optionally one or two substituents selected from a lower alkanoyl and lower alkyl; a
pyridylthio-substituted lower alkoxy; or a pyridylsuflonyl-substituted lower alkoxy wherein the pyridyl ring may optionally be substituted by oxo), n is an integer of 1 or 2, m is 0 or an integer of 1 to 3, R3 is a lower alkyl, R10 is a group of the formula: -(CO)ℓ -NR11 R 1 2 (wherein a is as defined above and R and R are the same or different and are each hydrogen atom, a lower alkyl, a phenyl(lower)alkyl, a lower alkenyl, a benzoyl which may optionally have a lower alkoxy substituent, tricyclo[3.3.1.1]decanyl, a phenyl which may optionally have a lower alkoxy substituent, or a
cycloalkyl, or R1 1 and R1 2 may bind together with the nitrogen atom to which they bond to form a saturated or unsaturated heterocyclic group which may be intervened or not wi th nitrogen , oxygen or sulfur atom , wherein the heterocyclic group may optionally have a substituent
selected from a benzoyl, a lower alkanoyl, a phenyl(lower)alkyl and a phenyl which may optionally be substituted by a lower alkoxy or a lower alkanoyl), the bond between 3- and 4-positions of the carbostyril ring is single bond or double bond, provided that when R1 is hydrogen atom and the ℓ in the formula: -(CO)ℓ-NR11R12 is 0 and R11, R12 are not simultaneously hydrogen atom.
The benzoheterocyclic compounds, which are also one of the active ingredient of the present oxytocin antagonist, have the following formula (2):
wherein R16 is hydrogen atom, a halogen atom, a lower alkyl, an amino having optionally a lower alkyl substituent, or a lower alkoxy,
R17 is hydrogen atom, a halogen atom, a lower alkoxy, a phenyl(lower)alkoxy, hydroxy, a lower alkyl, an amino having optionally a lower alkyl substituent, a
carbamoyl-substituted lower alkoxy, an amino-substituted lower alkoxy having optionally a lower alkyl substituent, or a benzoyloxy which has optionally a halogen substituent on the phenyl ring,
R18 is a group of the formula: -NR19R20 or a group of the formula: -CONR26R27,
R19 is hydrogen atom, a benzoyl which has optionally a halogen substituent on the phenyl ring, or a lower alkyl, R20 is a group of the formula:
[wherein R31 is a halogen atom; a lower alkyl which has optionally a substituent selected from a halogen atom and hydroxy; hydroxy; a lower alkoxy; a lower alkanoyloxy; a lower alkylthio; a lower alkanoyl; carboxy; a lower
alkoxycarbonyl; cyano; nitro; an amino which has optionally a substituent selected from a lower alkyl and a lower
alkanoyl; phenyl; a cycloalkyl; a lower alkanoyloxy-substituted lower alkoxy; a carboxy-substituted lower alkoxy; a halogen-substituted lower alkoxy; a carbamoyl-substituted lower alkoxy; a hydroxy-substituted lower alkoxy; a lower alkoxycarbonyl-substituted lower alkoxy; a phthalimido-substituted lower alkoxy; an aminocarbonyl-lower alkoxy having a lower alkyl substituent; or a group of the formula: -O-F-N21R22 (F is a lower alkylene, and R21 and R22 are the same or different and are each hydrogen atom, a lower alkyl having optionally a hydroxy substituent, a lower alkanoyl, or benzoyl, or R21 and R22 may bind together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with nitrogen or oxygen atom wherein the heterocyclic group has optionally a substituent selected from piperidinyl and a lower alkyl); and r is an integer of 0 to 3], a phenyl-lower alkoxycarbonyl, a lower alkanoyl, a phenyl-lower alkanoyl, a cycloalkyl-lower alkanoyl, a cycloalkylcarbonyl, tricyclo[3.3.1.1]decanylearbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-lower alkanoyl wherein the phenyl ring has
optionally 1 to 3 substituents selected from a lower alkyl, a lower alkoxy and an amino having optionally a lower alkanoyl substituent, a phthalimido-substituted lower alkanoyl, a lower alkoxycarbonyl-lower alkanoyl, a carboxy-lower alkanoyl, a naphthyloxy-lower alkanoyl, a halogen-substituted lower alkanoyl, a group of the formula:
(wherein R23 is hydrogen atom, a lower
alkyl, a phenyl-lower alkoxycarbonyl, a carbamoyl-lower alkyl, an amino-lower alkanoyl having optionally a lower alkyl substituent, or a lower alkanoyl), an anilinocarbonyl which has optionally a lower alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a lower alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: -CO-G-(CO)s-NR24R25 (wherein G is a lower alkylene, s is an integer of 0 or 1, and R24 and R25 are the same or different and are each hydrogen atom, a lower alkyl having optionally a hydroxy substituent, a cycloalkyl, a phenyl-lower alkyl, a lower alkanoyl, a lower alkenyl, a phenoxy-lower alkyl, a phenyl which has optionally 1 to 3
substituents selected from an amino-lower alkyl having optionally a lower alkanoyl substituent, a lower alkyl, a lower alkoxy and a halogen atom, a phthalimido-substituted lower alkyl, an amino-lower alkyl having optionally a lower alkanoyl substituent, a lower alkynyl, or an amino-lower alkyl having optionally a lower alkyl substituent, or R24 and R25 may bind together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with nitrogen or oxygen atom wherein the heterocylic group has optionally a substituent selected from a lower alkyl, a lower
alkoxycarboyl and piperidinyl),
R26 is hydrogen atom or a lower alkyl,
R27 is a cycloalkyl, or a phenyl which has optionally 1 to 3 substituents selected from a lower alkoxy,
a lower alkyl and a halogen atom,
W is a group of the formula: -(CH2)t- (t is an integer of 3 to 5), or a group of the formula:
-CH=CH-(CH2)v- (v is an integer of 1 to 3), the carbon atom of these groups: -(CH2)t- and -CH=CH-(CH2)v- being
optionally replaced by oxygen atom, sulfur atom, sulfinyl, sulfonyl, or a group of the formula: -NR28- (R28 is hydrogen atom, a cycloalkyl, or a lower alkyl), and further said -(CH2)t- and -CH=CH-(CH2)v- groups having optionally 1 to 3 substituents selected from a lower alkyl having optionally a hydroxy substituent, a lower alkoxycarbonyl, carboxy, hydroxy, oxo, a lower alkanoyloxy having optionally a halogen substituent, an amino-lower alkyl having optionally a substituent selected from a lower alkyl and a lower alkanoyl, a lower alkanoyloxy-substituted lower alkyl, a lower alkyl sulfonyloxy-lower alkyl, an azido-lower alkyl, a group of the formula: -OCH2-, an aminocarbonyloxy having optionally a lower alkyl substituent, a lower alkoxy, a lower alkoxycarbonyl-substituted lower alkoxy, a carboxy-substituted lower alkoxy, an aminocarbonyl-lower alkoxy having optionally a lower alkyl substituent, an amino-lower alkoxy having optionally a substituent selected from a lower alkyl and a lower alkanoyl, a phthalimido-substituted lower alkoxy, hydroxyimino, a lower alkanoyloxy-imino, a lower alkylidene, a halogen atom, azido, sulfoxyimino, a group of the formula: is hydrogen atom or a lower
alkyl), hydrazino, pyrrolyl, an amino-lower alkanoyloxy
having optionally a lower alkyl substituent, a group of the formula: -O-F-CO-NR33R34 (F is as defined above, and R33 and R34 are the same or different and are each hydrogen atom, a lower alkyl, a carbamoyl-substituted lower alkyl, a hydroxysubstituted lower alkyl, or a pyridyl-lower alkyl, or R 33 and R34 may bind together with nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with nitrogen, oxygen or sulfur atom wherein the heterocyclic group has optionally a substituent selected from oxo, a lower alkyl, a lower alkanoyl, and carbamoyl), or a group of the formula:
-(CO)s-NR29N30 (wherein s is as defined above, and R29 and R 30 are the same or different and are each hydrogen atom, a lower alkyl, a lower alkenyl, a lower alkanoyl, a
cycloalkyl, an oxiranyl-substituted lower alkyl, a lower alkyl having optionally 1 to 2 substituents selected from a lower alkoxy, hydroxy and an amino having optionally a lower alkyl substituent, a phenyl-lower alkyl, a pyridyl-lower alkyl, a lower alkylsulfonyl, benzoyl, a lower alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having
optionally a lower alkyl substituent, a cyano-substituted lower alkyl, a lower alkoxycarbonyl-substituted lower alkyl, a carbamoyl-substituted lower alkyl, a carboxy-substituted lower alkyl, a tetrahydropyranyloxy-substituted lower alkyl, a lower alkanoyloxy-substituted lower alkyl, a piperidinyl having optionally a phenyl-lower alkyl substituent on the piperidine ring, a halogen-substituted lower alkanoyl, an imidazolyl-substituted lower alkanoyl, an amino-lower
alkanoyl having optionally a substituent selected from a lower alkyl and a lower alkoxycarbonyl, an aminocarbonyl-lower alkyl having optionally a lower alkyl substituent, or a phenyl-lower alkoxycarbonyl, or R29 and R30 may bind together with nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with nitrogen or oxygen, wherein the heterocyclic group may optionally have a substituent
selected from a lower alkyl, a phenyl-lower alkyl and a lower alkanoyl).
The carbostyril derivatives of the formula (1) and their salts, and the benzoheterocyclic compounds of the formula (2) and their salts have excellent inhibitory effect on uterin smooth muscle constriction, inhibitory effect on milk secretion, inhibitory effect on synthesis and
secreation of prostaglandin, and vasodilation activity, and hence, they are useful in the protection or treatment of oxytocin relating diseases, expecially, for treatment of premature delivery, dysmenorrhea, endometritis, or for stopping labour preparatory to Caearian delivery.
Each group in the above formulae (1) and (2) includes specifically the following groups.
The "alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 12 carbon atoms, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy,
decyloxy, undecyloxy, dodecyloxy, and the like.
The "lower alkyl" includes a straight chain or
branched chain alkyl group having 1 to 6 carbon atoms, for example, methyl, ethyl, propyl, isopropyl, butyl, tertbutyl, pentyl, hexyl, and the like.
The "halogen atom" includes fluorine atom, chlorine atom, bromine atom and iodine atome.
The "amino having optionally one or two
substituents selected from a lower alkanoyl, a lower alkyl and benzoyl" includes an amino having optionally one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms and benzoyl group, for example, amino, methylamino, ethylamino, propylamino, isopropylamino, butylamino, tert-butylamino, pentylamino, hexylamino, dimethylamino, diethylamino, dipropylamino, dibutylamino, dipentylamino, dihexylamino, N-methyl-N-ethylamino, N-ethyl-N-propylamino, N-methyl-N-butylamino, N-methyl-N-hexylamino, N-methyl-N-acetylamino, N-acetylamino, N-formylamino, N-propionylamino, N-butyrylamino, N-isobutyrylamino, N-pentanoylamino, N-tert-butylcarbonylamino, N-hexanoylamino, N-ethyl-N-acetylamino, benzoylamino, N-methyl-N-benzoylamino, N-ethyl-N-benzoylamino, and the like.
The "amino having optionally one or two
substituents selected from a lower alkanoyl and a lower alkyl" includes an amino having optionally one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for
example, amino, methylamino, ethylamino, propylamino,
isopropylamino, butylamino, tert-butylamino, pentylamino, hexylamino, dimethylamino, diethylamino, dipropylamino, dibutylamino, dipentylamino, dihexylamino, N-methyl-N-ethylamino, N-ethyl-N-propylamino, N-methyl-N-butylamino, N-methyl-N-hexylamino, N-methyl-N-acetylamino, N-acetylamino, N-formylamino, N-propionylamino, N-butyrylamino, N-isobutyrylamino, N-pentanoylamino, N-tert-butylcarbonylamino, N-hexanoylamino, N-ethyl-N-acetylamino, and the like.
The "phenyl(lower)alkyl" includes a phenylalkyl group wherein the alkyl moiety is a straight chain or
branched chain alkyl group having 1 to 6 carbon atoms, for example, benzyl, 2-phenylethyl, 1-phenylethyl, 3-phenylpropyl, 4-phenylbutyl, 5-phenylpentyl, 6-phenylhexyl, 1,1-dimethyl-2-phenylethyl, 2-methyl-3-phenylpropyl, and the like.
The "amino having optionally one or two
substituents selected from a lower alkyl, phenyl and a phenyl(lower)alkyl" includes an amino having optionally one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, phenyl and a phenylalkyl wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, amino, phenylamino, diphenylamino, methylamino, ethylamino, propylamino, isopropylamino, butylamino, tert-butylamino, pentylamino, hexylamino, dimethylamino, diethylamino, dipropylamino, dibutylamino, dipentylamino, dihexylamino, N-methyl-N-ethylamino, N-ethyl-N-propylamino, N-
methyl-N-butylamino, N-methyl-N-hexylamino, N-methyl-N-phenylamino, N-ethyl-N-phenylamino, N-benzylamino, N-(2-phenylethyl)amino, N-(1-phenylethyl)amino, N-(3-phenylpropyl)amino, N-(4-phenylbutyl)amino, N-(5-phenylpentyl)amino, N-(6-phenylhexyl)amino, N-(1,1-dimethyl-2-phenylethyl)amino, N-(2-methyl-3-phenylpropyl)amino, N-methyl-N-benzylamino, N-ethyl-N-benzylamino, N-phenyl-N-benzylamino, and the like.
The "alkoxy which has one or two substituents selected from hydroxy, a lower alkanoyloxy, a tri(lower)alkylammonium, a lower alkoxy, and a group of the formula: -NR14R15" includes an alkoxy group having 1 to 10 carbon atoms which has one or two substituents selected from hydroxy, a straight chain or branched chain alkanoyloxy having 1 to 6 carbon atoms, a trialkylammonium group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, and a group of the formula: -NR14R15 [wherein R14 and R15 are the same or different and are each hydrogen atom, a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, a hydroxy-substituted alkyl group wherein the alkyl moiety is a strainght chain or branched chain alkyl group having 1 to 6 carbon atoms, a tetrahydropyranylalkyl group wherein the alkyl moiety is straight chain or branched chain alkyl group having 1 to 6 carbon atoms, phenyl, a phenylalkyl (wherein the alkyl
moiety is straight chain or branched chain alkyl group having 1 to 6 carbon atoms which may optionally be
substituted by hydroxy and the phenyl ring may optionally be substituted by one to three of straight chain or branched chain alkoxy group having 1 to 6 carbon atoms), or a
pyridylalkyl wherein the alkyl moiety is straight chain or branched chain alkyl group having 1 to 6 carbon atoms, or R14 and R15 may bind with the nitrogen atom to which they bond to form a 5- or 6-membered, saturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom (wherein the heterocyclic group may
optionally be substituted by one to three substituents selected from carbamoyl, a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a phenylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, phenyl and a hydroxy-substituted alkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms)], for example, hydroxymethoxy, 2-hydroxyethoxy, 1-hydroxyethoxy, 3-hydroxypropoxy, 2,3-dihydroxyethoxy, 4-hydroxybutoxy, 3,4-dihydroxybutoxy, 1,1-dimethyl2-hydroxyethoxy, 5,6-dihydroxyhexyloxy, 5-hydroxypentyloxy, 6-hydroxyhexyloxy, 7-hydroxyheptyloxy, 8-hydroxyoctyloxy, 9-hydroxynonyloxy, 10-hydroxydecyloxy, 6-(3,4-dimethoxybenzylamino)-5-hydroxyhexyloxy, 6-( 3-methoxybenzylamino)-5-hydroxyhexyloxy, 6-[2-(2-pyridyl)ethylamino]-5-hydroxyhexyloxy, 6-[N-methyl-N-(2-pyridylethyl)amino]-5-hydroxyhexyloxy, 6-{N-ethyl-N-2-(2-pyridylethyl)amino}-5-hydroxy
hexyloxy, 6-[N-ethyl-N-(4-pyridylmethyl)amino]-5-hydroxyhexyloxy, 6-(3-pyridylmethylamino)-5-hydroxyhexyloxy, 6-(2-pyridylmethylamino)-5-hydroxyhexyloxy, 6-(diethyl,methylammonium)-5-methoxyhexyloxy, 4-(trimethylammonium)-3-hydroxyhexyloxy, 5-(dipropyl,ethylammonium)-4-acetyloxypentyloxy, 7-(2-ethoxybenzylamino)-6-acetyloxyheptyloxy, 8-(3,4,5-trimethoxybenzylamino)-7-ethoxyoctyloxy, 5-[3-(2-pyridyl)propyl]-4-acetyloxypentyloxy, 7-[4-(3-pyridyl)butyl]-6-propoxyheptyloxy, 2-methyl-3-hydroxypropoxy, aminomethoxy, 1-aminoethoxy, 2-aminoethoxy, 3-aminopropoxy, 4-aminobutoxy, 5-aminopentyloxy, 6-aminohexyloxy, 1,1-dimethyl-2-aminoethoxy, 2-methyl-3-aminopropoxy, methylaminomethoxy, ethylaminomethoxy, propylaminomethoxy, isopropylaminomethoxy, butylaminomethoxy, tert-butylaminomethoxy, pentylaminomethoxy, hexylaminomethoxy, dimethylaminomethoxy, diethylaminomethoxy, dipropylaminomethoxy, dibutylaminomethoxy, dipentylaminomethoxy,
dihexylaminomethoxy, N-methyl-N-ethylaminomethoxy, N-methylN-propylaminomethoxy, N-methyl-N-butylaminomethoxy, N-methyl-N-hexylaminomethoxy, 1-methylaminoethoxy, 2-ethylaminoethoxy, 3-propylaminopropoxy, 4-butylaminobutoxy, 1,1-dimethyl-2-pentylaminoethoxy, 5-hexylaminopentyloxy, 6-dimethylaminohexyloxy, 7-methylaminoheptyloxy, 8-dimethylaminooctyloxy, 4-dimethylaminobutoxy, 2-diethylaminoethoxy, 1-(N-methyl-N-hexylamino)ethoxy, 3-dihexylaminopropoxy, 6-diethylaminohexyloxy, 4-dibutylaminobutoxy, 9-(N-methyl-N-propylamino)nonyloxy, 2-(N-methyl-N-pentylamino)ethoxy, 7-hydroxy-8-dimethylaminooctyloxy, 2-hydroxy-3-diethylamino
propoxy, 7-hydroxy-8-diethylaminooctyloxy, 2-hydroxy-3-(N-phenyl-N-benzylamino)propoxy, 7-hydroxy-8-ethylaminooctyloxy, 3-hydroxy-4-methylaminobutoxy, 5-hydroxy-6-diethylaminohexyloxy, 3-hydroxy-4-phenylaminobutoxy, 8-hydroxy-9-dimethylaminononyloxy, 4-hydroxy-5-dimethylaminopentyloxy, 9-hydroxy-10-diethylaminodecyloxy, 4-hydroxy-5-methylaminopentyloxy, 4-hydroxy-5-diethylaminopentyloxy, phenylaminomethoxy, diphenylaminomethoxy, benzylaminomethoxy, 5-hydroxy-6-benzylaminohexyloxy, 5-hydroxy-6-[N-methyl-N-(2-phenylethyl)amino]hexyloxy, 5-hydroxy-6-ethylaminohexyloxy, 5-hydroxy-6-isopropylaminohexyloxy, 5-hydroxy-6-(N-methyl-N-benzylamino)hexyloxy, 5-hydroxy-6-aminohexyloxy, (N-methyl-N-benzylamino)methoxy, (N-ethyl-N-benzylamino)methoxy, (N-phenyl-N-benzylamino)methoxy, 2-(phenylamino)ethoxy, 3-(2-phentylethylamino)propoxy, 4-(3-phenylpropylamino)butoxy, 1,1-dimethyl-2-(4-phenylbutylamino)ethoxy, 5-(5-phenylpentylamino)pentyloxy, 6-(6-phenylhexylamino)hexyloxy, 7-hydroxy-8-(N-phenyl-N-benzylamino)octyloxy, 8-hydroxy-9-[N-(2-phenylethyl)amino]nonyloxy, 9-hydroxy-10-(N-ethyl-N-benzylamino)decyloxy, acetyloxymethoxy, 2-propionyloxyethoxy, 1-butyryloxyethoxy, 3-acetyloxypropoxy, 4-isobutyryloxybutoxy, 5-pentanoyloxypentyloxy, 6-tert-butylcarbonyloxyhexyloxy, 1,1-dimethyl-2-hexanoyloxyethoxy, 2-methyl-3-acetyloxypropoxy, 7-acetyloxyheptyloxy, 8-acetyloxyoctyloxy, 9-acetyloxynonyloxy, 10acetyloxydecyloxy, (hydroxymethyl)aminomethoxy, 1-[N,N-di(2-hydroxyethyl)amino]ethoxy, 2-(3-hydroxypropyl)aminoethoxy, 3-(4-hydroxybutyl)aminopropoxy, 4-(5-hydroxypentyl)
aminobutoxy, 5-(6-hydroxyhexyl)aminopentyloxy, 6-[N-(2-hydroxyethyl)-N-methylamino]hexyloxy, 5-hydroxy-6-[N-(2-hydroxyethyl)-N-methylamino]hexyloxy, 5-hydroxy-6-[N,N-di(2-hydroxyethyl)amino]hexyloxy, 6-hydroxy-7-[N-(2-hydroxyethyl)-N-benzylamino]heptyloxy, 7-hdroxy-8-[N-(3-hydroxypropyl)-N-phenylamino]octyloxy, 7-hydroxy-9-{N-(4-hydroxybutyl)-N-[(tetrahydropyranyl-2-yl)methyl]amino}nonyloxy, 8-hydroxy-10-[N-(2-hydroxyethyl)-N-acetylamino]decyloxy, acetylaminomethoxy, 2-(formylamino)ethoxy, 1-(propionylamino)ethoxy, 3-(butyrylamino)propoxy, 4-(isobutyrylamino)butyloxy, 5-(pentanoylamino)pentyloxy, 6-(hexanoylamino)hexyloxy, 5-acetyloxy-6-acetylaminohexyloxy, 5-hydroxy-6-acetylaminohexyloxy, 6-hydroxy-7-(N-methyl-N-acetylamino)heptyloxy, 7-hydroxy-8-(N-benzyl-N-acetylamino)octyloxy, 8-hydroxy-9-(N-phenyl-N-acetylamino)nonyloxy, 9-acetyloxy-10-[N-(tetrahydro-2-pyranylmethyl)-N-acetylamino]decyloxy, (tetrahydro-2-pyranyl)methylaminomethoxy, 2-(tetrahydro-3-pyranylmethylamino)ethoxy, 1-(tetrahydro-4-pyranylmethylamino)ethoxy, 3-[2-(tetrahydro-2-pyranyl)ethylamino]propoxy, 4-[3-(tetrahydro-2-pyranyl)propylamino]butoxy, 5-[4-(tetrahydro-2-pyranyl)butylamino]pentyloxy, 5-hydroxy-6-[N-ethyl-N-tetrahydro-2-pyranylmethylamino]hexyloxy, 6-hydroxy-7-{N-phenyl-N-[5-(tetrahydro-2-pyranyl)pentylamino}heptyloxy, 7-hydroxy-8-{N-benzyl-N-[6-(tetrahydro2-pyranyl)hexylamino}octyloxy, (2-hydroxy-2-phenylethyl)aminomethoxy, 2-[(3-hydroxy-3-phenylpropyl)amino]ethoxy, 3-[(2-hydroxy-4-phenylbutyl)amino]propoxy, 4-[(6-hydroxy-6-phenylhexyl)amino]butoxy, 5-[(2-hydroxy-2-phenylethyl)amino]pentyloxy,
5-hydroxy-6-[(2-hydroxy-2-phenylethyl)amino]hexyloxy, 6-hydroxy-7-[N-(2-hydroxy-2-phenylethyl)-N-methylamino]heptyloxy, 7-hydroxy-8-[N-(2-hydroxy-2-phenylethyl)-N-phenylamino]octyloxy, 8-hydroxy-9-[N-(2-hydroxy-2-phenylethyl)-N-benzylamino]nonyloxy, 9-hydroxy-10-[N-(2-hydroxy-2-phenylethyl)-N-acetylamino]decyloxy, (piperazin-1-yl)methoxy, 2-(pyrrolidin-1-yl)ethoxy, 3-(piperidin-1-yl)propoxy, 4-morpholinobutoxy, 5-thiomorpholinopentyloxy, 6-(piperazin-1-yl)hexyloxy, 5-hydroxy-6-(4-benzyl-1-piperazinyl)hexyloxy, 5-hydroxy-6-(1-piperazinyl)hexyloxy, 5-hydroxy-6-(4-methyl-1-piperazinyl)hexyloxy, 4-hydroxy-5-(1-pyrrolidinyl)pentyloxy, 4-hydroxy-5-(1-piperidinyl)pentyloxy, 4-hydroxy-5-morpholinopentyloxy, 5-hydroxy-6-(1-pyrrolidinyl)hexyloxy, 5-hydroxy-6-(1-piperidinyl)hexyloxy, 5-hydroxy-6-(4-phenyl-1-piperazinyl)hexyloxy, 5-hydroxy-6-(2-carbamoyl-1-pyrrolidinyl)hexyloxy, 7-hydroxy-8-(1-pyrrolidinyl)octyloxy, 5-hydroxy-6-(2-hydroxymethyl-1-pyrrolidinyl)hexyloxy, 7-(2-carbamoylmorpholino)-6-hydroxyheptyloxy, 8-hydroxy-9-(4-benzyl-1-piperazinyl)nonyloxy, 4-(3-carbamoyl-1-piperidinyl)-3-hydroxybutoxy, 9-hydroxy-10-(4-ethyl-1-piperazinyl)decyloxy, 6-(4-carbamoyl-1-piperazinyl)-5-hydroxyhexyloxy, and the like.
The "carboxy-substituted alkoxy" includes a carboxy-substituted alkoxy group wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 12 carbon atoms, for example, carboxymethoxy, 2-carboxyethoxy, 1-carboxyethoxy, 3-carboxypropoxy, 4-carboxybutoxy, 5-carboxypentyloxy, 6-carboxyhexyloxy, 1,1-dimethyl-2-
carboxyethoxy, 2-methyl-3-carboxypropoxy, 7-carboxyheptyloxy, 8-carboxyoctyloxy, 9-carboxynonyloxy, 10-carboxydecyloxy, 11-carboxyundecyloxy, 12-carboxydodecyloxy, and the like.
The "lower alkoxycarbonyl-substituted alkoxy" includes an alkoxycarbonyl-substituted straight chain or branched chain alkoxy group having 1 to 12 carbon atoms wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, methoxycarbonylmethoxy, 3-methoxycarbonylpropoxy, ethoxycarbonylmethoxy, 3-ethoxycarbonylpropoxy, 4-ethoxycarbonylbutoxy, 5-isopropoxycarbonylpentyloxy, 6-propoxycarbonylhexyloxy, 1,1-d-methyl-2-butoxycarbonylethoxy, 2-methyl-3-tert-butoxycarbonylpropoxy, 2-pentyloxycarbonylethoxy, hexyloxycarbonylmethoxy, 7-methoxycarbonylheptyloxy, 8-ethoxycarbonyloctyloxy, 9-propoxycarbonylnonyloxy, 10-butoxycarbonyldecyloxy, 11-methoxycarbonylundecyloxy, 12-ethoxycarbonyldodecyloxy, and the like.
The "lower alkanoyloxy-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by a
straight chain or branched chain alkanoyloxy group having 2 to 6 carbon atoms, for example, acetyloxymethoxy, 2-propionyloxyethoxy, 1-butyryloxyethoxy, 4-acetyloxybutoxy, 3-acetyloxypropoxy, 4-isobutyryloxybutoxy, 5-pentanoyloxypentyloxy, 6-acetyloxyhexyloxy, 6-tert-butylcarbonyloxyhexyloxy, 1,1-di-ethyl-2-hexanoyloxyethoxy, 2-methyl-3-
acetyloxypropoxy, and the like.
The "lower alkenyloxy-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by a
straight chain or branched chain alkenyloxy group having 2 to 6 carbon atoms, for example, vinyloxymethoxy, 2-allyloxyethoxy, 1-(2-butenyloxy)ethoxy, 3-allyloxypropoxy, 4-(3-butenyloxy)butoxy, 5-(1-methylallyloxy)pentyloxy, 6-(2-pentenyloxy)hexyloxy, 1,1-dimethyl-2-(2-hexenyloxy)ethoxy, 2-methyl-3-allyloxypropoxy, and the like.
The "lower alkoxy(lower)alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, methoxymethoxy, 3-methoxypropoxy, 4-ethoxybutoxy, 6-propoxyhexyloxy, 5-isopropoxypentyloxy, 1,1-dimethyl-2-butoxyethoxy, 2-methyl-3-tert-butoxypropoxy, 2-pentyloxyethoxy, hexyloxymethoxy, and the like.
The "lower alkylsulfonyloxy-substi tuted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by a straight chain or branched chain alkylsulfonyloxy group having 1 to 6 carbon atoms, for example, methylsulfonyloxymethoxy, 3-methylsulfonyloxypropoxy, 4-ethylsulfonyloxybutoxy, 2-methylsulfoyloxyethoxy, 6-propylsulfonyloxyhexyloxy, 5-isopropylsulfonyloxypentyloxy, 1,1-dimethyl-2-butylsulfonyloxyethoxy, 2-methyl-3-methlsulfonyloxypropoxy, and the like.
The "benzoyloxy-substituted lower alkoxy" includes a benzoyloxyalkoxy group wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, benzoyloxymethoxy, 2-benzoyloxyethoxy, 1-benzoyloxyethoxy, 3-benzoyloxypropoxy, 4-benzoyloxybutoxy, 6-benzoyloxyhexyloxy, 5-benzoyloxypentyloxy, 1,1-dimethyl-2-benzoyloxyethoxy, 2-methyl-3-benzoyloxypropoxy, and the like.
The "tricyclo[3.3.1.1]decanyl-substituted lower alkoxy" includes a tricyclo[3.3.1.1]decanyl-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, tricyclo[3.3.1.1]decanylmethoxy, 2-tricyclo[3.3.1.1]decanylethoxy, 1-tricyclo[3.3.1.1]decanylethoxy, 3-tricyclo[3.3.1.1]decanylpropoxy, 4-tricyclo[3.3.1.1]decanylbutoxy, 5-tricyclo[3.3.1.1] decanylpentyloxy, 6-tricyclo[3.3.1.1]decanylhexyloxy, 1,1-dimethyl2-tricyclo[3.3.1.1]decanylethoxy, 2-methyl-3-tricyclo[3.3.1.1]decanylpropoxy, and the like.
The "lower alkylene" includes a straight chain or branched chain alkylene group having 1 to 6 carbon atoms, for example, methylene, ethylene, trimethylene, 2-methyltrimethylene, 2,2-dimethyltrimethylene, 1-methyltrimethylene, methylmethylene, ethylmethylene, tetramethylene, pentamethylene, hexamethylene, and the like.
The "lower alkanoyl" includes a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, formyl, acetyl, propionyl, butyryl, isobutyryl, pentanoyl, tert-butylcarbonyl, hexanolyl, and the like.
The "amino having optionally one or two substituents selected from a lower alkyl, a lower alkanoyl and a phenyl(lower)alkoxycarbonyl" includes an amino having optionally one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms and a phenylalkoxycarbonyl group wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, amino, methylamino, ethylamino, propylamino, isopropylamino, butylamino, tert-butylamino, pentylamino, hexylamino, dimethylamino, diethylamino, dipropylamino, dibutylamino, dipentylamino, dihexylamino, N-methyl-N-ethylamino, N-ethyl-N-propylamino, N-methyl-N-butylamino, N-methyl-N-hexylamino, N-benzyloxycarbonylamino, N-(2-phenylethoxycarbonyl)amino, N-(1-phenylethoxycarbonyl)amino, N-(3-phenylpropoxy¬carbonyl)amino, N-(4-phenylbutoxycarbonyl)amino, N-(5-phenylpentyloxycarbonyl)amino, N- (6-phenylhexyloxycarbonyl)amino, N-(1,1-dimethyl-2-phenylethoxycarbonyl)amino, N-(2-methyl-3-phenylpropoxycarbonyl)amino, N-methyl-N-benzyloxycarbonylamino, N-ethyl-N-benzyloxycarbonylamino, acetylamino, formylamino, propionylamino, butyrylamino, isobutyrylamino, pentanoylamino, tert-butylcarbonylamino, hexanoylamino, N-methyl-N-acetylamino, N-ethyl-N-acetylamino, N-benzyloxycarbonyl-N-acetylamino, and the like.
The "benzoyl wherein the phenyl ring may optionally has a substituent selected from nitro and an amino having optionally one or two substituents selected from a lower
alkyl, a lower alkanoyl and a phenyl(lower)alkoxycarbonyl" includes a benzoyl group wherein the phenyl ring may
optionally have one to three substituents selected from nitro and an amino optionally having one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms and a phenylalkoxycarbonyl group wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, benzoyl, 2-aminobenzoyl, 4-aminobenzoyl, 4-methylaminobenzoyl, 3-ethylaminobenzoyl, 2-(N-methyl-N-ethylamino)benzoyl, 3-(N-methyl-N-hexylamino)benzoyl, 4-dimethylaminobenzoyl, 4-dipentylaminobenzoyl, 2-isopropylaminobenzoyl, 3-butylaminobenzoyl, 4-(N-methyl-N- benzyloxycarbonylamino)benzoyl, 2-[N-(2-phenylethoxycarbonyl)amino]benzoyl, 2,3-bis(dimethylamino)benzoyl, 3,4-bis(methylamino)benzoyl, 3,4,5-tri(methylamino)benzoyl, 2,6-di(N-methyl-N-benzyloxycarbonylamino)benzoyl, 3-[N-(3-phenylpropoxycarbonyl)amino]benzoyl, 4-[N-(5-phenylpentyloxycarbonyl)amino]benzoyl, 2-[N-(6-phenylhexyloxycarbonyl)amino]benzoyl, 3-[N[(4-phenylbutoxycarbonyl)amino]benzoyl, 4-acetylaminobenzoyl, 3-(N-methyl-N-acetylamino)benzoyl, 2-(N-benzyloxycarbonyl-N-acetylamino)benzoyl, 4-nitrobenzoyl, 4-nitro-3-methylaminobenzoyl, 2,4-dinitrobenzoyl, 2,4,6-trinitrobenzoyl, and the like.
The "lower alkoxycarbonyl" includes a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms in the alkoxy moiety, for example, methoxy-
carbonyl, ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, butoxycarbonyl, tert-butoxycarbonyl, pentyloxycarbonyl, hexyloxycarbonyl, and the like.
The "lower alkoxycarbonyl(lower)alkyl" includes a straight chain or branched chain alkoxycarbonylalkyl group having 1 to 6 carbon atoms in the alkoxy moiety wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, methoxycarbonylmethyl, 3-methoxycarbonylpropyl, 3-ethoxycarbonylpropyl, ethoxycarbonylmethyl, 4-ethoxycarbonylbutyl, 1-ethoxycarbonylethyl, 1-methoxycarbonylethyl, 6-propoxycarbonylhexyl, 5-isopropoxycarbonylpentyl, 1,1-dimethyl-2-butoxycarbonylethyl, 2-methyl-3-tert-butoxycarbonylpropyl, 2-pentyloxycarbonylethyl, hexyloxycarbonylmethyl, and the like.
The "amido having optionally a lower alkyl substituent" includes an amido having optionally one or two substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, carbamoyl, methylamido, ethylamido, propylamido, isopropylamido, butylamido, tert-butylamido, pentylamido, hexylamido, dimethylamido, diethylamido, dipropylamido, dibutylamido, dipentylamido, dihexylamido, N-methyl-N-ethylamido, N-ethyl-N-propylamido, N-methyl-N-butylamido, N-methyl-N-hexylarnido, and the like.
The "lower alkylsulfonyl" includes a straight chain or branched chain alkylsulfonyl group having 1 to 6 carbon atoms, for example, methylsulfonyl, ethylsulfonyl, propyl
sulfonyl, isopropylsulfonyl, butylsulfonyl, tert-butylsulfonyl, pentylsulfonyl, hexylsulfonyl, and the like.
The "5- or 6-membered, saturated or unsaturated heterocyclic group which is formed by binding the groups R4 and R5 together with the nitrogen atom to which they bond and may be intervened or not with nitrogen, oxygen or sulfur atom" includes, for example, pyrrolidinyl, piperidinyl, piperazinyl, morpholino, thiomorpholino, pyrrolyl,
pyrazolyl, imidazolyl, imidazolidinyl, 1,2,4-triazolyl, 1,2,3,4-tetrazolyl, pyrrolinyl, imidazolinyl, pyrazolinyl, pyrazolidinyl, oxazolinyl, oxazolidinyl, isoxazolinyl, isoxazolidinyl, thiazolinyl, thiazolidinyl, isothiazolinyl, isothiazolidinyl, and the like.
The "phenyl which may optionally have a substituent selected from a lower alkoxy and a halogen atom" includes a phenyl group which may optionally have one to three
substituents selected from a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms and a halogen atom, for example, phenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 2-ethoxyphenyl, 3-ethoxyphenyl, 4-ethoxyphenyl, 4-isopropoxyphenyl, 4-pentyloxyphenyl, 2,4-dimethoxyphenyl, 4-hexyloxyphenyl, 3 , 4-dimethoxyphenyl, 3-ethoxy-4-methoxyphenyl, 2,3-dimethoxyphenyl, 3 , 4-diethoxyphenyl, 2,5-dimethoxyphenyl, 2,6-dimethoxyphenyl, 3,5dimethoxyphenyl, 3,4-dipentyloxyphenyl, 3,4,5-trimethoxyphenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2-iodophenyl, 3-iodophenyl, 4-
iodophenyl, 3,4-dichlorophenyl, 3,5-dichlorophenyl, 2,6-dichlorophenyl, 2,3-dichlorophenyl, 2,4-dichlorophenyl, 3,4-difluorophenyl, 3,5-dibromophenyl, 3,4,5-trichlorophenyl, 2-methoxy-3-chlorophenyl, and the like.
The "heterocyclic group which is substituted by a member selected from a phenyl having optionally a
subsitutent selected from a lower alkoxy and a halogen atom, oxo, hydroxy, a lower alkenyl, carboxy, a phenyl(lower)alkyl having optionally a hydroxy substituent on the lower alkyl moiety, a lower alkanoyl, a lower alkyl having optionally a hydroxy substituent, benzoyl, an amido having optionally a lower alkyl substituent, anilinocarbonyl, a benzoyl(lower)alkyl, a lower alkylsulfonyl, piperidinyl, pyrimidinyl, pyridyl, and a lower alkoxycarbonyl" includes the above-mentioned heterocyclic groups which is substituted by one to three substituents selected from a phenyl having optionally one to three subsitutents selected from a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms and a halogen atom, an oxo group, a hydroxy group, a straight chain or branched chain alkenyl group having 2 to 6 carbon atoms, carboxy, a phenylalkyl wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and having optionally a hydroxy substituent, a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and having optionally one to three hydroxy substituents, benzoyl, an amido croup having optionally one or two substituents of a straight
chain or branched chain alkyl group having 1 to 6 carbon atoms, anilinocarbonyl, a benzoylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkylsulfonyl group having 1 to 6 carbon atoms in the alkyl moiety , piper idinyl , pyr imidinyl , pyr idyl , and a st raight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, 4-phenylpiperazinyl, 4-(4-methoxyphenyl)piperazinyl, 4-(4-chlorophenyl)piperazinyl, 3-(2-ethoxyphenyl)pyrrolidinyl, 2-(4-isopropoxyphenyl)pyrrolidinyl, 4-(4-pentyloxyphenyl)piperidinyl, 3-(4-hexyloxyphenyl)piperidinyl, 3-(2,3-dimethoxyphenyl)morpholino, 2-(2-methoxyphenyl)morpholino, 3-(3-ethoxyphenyl)thiomorpholino, 2-(3,4,5-trimethoxyphenyl)thiomorpholino, 4-(3,4-dimethoxyphenyl)piperazinyl, 4-(3,4,5-trimethoxyphenyl)piperazinyl, 3-(2-fluorophenyl)pyrrolidinyl, 2-(3-bromophenyl)pyrrolidinyl, 4-(3-iodophenyl)piperidinyl, 3-(4-bromophenyl)piperidinyl, 2-(3,4-dichlorophenyl)morpholino, 3-(3-chlorophenyl)morpholino, 3-(2-bromophenyl)thiomorpholino, 2-(4-fluorophenyl)thiomorpholino, 4-(3,4,5-trichlorophenyl)piperazinyl, 4-(2,6- dichlorophenyl)piperazinyl, 4-benzylpiperazinyl, 3-(2-phenylethyl)pyrrolidinyl, 2-(3-phenylpropyl)pyrrolidinyl, 4-(4-phenylbutyl)piperidinyl, 3-(5-phenylpentyl)morpholino, 2-(6-phenylhexyl)thiomorpholino, 4-(2-phenyl-2-hydroxyethyl)piperazinyl, 3-(1-hydroxy-1-phenylmethyl)pyrrolidinyl, 2-(3-hydroxy-3-phenylpropyl)pyrrolidinyl, 4-(2-hydroxy-4-phenylbutyl)piperidinyl, 2-( 5-hydroxy-5-phenylpentyl)thio
morpholino, 3-(6-hydroxy-6-phenylhexyl)morpholino, 4-acetylpiperazinyl, 3-formylpyrrolidinyl, 2-propionylpyrrolidinyl, 4-butyrylpiperidinyl, 3-pentanoylthiomorpholino, 2-hexanoylmorpholino, 4-methylpiperazinyl, 3,4-dimethylpiperazinyl, 3-ethylpyrrolidinyl, 2-propylpyrrolidinyl, 3,4,5-trimethylpiperidinyl, 4-butylpiperidinyl, 3-pentylmorpholino, 2-hexylthiomorpholino, 4-benzoylpiperazinyl, 3-benzoylpyrrolidinyl, 3-benzoylmorpholino, 2-benzoylthiomorpholino, 3-benzoylpiperidinyl, 4-anilinocarbonylpiperazinyl, 2-anilinocarbonylpyrrolidinyl, 3-anilinocarbonylpiperidinyl, 2-anilinocarbonylmorpholino, 3-ani1inocarbonylthiomorpholino, 4-(benzoylmethyl)piperazinyl, 3-(1-benzoylethyl)pyrrolidinyl, 2-(3-benzoylpropyl)pyrrolidinyl, 4-(4-benzoylbutyl)piperidinyl, 3-(5-benzoylpentyl)morpholino, 2-(6-benzoylhexyl)thiomorpholino, 3-methyl-4-benzoylpiperazinyl, 3-ethyl-4-acetylpiperidinyl, 3-methyl-4-benzylpyrrolidinyl, 3-propyl-4-anilinocarbonylpyrrolidinyl, 3-methyl-5-(benzoylmethyl)morpholino, 3-methyl-5-(2-phenyl-2-hydroxyethyl)thiomorpholino, 4-methylsulfonylpiperazinyl, 4-methoxycarbonylpiperazinyl, 3-ethylsulfonylpyrrolidinyl, 3-ethoxycarbonylpyrrolidinyl, 4-propylsulfonylpiperidinyl, 3-propoxycarbonylpiperidinyl, 3-butylsulfonylmorpholino, 2-pentyloxycarbonylmorpholino, 2-hexylsulfonylthiomorpholino, 3-hexyloxycarbonylthiomorpholino, 4-allylpiperazinyl, 4-ethoxycarbonylpiperidinyl, 4-carboxypiperidinyl, 4-dimethylamidopiperidinyl, 4-carbamoylpiperidinyl, 4-(1-piperidinyl)piperidinyl, 3-hydroxypiperidinyl, 2-carbamoylpyrrolidinyl, 2-hydroxy
methylpiperidinyl, 2-hydroxymethylpyrrolidinyl, 3-hydroxymethylpiperidinyl, 3-hydroxypyrrolidinyl, 4-(2-hydroxyethyl)piperidinyl, 2-methoxycarbonylpyrrolidinyl, 2-(2-hydroxyethyl)piperidinyl, (2-pyrimidyl)piperazinyl, (2-pyridyl)piperazinyl, 4-oxothiomorpholino, 4,4-dioxothiomorpholino, 2-methylimidazolyl, 3-methyl-1,2,4-triazolyl, 5-methyl-1,2,3,4-tetrazolyl, 4-hydroxymethylimidazolyl, 3- allyl-1,2,4-triazolyl, 5-phenyl-1,2,3,4-tetrazolyl, 3-carboxypyrrolyl, 2-hydroxyoxazolidinyl, 2-carbamoylthiazolidinyl, and the like.
The "phenyl(lower)alkyl having optionally a hydroxy-substituent on the alkyl moiety and having
optionally a lower alkoxy substituent on the phenyl ring" includes a phenylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and having optionally a hydroxy-substituent and the phenyl ring has optionally one to three substituents of a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, in addition to the abovementioned phenyl(lower)alkyl groups, 1-hydroxy-1-phenylmethyl, 1-phenyl-2-hydroxyethyl, 2-phenyl-2-hydroxyethyl, 3-hydroxy-3-phenylpropyl, 2-hydroxy-4-phenylbutyl, 6-hydroxy6-phenylhexyl, 3,4-dimethoxybenzyl, 3-methoxybenzyl, 1-(2-methoxyphenyl)ethyl, 2-(4-methoxyphenyl)ethyl, 3-(2-ethoxyphenyl)propyl, 4-(3-ethoxyphenyl)butyl, 5-(4-ethoxyphenyl)pentyl, 6-(4-isopropoxyphenyl)hexyl, 1,1-dimethyl-2-(4-pentyloxyphenyl)ethyl, 2-methyl-3-(4-hexyloxyphenyl)propyl, 3-ethoxy-4-methoxybenzyl, 2,3-dimethoxybenzyl, 3,4-diethoxy
benzyl, 3,4,5-trimethoxybenzyl, 1-hydroxy-1-(3-methoxyphenyl)methyl, 1-(2,5-dimethoxyphenyl)-2-hydroxyethyl, 2-(2,6-dimethoxyphenyl)-2-hydroxyethyl, 5-hydroxy-5-(3,4-dipentyloxyphenyl)pentyl, and the like.
The "benzoyl(lower)alkyl" includes a benzoylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, benzoylmethyl, 1-benzoylethyl, 2-benzoylethyl, 3- benzoylpropyl, 4-benzoylbutyl, 5-benzoylpentyl, 6-benzoylhexyl, 1,1-dimethyl-2-benzoylethyl, 2-methyl-3-benzoylpropyl, and the like.
The "carbamoyloxy-substituted lower alkoxy" includes a carbamoyloxy-substituted alkoxy group wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, carbamoyloxymethoxy, 2-carbamoyloxyethoxy, 1-carbamoyloxyethoxy, 3carbamoyloxypropoxy, 4-carbamoyloxybutoxy, 5-carbamoyloxypentyloxy, 6-carbamoyloxyhexyloxy, 1,1-dimethyl-2-carbamoyloxyethoxy, 2-methyl-3-carbamoyloxypropoxy, and the like.
The "lower alkylthio-substituted alkoxy" includes a alkylthio-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms wherein the
alkylthio moiety is a straight chain or branched chain alkylthio group having 1 to 6 carbon atoms, for example, methylthiomethoxy, 3-ethylthiopropoxy, 4-methylthiobutoxy, 2-methylthioethoxy, 6-propylthiohexyloxy, 5-isopropylthiopentylsxy, 1,1-dimethyl-2-butylthioethoxy, 2-methyl-3-methylthiopropoxy, and the like.
The "lower alkylsulfonyl-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by a
straight chain or branched chain alkylsulfonyl group having 1 to 6 carbon atoms, for example, methylsulfonylmethoxy, 3-ethylsulfonylpropoxy, 4-methylsulfonylbutoxy, 2-methylsulfonylethoxy, 6-propylsulfonylhexyloxy, 5-isopropylsulfonylpentyloxy, 1,1-dimethyl-2-butylsulfonylethoxy, 2-methyl-3-methylsulfonylpropoxy, and the like.
The "lower alkylsulfinyl-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by a
straight chain or branched chain alkylsulfinyl group having 1 to 6 carbon atoms, for example, methylsulfinylmethoxy, 3-ethylsulfinylpropoxy, 4-methylsulfinylbutoxy, 2-methylsulfinylethoxy, 6-propylsulfinylhexyloxy, 5-isopropylsulfinylpentyloxy, 1,1-dimethyl-2-butylsulfinylethoxy, 2-methyl-3-methylsulfinylpropoxy, and the like.
The "alkenyloxy" includes a straight chain or branched chain alkenyl group having 2 to 12 carbon atoms and containing one to three double bonds, for example, vinyloxy, allyloxy, 3-methyl-2-butenyloxy, 2-butenyloxy, 3-butenyloxy, 1-methylallyloxy, 2-pentenyloxy, 2-hexenyloxy, 1-heptenyloxy, 1-octenyloxy, 1-nonenyloxy, 1-decenyloxy, 1-undecenyloxy, 1-dodecenyloxy, 2-heptenyloxy, 3-heptenyloxy, 2-methyl4-heptenyloxy, 2-methyl-5-heptenyloxy, 4-methyl-2-heptenyloxy, 3-methyl-1-heptenyloxy, 1,3-heptadienyloxy, 1,4-heptadienyloxy, 1,5-heptadienyloxy, 1,6-heptadienyloxy, 2,4-
heptadienyloxy, 2-methyl-2,4-heptadienyloxy, 2,6-dimethyl-2,4-heptadienyloxy, 2,5-dimethyl-1,3-heptadienyloxy, 2,4,6-trimethyl-2,4-heptadienyloxy, 2-octenyloxy, 3-octenyloxy, 4-octenyloxy, 2-methyl-5-octenyloxy, 2-methyl-6-octenyloxy, 2-methyl-7-octenyloxy, 1,3-octadienyloxy, 1,4-octadienyloxy, 1,5-octadienyloxy, 1,6-octadienyloxy, 1,7-octadienyloxy, 2,4-octadienyloxy, 3,7-octadienyloxy, 4,8-dimethyl-3,7-octadienyloxy, 2,4,6-trimethyl-3,7-octadienyloxy, 3,4-dimethyl-2,5-octadi nyloxy, 3,7-dimethyl-2,6-octadienyloxy, 4,8-dimethyl-2,6-octadienyloxy, 2-nonenyloxy, 3-nonenyloxy, 4-nonenyloxy, 2-methyl-5-nonenyloxy, 2-methyl-6-nonenyloxy, 2-methyl-7-nonenyloxy, 2-methyl-8-nonenyloxy, 1,3-nonadienyloxy, 1,4-nonadienyloxy, 1,5-nonadienyloxy, 1,6-nonadienyloxy, 1,7-nonadienyloxy, 1,8-nonadienyloxy, 2,4-nonadienyloxy, 3,7-nonadienyloxy, 4,8-dimethyl-3,7-nonadienyloxy, 2,4,6-trimethyl-3,7-nonadienyloxy, 3,4-dimethyl-2,5- nonadienyloxy, 4,8-dimethyl-2,6-nonadienyloxy, 2-decenyloxy, 3-decenyloxy, 4-decenyloxy, 5-decenyloxy, 2-methyl-6-decenyloxy, 3-methyl-7-decenyloxy, 4-methyl-8-decenyioxy, 5-methyl-9-decenyloxy, 1,3-decadienyloxy, 1,4-decadienyloxy, 1,5-decadienyloxy, 1,6-decadienyloxy, 1,7-decadienyloxy, 1,8-decadienyloxy, 1,9-decadienyloxy, 2-methyl-2,4-decadienyloxy, 3-methyl-2,5-decadienyloxy, 4,8-dimethyl-2,6-decadienyloxy, 2,4,6-trimethyl-3,7-decadienyloxy, 2,9-dimethyl-3,7-decadienyloxy, 2-undecenyloxy, 3-uncecenyloxy, 4-undecenyloxy, 5-undecenyloxy, 2-methyl-6-undecenyloxy, 3-methyl-7-undecenyloxy, 4-methyl-8-undecenyloxy, 5-methyl-9-undecenyloxy, 2-methyl-10-undecenyloxy, 1,3-undecadienyloxy,
1,4-undecadienyloxy, 1,5-undecadienyloxy, 1,6-undecadienyloxy, 1,7-undecadienyloxy, 1,8-undecadienyloxy, 1,9-undecadienyloxy, 1,10-undecadienyloxy, 2-methyl-2,4-undecadienyloxy, 3-methyl-2,5-undecadienyloxy, 4,8-dimethyl-2,6-undecadienyloxy, 2,4,6-trimethyl-3,8-undecadienyloxy, 2,9-dimethyl-3,8-undecadienyloxy, 2-dodecenyloxy, 3-dodecenyloxy, 4-dodecenyloxy, 5-dodecenyloxy, 6-dodecenyloxy, 2-methyl-7-dodecenyloxy, 3-methyl-8-dodecenyloxy, 4-methyl-9-dodecenyloxy, 5-methyl-10-dodecenyloxy, 6-methyl-11-dodecenyloxy, 2-methyl-2,4-dodecadienyloxys , 3-methyl-2,5- dodecadienyloxy, 4,8-dimethyl-2,6-dodecadienyloxy, 2,4,6-trimethyl-2,7-dodecadienyloxy, 2,10-dimethyl-2,8-dodecadienyloxy, 2,5-dimethyl-3,7-dodecadienyloxy, 4,8,12-trimethyl-3,7,11-dodecatrienyloxy, 1,3,5-heptatrienyloxy,
2,4,6-octatrienyloxy, 1,3,6-nonatrienyloxy, 2,6,8-dodecatrienyloxy, 1,5,7-undecatrienyloxy, and the like.
The "lower alkanoyloxy" includes a straight chain or branched chain alkanoyloxy group having 1 to 6 carbon atoms, for example, formyloxy, acetyloxy, propionyloxy,
butyryloxy, isobutyryloxy, pentanoyloxy, tert-butylcarbonyloxy, hexanoyloxy, and the like.
The "lower alkylsulfonyloxy" includes a straight chain or branched chain alkylsulfonyloxy group having 1 to 6 carbon atoms, for example, methylsulfonyloxy, ethylsulfonyloxy, isopropylsulfonyloxy, butylsulfonyloxy, tert-butylsulfonyloxy, pentylsulfonyloxy, hexylsulfonyloxy, and the like.
The "lower alkynyloxy" includes a straight chain or branched chain alkynyloxy group having 2 to 6 carbon atoms,
for example, ethynyloxy, 2-propynyloxy, 2-butynyloxy, 3-butynyloxy, 1-methyl-2-propynyloxy, 2-pentynyloxy, 2-hexynyloxy, and the like.
The "phenyl (lower )alkoxy" includes a phenylalkoxy group wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, benzyloxy, 2-phenylethoxy, 1-phenylethoxy, 3-phenylpropoxy, 4-phenylbutoxy, 5-phenylpentyloxy, 6-phenylhexyloxy, 1,1-dimethyl-2-phenylethoxy, 2-methyl-3- phenylpropoxy, and the like.
The "cycloalkyloxy" includes a cycloalkyloxy group having 3 to 8 carbon atoms, for example, cyclopropyloxy, cyclopentyloxy, cyclohexyloxy, cycloheptyloxy, cyclooctyloxy, and the like.
The "cycloalkenyloxy" includes a cycloalkenyloxy group having 3 to 8 carbon atoms, for example, cyclopropenyloxy, cyclobutenyloxy, cyclopentenyloxy, cyclohexenyloxy, cycloheptenyloxy, cyclooctenyloxy, and the like.
The "lower alkanoyl which may optionally have one to three substituents of a halogen atom" includes a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms which may optionally have one to three substituents of a halogen atom, for example, in addition to the above mentioned lower alkanoyl groups, 2,2,2-trifluoroacetyl, 2,2 ,2-trichloroacetyl, 2-chloroacetyl, 2-bromoacetyl, 2-fluoroacetyl, 2-iodoacetyl, 2,2-difluoroacetyl, 2,2-dibromoacetyl, 3,3,3-trifluoropropionyl, 3,3,3-trichloropropionyl, 3-chloropropionyl, 2,3-dichlopropionyl, 4,4,4-trichloro
butyryl, 4-fluorobutyryl, 5-chloropentanoyl, 3-chloro-2-methylpropionyl, 6-bromohexanoyl, 5,6-dibromohexanoyl, and the like.
The "lower alkenyl" includes a straight chain or branched chain alkenyl group having 2 to 6 carbon atoms, for example, vinyl, allyl, 2-butenyl, 3-butenyl, 1-methylallyl, 2-pentenyl, 2-hexenyl, and the like.
The "lower alkylthio" includes a straight chain or branched chain alkylthio group having 1 to 6 carbon atoms, for example, methylthio, ethylthio, propylthio, isopropylthio, butylthio, tert-butylthio, pentylthio, hexylthio, and the like.
The "5- or 6-membered, saturated or unsaturated heterocyclic group which is formed by binding R6 and R7 together with the nitrogen atom to which they bond and may be intervened or not with nitrogen, oxygen or sulfur atom" includes, for example, pyrrolidinyl, piperidinyl, piperazinyl, morpholino, thiomorpholino, pyrrolyl, pyrazolyl, imidazolyl, imidazolidinyl, pyrrolyl, imidazolinyl, pyrazolinyl,
pyrazolidinyl, oxazolinyl, oxazolidinyl, isoxazolinyl,
isoxazolidinyl, thiazolinyl, thiazolidinyl, isothiazolinyl, isothiazolidinyl, and the like.
The "heterocyclic group having a substituent selected from a lower alkoxycarbonyl, lower alkyl, lower alkylthio and oxo" includes the above heterocyclic groups which have a substituent selected from a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkyl group having
1 to 6 carbon atoms, a straight chain or branched chain alkylthio group having 1 to 6 carbon atoms, and an oxo group, for example, 4-tert-butoxycarbonylpiperazinyl, 4methylpiperazinyl, 2-ethylthioimidazolyl, 2-oxopyrrolidinyl, 2-oxo-oxazolidinyl, 3-oxopiperazinyl, 4-methoxycarbonylpiperazinyl, 3-ethoxycarbonylpiperidinyl, 2-propoxycarbonylpyrrolidinyl, 3-pentyloxycarbonylthiomorpholino, 2-hexyloxycarbonylthiomorpholino, 3-ethoxycarbonylpyr rolyl, 3-methoxycarbonylimidazolyl, 3-ethylpiperidinyl, 3-propylpyrrolidinyl, 3-butylpyrrolyl, 2-pentylimidazolyl, 3-hexylmorpholino, 2-methylthiomorpholino, 2-methyloxazolidinyl, 2-ethylthiazolinyl, 3-methylisoxazolinyl, 2-methylthioimidazolyl, 2-propylthioimidazolinyl, 2-butylthioimidazolidinyl, 3-pentylthiopyrrolyl, 3-hexylthiopyrrolinyl, 3-methylthiopyrrolidinyl, 3-ethylthiomorpholino, 2-methylthiomorpholino, 2-methylthioisoxazolidinyl, and the like.
The "lower alkyl which may optionally have one to three substituents selected from a halogen atom, hydroxy, phenyl and a lower alkoxy" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which may optionally have one to three substituents selected from a halogen atom, hydroxy, phenyl and a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, in addition to the above-mentioned lower alkyl groups, hydroxymethyl, 2-hydroxyethyl, 1-hydroxyethyl, 3-hydroxypropyl, 2,3-dihyroxypropyl, 4-hydroxybutyl, 1,1-dimethyl-2-hydroxyethyl, 5 ,5,4-tri'hydroxypentyl, 5-hydroxypentyl, 6-hydroxyhexyl, 1-hydroxyisopropyl, 2-methyl-3-
hydroxypropyl, trifluoromethyl, trichloromethyl, chloromethyl, bromomethyl, fluoromethyl, iodomethyl, difluoromethyl, dibromomethyl, 2-chloroethyl, 2,2,2-trifluoroethyl, 2,2,2-trichloroethyl, 3-chloropropyl, 2,3-dichloropropyl, 4,4,4-trichlorobutyl, 4-fluorobutyl, 5-chloropentyl, 3-chloro-2-methylpropyl, 5-bromohexyl, 5,6-dichlorohexyl, benzyl, 1-phenylethyl, 2-phenylethyl, 3-phenylpropyl, 4-phenylbutyl, 1,1-dimethyl-2-phenylethyl, 5-phenylpentyl, 6-phenylhexyl, 2-methyl-3-phenylpropyl, methoxymethyl, 3-methoxypropyl, 4-ethoxybutyl, 6-propoxyhexyl, 5-isopropoxypentyl, 1,1-dimethyl-2-butoxyethyl, 2-methyl-3-tert-butoxypropyl, 2-pentyloxyethyl, hexyloxymethyl, dimethoxymethyl, 2,3-dimethoxyethyl, 6,6,5-trimethoxyhexyl, 1-hydroxy-1-phenylmethyl, 1-hydroxy-2-phenylethyl, l-hydroxy-3-phenylpropyl, 1-methoxy-1-phenylmethyl, and the like.
The "cyano-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by cyano group, for example, cyanomethoxy, 2-cyanoethoxy, 1-cyanoethoxy, 3-cyanopropoxy, 4-cyanobutoxy, 5-cyanopentyloxy, 6-cyanohexyloxy, 1,1-dimethyl-2-cyanoethoxy, 2-methyl-3-cyanopropoxy, and the like.
The "oxiranyl-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by oxiranyl group, for example, glycidoxy, 2-oxiranylethoxy, 1-oxiranylethoxy, 3- oxiranylpropoxy, 4-oxiranylbutoxy, 5-oxiranylpentyloxy, 6-oxiranylhexyloxy, 1,1-dimethyl-2-oxiranylethoxy, 2-methyl-3-
oxiranylpropoxy, and the like.
The "phthalimido-substituted alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 12 carbon atoms which is substituted by phthalimido group, for example, phthalimidomethoxy, 2-phthalimidoethoxy, 1-phthalimidoethoxy, 3-phthalimidopropoxy, 4-phthalimidobutoxy, 5phthalimidopentyloxy, 6-phthalimidohexyloxy, 1,1-dimethyl-2-phthalimidoethoxy, 2-methyl-3-phthalimidopropoxy, 7-phthalimidoheptyloxy, 8-phthalimidooctyloxy, 9-phthalimidononyloxy, 10-phthalimidodecyloxy, 11-phthalimidoundecyloxy, 12- phthalimidododecyloxy, and the like.
The "pyrrolyl-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by pyrrolyl group, for example, (1-pyrrolyl)methoxy, 2-(2-pyrrolyl)ethoxy, 1-(3-pyrrolyl)ethoxy, 3-(1-pyrrolyl)propoxy, 4-(1-pyrrolyl)butoxy, 5-(2-pyrrolyl)pentyloxy, 6-(3-pyrrolyl)hexyloxy, 1,1-dimethyl-2-(1-pyrrolyl)ethoxy, 2-methyl-3-(1-pyrrolyl)propoxy, and the like.
The "amidino-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by amidino group, for example, amidinomethoxy, 2-amidinoethoxy, 1-amidinoethoxy, 3-amidinopropoxy, 2-amidinobutoxy, 5-amidinopentyloxy, 6-amidinohexyloxy, 1,1-dimethyl-2-amidinoethoxy, 2-methyl-3- amidinopropoxy, and the like.
The "lower alkanoyloxy ( lower)alkyl" includes a straight chain or branched chain alkyl group having 1 to 6
carbon atoms which is substituted by a straight chain or branched chain alkanoyloxy group having 2 to 6 carbon atoms, for example, acetyloxymethyl, 2-propionyloxyethyl, 1-butyryloxyethyl, 3-acetyloxypropyl, 4-isobutyryloxybutyl, 5-pentanoyloxypentyl, 6-tert-butylcarbonyloxyhexyl, 1,1-dimethyl-2-hexanoyloxyethyl, 2-methyl-3-acetyloxypropyl, and the like.
The "lower alkylsulfinyl" includes a straight chain or branched chain alkylsulfinyl group having 1 to 6 carbon atoms, for example, methylsulfinyl, ethylsulfinyl,
isopropylsulfinyl, butylsulfiyl, tert-butylsulfinyl,
pentylsulfinyl, hexylsulfinyl, and the like.
The "lower alkenyl having optionally a hydroxysubstituent" include a straight chain or branched chain alkenyl group having 2 to 6 carbon atoms and having
optionally a hydroxy-substituent, for example, in addition to the above-mentioned lower alkenyl groups, 1-hydroxyallyl, 4-hydroxy-1-butenyl, 4-hydroxy-2-butenyl, 2-hydroxy-3-butenyl, 5-hydroxy-2-pentenyl, 6-hydroxy-2-hexenyl, and the like.
The "lower alkylenedioxy" includes a straight chain or branched chain alkylenedioxy group having 1 to 4 carbon atoms, for example, methylenedioxy, ethylenedioxy,
trimethylenedioxy, tetramethylenedioxy, and the like.
The "lower alkylsilyl" includes a silyl group having one to three substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, methylsilyl, ethylsilyl, propylsilyl,
isopropylsilyl, butylsilyl, tert-butylsilyl, pentylsilyl,
hexylsilyl, dimethylsilyl, trimethylsilyl, dimethyl-tert-butylsilyl, and the like.
The "amino which may optionally be substituted by a lower alkanoyl" includes an amino which may optionally be substituted by a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, amino, formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino, pentanoylamino, tert-butylcarbonylamino, hexanoylamino, and the like.
The "phenoxycarbonyl which may optionally have one to three substituents selected from nitro and an amino having optionally one or two substituents selected from a lower alkanoyl, lower alkyl and benzoyl" includes a
phenoxycarbonyl group which may optionally have one to three substituents selected from nitro group and an amino group having optionally one or two substituents selected from a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and benzoyl group, for example, phenoxycarbonyl, 2-nitrophenoxycarbonyl, 3-nitrophenoxycarbonyl, 4-nitrophenoxycarbonyl, 3,4-dinitrophenoxycarbonyl, 2,5-dinitrophenoxycarbonyl, 2,6-dini-rophenoxycarbonyl, 3,4,5-trinitrophenoxycarbonyl, 2-aminophenoxycarbonyl, 3-aminophenoxycarbonyl, 4-aminophenoxycarbonyl, 3-acetylaminophenoxycarbonyl, 4-formylaminophenoxycarbonyl, 4-isobutyrylaminophenoxycarbonyl, 2-pentanoylaminophenoxycarbonyl, 3-hexanoylaminophenoxycarbonyl, 3,4-diacetylaminophenoxycarbonyl, 3,4-diaminophenoxycarbonyl, 2,6-diaminophe-
noxycarbonyl, 2,5-diaminophenoxycarbonyl, 2,4,6-triaminophenoxycarbonyl, 4-acetylaminophenoxycarbonyl, 4-dimethylaminophenoxycarbonyl, 4-benzoylaminophenoxycarbonyl, 3-(N-methyl-N-benzoylamino)phenoxycarbonyl, 2-(N-ethyl-N-acetylamino)phenoxycarbonyl, and the like.
The "phenyl(lower)alkenylcarbonyl" includes a phenylalkenylcarbonyl group wherein the alkenylcarbonyl moiety is a straight chain or branched chain alkenylcarbonyl group having 3 to 6 carbon atoms, for example, cinnamoyl, 4-phenyl-3-butenoyl, 4-phenyl-2-butenoyl, 5-phenyl-4-pentenoyl, 5-phenyl-3-pentenoyl, 5-phenyl-2-pentenoyl, 6-phenyl-5-hexenoyl, 6-phenyl-4-hexenoyl, 6-phenyl-3-hexenoyl, 6-phenyl-2-hexenoyl, 2-methyl-4-phenyl-3-butenoyl, and the like.
The "amino having optionally a lower alkoxycarbonyl substituent" includes an amino being optionally substituted by a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, amino, methoxycarbonylamino, ethoxycarbonylamino, propoxycarbonylamino, isopropoxycarbonylamino, butoxycarbonylamino, tert-butoxycarbonylamino, pentyloxycarbonylamino, hexyloxycarbonylamino, and the like.
The "phenyl(lower)alkanoyl wherein the lower alkanoyl moiety may optionally be substituted by an amino having optionally a lower alkoxycarbonyl substituent" includes a phenylalkanoyl wherein the alkanoyl moiety is a straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms and may optionally be substituted by an amino
group which may optionally be substituted by a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, phenylacetyl, 3-phenylpropionyl, 2-phenylpropionyl, 4-phenylbutyryl, 2 , 2-dimethyl-3-phenylpropionyl, 5-phenylpentanoyl, 6-phenylhexanoyl, 3-methyl-4-phenylbutyryl, 2-amino-4-phenylacetyl, 2-tert-butoxycarbonylamino-2-phenylacetyl, 2-methoxycarbonylamino-2-phenylacetyl, 2-ethoxycarbonylamino-3-phenylpropionyl, 2-propoxycarbonylamino-4-phenylbutyryl, 2-pentyloxycarbonylamino-5-phenylpentanoyl, 2-hexyloxycarbonylamino-6-phenylhexanoyl, and the like.
The "alkanoyl" includes a straight chain or branched chain alkanoyl group having 1 to 12 carbon atoms, for example, in addition to the above-mentioned lower alkanoyl groups, heptanoyl, octanoyl, nonanoyl, decanoyl, undecanoyl, dodecanoyl, neopentanoyl, and the like.
The "alkenylcarbonyl" includes a straight chain or branched chain alkenylcarbonyl group having 2 to 12 carbon atoms and having one to three double bonds, for example, vinylcarbonyl, acrylcarbonyl, 3-methyl-2-butenylcarbonyl, 2-butenylcarbonyl, 1-methylallylcarbonyl, 2-pentenylcarbonyl, 2-hexenylcarbonyl, 1-heptenylcarbonyl, 1-octenylcarbonyl, 1-nonenylcarbonyl, 1-decenylcarbonyl, 1-undecenylcarbonyl, 1-dodecenylcarbonyl, 2-heptenylcarbonyl, 3-heptenylcarbonyl, 2-methyl-4-heptenylcarbonyl, 2-methyl-5-heptenylcarbonyl, 4-methyl-2-heptenylcarbonyl, 3-methyl-1-heptenylcarbonyl, 1,3-heptadienylcarbonyl, 1,4-heptadienylcarbonyl, 1,5-hepta- dienylcarbonyl, 1,6-heptadienylcarbonyl, 2,4-heptadienyl-
carbonyl, 2-methyl-2,4-heptadienylcarbonyl, 2,6-dimethyl2,4-heptadienylcarbonyl, 2,6-dimethyl-1,5-heptadienylcarbonyl, 2, 5-dimethyl-1,3-heptadienylcarbonyl, 2,4,6trimethyl-2,4-heptadienylcarbonyl, 2-octenylcarbonyl, 3octenylcarbonyl, 4-octenylcarbonyl, 2-methyl-5-octenylcarbonyl, 2-methyl-6-octenylcarbonyl, 2-methyl-7-octenylcarbonyl, 1,3-octadienylcarbonyl, 1 , 4-octadienylcarbonyl , 1 , 5-octadienylcarbonyl , 1 ,6-octadienylcarbonyl, 1,7-octadienylcarbonyl, 2,4-octadienylcarbonyl, 3,7-octadienylcarbonyl, 4,8-dimethyl-3,7-octadienylcarbonyl, 2,4,6-trimethyl-3,7-octadienylcarbonyl, 3,4-dimethyl-2,5-octadienylcarbonyl, 4,8-dimethyl-2,6-octadienylcarbonyl, 2-nonenylcarbonyl, 3-nonenylcarbonyl, 4-nonenylcarbonyl, 2-methyl-5-nonenylcarbonyl, 2-methyl-6-nonenylcarbonyl, 2-methyl-7-nonenylcarbonyl, 2-methyl-8-nonenylcarbonyl, 1,3-nonadienylcarbonyl, 1,4-nonadienylcarbonyl, 1,5-nonadienylcarbonyl, 1,6-nonadienylcarbonyl, 1,7-nonadienylcarbonyl, 1,8-nonadienylcarbonyl, 2,4-nonadienylcarbonyl, 3,7-nonadienylcarbonyl, 4,8-dimethyl-3,7-nonadienylcarbonyl, 2,4,6-trimethyl-3,7-nonadienylcarbonyl, 3,4-dimethyl-2,5-nonadienylcarbonyl, 4,8-dimethyl-2,6-nonadienylcarbonyl, 2-decenylcarbonyl, 3-decenylcarbonyl, 4-decenylcarbonyl, 5- decenylcarbonyl, 2-methyl-6-decenylcarbonyl, 3-methyl-7-decenylcarbonyl, 4-methyl-8-decenylcarbonyl, 5-methyl-9-decenylcarbonyl, 1,3-decadienylcarbonyl, 1,4-decadienylcarbonyl, 1,5-decadienylcarbonyl, 1, 6-decadienylcarbonyl, 1,7-decadienylcarbonyl, 1,8-decadienylcarbonyl, 1,9-decadienylcarbonyl, 2-methyl-2,4-decadienylcarbonyl, 3-
methyl-2,5-decadienylcarbonyl, 4,8-dimethyl-2,6-decadienylcarbonyl, 2,4,6-trimethyl-3,7-decadienylcarbonyl, 2,9-dimethyl-3,7-decadienylcarbonyl, 2-undecenylcarbonyl, 3-undecenylcarbonyl, 4-undecenylcarbonyl, 5-undecenylcarbonyl, 2-methyl-6-undecenylcarbonyl, 3-methyl-7-undecenylcarbonyi, 4-methyl-8-undecenylcarbonyl, 5-methyl-9-undecenylcarbonyl, 2-methyl-10-undecenylcarbonyl, 1,3-undecadienylcarbonyl, 1,4-undecadienylcarbonyl, 1,5-undecadienylcarbonyl, 1,6- undecadienylcarbonyl, 1,7-undecadienylcarbonyl, 1,8-undecadienylcarbonyl, 1,9-undecadienylcarbonyl, 1,10-undecadienylcarbonyl, 2-methyl-2,4-undecadienylcarbonyl, 3-methyl-2,5-undecadienylearbonyl, 4,8-dimethyl-2,6- undecadienylearbonyl, 2,4,6-trimethyl-3,8-undecadienylcarbonyl, 2 ,9-dimethyl-3,8-undecadienylcarbonyl, 2-dodecenylcarbonyl, 3-dodecenylcarbonyl, 4-dodecenylcarbonyl, 5-dodecenylcarbonyl, 6-dodecenylcarbonyl, 2-methyl-7-dodecenylcarbonyl, 3-methyl-8-dodecenylcarbonyl, 4-methyl-9-dodecenylcarbonyl, 5-methyl-10-dodecenylcarbonyl, 6-methyl-11-dodecenylcarbonyl, 2-methyl-2,4-dodecadienylcarbonyl, 3-methyl-2,5-dodecadienylcarbonyl, 4,8-dimethyl-2,6-dodecadienylcarbonyl, 2,4,6-trimethyl-2,7-dodecadienylcarbonyl, 2,10-dimethyl-2,8-dodecadienylcarbonyl, 2,5- dimethyl-3,7-dodecadienylcarbonyl, 4,8,12-trimethyl-3,7,11-dodecatrienylcarbonyl, 1,3,5-heptatrienylcarbonyl, 2,4,6-octatrienylcarbonyl, 1,3,6-nonatrienylcarbonyl, 2,6,8-dodecatrienylcarbonyl, 1,5,7-undecatrienylcarbonyl, and the like.
The "phenylsulfonyl wherein the phenyl ring may
optionally have a lower alkoxy substituent" includes a phenylsulfonyl group wherein the phenyl ring may optionally have one to three substituents of a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, phenylsulfonyl, 2-methoxyphenylsulfonyl, 3-methoxyphenylsulfonyl, 4-methoxyphenylsulfonyl, 2-ethoxyphenylsulfonyl, 3-ethoxyphenylsulfonyl, 4-ethoxyphenylsulfonyl, 4-isopropoxyphenylsulfonyl, 4-pentyloxyphenylsulfonyl, 4-hexyloxyphenylsulfonyl, 3,4-dimethoxyphenylsulfonyl, 3-ethoxy-4-methoxyphenylsulfonyl, 2,3-dimethoxyphenylsulfonyl, 3,4-diethoxyphenylsulfonyl, 2,5-dimethoxyphenylsulfonyl, 2,6-dimethoxyphenylsulfonyl, 3 ,5-dimethoxyphenylsulfonyl, 3,4-dipentyloxyphenylsulfonyl, 3,4, 5-trimethoxyphenylsulfonyl, and the like.
The "phenyl which may optionally have one to three substituents selected from a lower alkoxy, a lower alkyl, a halogen atom, an amino having optionally one or two
substituents selected from a lower alkyl and a lower
alkanoyl, and nitro" includes a phenyl group which may optionally have one to three substituents selected from a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a halogen atom, an amino group having optionally one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, and a nitro group, for example, phenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-
methoxyphenyl, 2-ethoxyphenyl, 3-ethoxyphenyl, 4-ethoxyphenyl, 4-isopropoxyphenyl, 3-butoxyphenyl, 4-pentyloxyphenyl, 4-hexyloxyphenyl, 3,4-dimethoxyphenyl, 3-ethoxy-4-methoxyphenyl, 2,3-dimethoxyphenyl, 3,4-diethoxyphenyl, 2,4-diethoxyphenyl, 2,5-dimethoxyphenyl, 2,6-dimethoxyphenyl, 3,5-dimethoxyphenyl, 3,4-dipentyloxyphenyl, 3,4,5-trimethoxyphenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2-ethylphenyl, 3-ethylphenyl, 4-ethylphenyl, 4isopropylphenyl, 3-butylphenyl, 4-pentylphenyl, 4-hexylphenyl, 3,4-dimethylphenyl, 3,4-diethylphenyl, 2,5-dimethylphenyl, 2,6-dimethylphenyl, 3,4,5-trimethylphenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2-iodophenyl, 3-iodophenyl, 4-iodophenyl, 3,4-dichlorophenyl, 3,5-dichlorophenyl, 2,6-dichlorophenyl, 2,3-dichlorophenyl, 2,4-dichlorophenyl, 3,4-difluorophenyl, 3,5-dibromophenyl, 3,4,5-trichlorophenyl, 2-nitrophenyl, 3-nitrophenyl, 4-nitrophenyl, 3,4-dinitrophenyl, 2,5-dinitrophenyl, 2,6-dinitrophenyl, 3,4,5-trinitrophenyl, 2-aminophenyl, 3-aminophenyl, 4-aminophenyl, 3-(N-acetylamino)phenyl, 4-(N-formylamino)phenyl, 4-(N-isobutyrylamino)phenyl, 2-(N-pentanoylamino)phenyl, 3,4-diaminophenyl, 3,4-di(N-acetylamino)phenyl, 3,4,5-triaminophenyl, 2,6-diaminophenyl, 2,5-diaminophenyl, 3,5-di-t-butyl-4-hydroxyphenyl, 3-hydroxy-4-pentyloxyphenyl, 2-hydroxy-5-t-butylpheήyl, 3,5-dichloro-4-aminophenyl, 3-amino-4-hydroxyphenyl, 3-acetylamino-4-methoxyphenyl, 3-nitro-4-acetylaminophenyl, 3-nitro4-chlorophenyl, 3-chloro-4-methylphenyl, 3-methoxy-4-methyl
5-iodophenyl, 3,4-dimethoxy-5-bromophenyl, 3,5-diiodo-4-methoxyphenyl, 4-dimethylaminophenyl, 3-methylaminophenyl, 2-butylaminophenyl, 4-diethylaminophenyl, 3-dipropylaminophenyl, 2-(N-methyl-N-hexaylamino)phenyl, 4-(N-methyl-N-acetylamino)phenyl, 2,4-dimethylaminophenyl, and the like.
The "heterocyclic group-substituted carbonyl" includes a carbonyl group which is substituted by a 5- to 10-membered, monocyclic or dicyclic heterocyclic groups containing one or two hetero atoms selected from nitrogen atom, oxygen atom and/or sulfur atom, for example, 2-pyrrolidinylcarbonyl, 3-pyrrolidinylcarbonyl, 1-piperidinylcarbonyl, 1-piperazinylcarbonyl, morpholinocarbonyl, thiomorpholinocarbonyl, 2-tetrahydrofurylcarbonyl, 2-thienylcarbonyl, 3-thienylcarbonyl, 2-pyrrolylcarbonyl, 3-pyrrolylcarbonyl, 2-furoyl, 3-furoyl, 2-pyridylcarbonyl, 3-pyridylcarbonyl, 4-pyridylcarbonyl, 3-pyridazylcarbonyl, 2-thiazolylcarbonyl, 2-oxazolylcarbonyl, 2-imidazolylcarbonyl, 4-pyridazylcarbonyl, 5-pyr idazylcarbonyl, 6-pyridazylcarbonyl, 2-pyrimidylcarbonyl, 4-pyrimidylcarbonyl, 5-pyrimidylcarbonyl, 6-pyr imidylcarbonyl, 2-pyradylcarbonyl, 3-pyradylcarbonyl, 6-quinolylcarbonyl, 5-indolylcarbonyl, 6-isoquinolylcarbonyl, 4-cinnolylcarbonyl, 3-quinoxalylcarbonyl, 4-phthalazylcarbonyl, 5-quinazolylcarbonyl, 3-benzo[b]furanylcarbonyl, 5-benzo[b]thiophenylcarbonyl, 2-oxo-6-quinolylcarbonyl, 2-oxo-4-quinolylcarbonyl, and the like.
The above "heterocyclic group-substituted carbonyl which has one to three substitutents selected from a phenyl
(lower)alkoxycarbonyl, a phenyl(lower)alkoxy, oxo, a lower alkyl and a lower alkylenedioxy" includes the above-mentioned heterocyclic group-substituted carbonyl groups which have one to three substituents selected from a phenylalkoxycarbonyl group wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, a phenylalkoxy group wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, an oxo group, a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, and a straight chain or branched chain alkylenedioxy group having 1 to 4 carbon atoms, for example, 1-benzyloxycarbonyl-2-pyrrolidinylcarbonyl, 3-benzyloxycarbonyl-4,5-(1,1-dimethylmethylene)-2-tetrahydrofurylcarbonyl, 4-(2-phenylethoxycarbonyl)-1-piperazinylcarbonyl, 3-methyl-2-thienylcarbonyl, 3-ethyl-2-pyrrolylcarbonyl, 3-propyl-2-furoyl, 4-butyl-2-oxo-6-quinolylcarbonyl, 6-pentyl-2-oxo-4-quinolylcarbonyl, 5-hexyl-2-pyrazylcarbonyl, 1,3-dioxo-2-methyl-6-quinazolylcarbonyl, 4,5-methylenedioxy-3-indolylcarbonyl, 3-(3-phenylpropoxy)morpholinocarbonyl, and the like.
The "thienyl(lower)alkanoyl" includes a thienylalkanoyl wherein the alkanoyl moiety is a straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms, for example, 2-(2-thienyl)acetyl, 3-(3-thienyl)propionyl, 2-(3-thienyl)propionyl, 4-(2-thienyl)butyryl, 2,2-dimethyl-3-(3-thienyl)propionyl, 5-(2-thienyl)pentanoyl, 6-(3-thienyl)¬hexanoyl, 3-methyl-4-(2-thienyl)butyryl, and the like.
The "tricyclo[3.3.1.1]decanyl(lower)adkanoyl" includes a tricyclo[3.3.1.1]decanylalkanoyl wherein the alkanoyl moiety is a straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms, for example, 2- tricyclo[3.3.1.1]decanylacetyl, 3-tricyclo[3.3.1.1]decanylpropionyl, 2-tricyclo[3.3.1.1]decanylpropionyl, 4-tricyclo[3.3.1.1]decanylbutyryl, 2,2-dimethyl-3-tricyclo[3.3.1.1]decanylpropionyl, 5-tricyclo[3.3.1.l]decanylpentanoyl, 6-tricyclo[3.3.1.1]decanylhexanoyl, 3-methyl-4-tricyclo[ 3.3.1.1]decanylbutyryl, and the like.
The "benzoyl wherein the phenyl ring may optionally have a lower alkoxy substituent" includes a benzoyl which may optionally have one to three substituents of a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms on the phenyl ring, for example, benzoyl, 2-methoxybenzoyl, 3-methoxybenzoyl, 4-methoxybenzoyl, 2-ethoxybenzoyl, 3-ethoxybenzoyl, 4-butoxybenzoyl, 4-isopropoxybenzoyl, 4-pentyloxybenzoyl, 4-hexyloxybenzoyl, 3,4dimethoxybenzoyl, 3-ethoxy-4-methoxybenzoyl, 2,3-dimethoxybenzoyl, 3,4-diethoxybenzoyl, 2 ,5-dimethoxybenzoyl, 2,6dimethoxybenzoyl, 2,4-dimethoxybenzoyl, 2,4,6-trimethoxybenzoyl, 3,5-dimethoxybenzoyl, 3,4-dipentyloxybenzoyl, 3,4,5-trimethoxybenzoyl, and the like.
The "phenyl which may optionally have a lower alkoxy substituent" includes a phenyl group which may optionally have one to three substituents of a straight chain or branched .chain alkoxy group having 1 to 6 carbon atoms, for example, phenyl, 2-methoxyphenyl, 3-methoxy
phenyl, 4-methoxyphenyl, 2-ethoxyphenyl, 3-ethoxyphenyl, 4-ethoxyphenyl, 4-isopropoxyphenyl, 3-butoxyphenyl, 4-pentyloxyphenyl, 4-hexyloxyphenyl, 3,4-dimethoxyphenyl, 3-ethoxy-4-methoxyphenyl, 2,3-dimethoxyphenyl, 3,4-diethoxyphenyl, 2,5-dimethoxyphenyl, 2,6-dimethoxyphenyl, 3,5dimethoxyphenyl, 3,4-dipentyloxyphenyl, 3,4,5-trimethoxyphenyl, and the like.
The "cycloalkyl" includes a cycloalkyl having 3 to 8 carbon atoms, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, and the like.
The "saturated or unsaturated heterocyclic group which is formed by binding the groups R 11 and R1 2 together with the nitrogen atom to which they bond and may be
intervened or not with nitrogen, oxygen or sulfur atom" includes, a 5- to 10-membered, saturated or unsaturated, monocyclic or dicyclic heterocyclic group, for example, pyrrolidinyl, piperidinyl, piperazinyl, morpholino,
thiomorpholino, pyrrolyl, imidazolyl, pyrazolyl,
imidazolidinyl, pyrazolinyl, pyrazolidinyl, oxazolinyl, oxazolidinyl, isoxazolinyl, isoxazolidinyl, thiazolinyl, thiazolidinyl, isothiazolinyl, isothiazolidinyl, 1,2,3,4tetrahydroquinolyl, 1,2-dihydroquinolyl, indolyl,
isoindolyl, 1,2-dihydroisoquinolyl, 1,2,3,4-tetrahydroisoquinolyl, 1H-indazolyl, 1,2-dihyroquinazolyl, 1,2-dihydrocinnolyl, 1,2-dihydroquinoxalyl, 1,2,3,4-tetrahydroquinazolyl, 1,2,3,4-tetrahydrocinnolyl, 1,2,3,4-tetrahydroquinoxalyl, and the like.
The "phenyl which may optionally have a substituent
selected from a lower alkoxy and a lower alkanoyl" includes a phenyl group which may optionally have one to three substituents selected from a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms and a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, phenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 2-ethoxyphenyl, 3-ethoxyphenyl, 4-ethoxyphenyl, 4-isopropoxyphenyl, 3-butoxyphenyl, 4-pentyloxyphenyl, 4-hexyloxyphenyl, 3,4-dimethoxyphenyl, 3-ethoxy4-methoxyphenyl, 2,3-dimethoxyphenyl, 3,4-diethoxyphenyl, 2,5-dimethoxyphenyl, 2,6-dimethoxyphenyl, 3,5-dimethoxyphenyl, 3,4-dipentyloxyphenyl, 3,4,5-trimethoxyphenyl, 3-methoxy-4-acetylphenyl, 2-acetylphenyl, 3-acetylphenyl, 4-acetylphenyl, 2-formylphenyl, 3-propionylphenyl, 4-isobutyrylphenyl, 2-pentanoylphenyl, 3-hexanoylphenyl, 3,4-diacetylphenyl, 2,5-diacetylphenyl, 3,4,5-triacetylphenyl, and the like.
The "heterocyclic group which is substituted by a member selected from benzoyl, a lower alkanoyl, a phenyl(lower)alkyl, and a phenyl having optionally a substituent selected from a lower alkoxy and a lower alkanoyl" includes the above heterocyclic groups which have a substituent selected from benzoyl group, a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, a phenylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, and a phenyl group having optionally one to three substituents selected from a straight chain or branched chain alkoxy
group having 1 to 6 carbon atoms and a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, 3-benzoyl-1-pyrrolidinyl, 4-benzoyl-1-piperidinyl, 4-benzoyl-1-piperazinyl, 4-benzyl-1-piperazinyl, 3-(2-phenylethyl)morpholino, 3-(3-phenylpropyl)thiomorpholino, 3-(4-phenylbutyl)-1-pyrrolyl, 4-acetyl-1-piperidinyl, 4-acetyl-1-piperazinyl, 4-formyl-1-piperazinyl, 2-(5-phenylpentyl)-1-imidazolyl, 3-(6-phenylpentyl)-1-pyrazolyl, 4-(4-methoxyphenyl)-1-piperazinyl, 4-(4-acetylphenyl)-1-piperazinyl, 4-(3-ethoxyphenyl)-1-piperazinyl, 4-(3-propionylphenyl)-1-piperazinyl, 5-benzyl-1,2,3,4-tetrahydroquinolin-1-yl, 6-(4-butyrylphenyl)-1,2,3,4-tetrahydroisoquinolin-2-yl, 4-(2-propoxyphenyl)-1- indolyl, 5-(3-pentanoylphenyl)-1H-indazol-1-yl, 6-(3-butoxyphenyl)-1,2-dihydroquinazolin-1-yl, 7-(4-hexanoylphenyl)-1,2-dihydrocinnolin-2-yl, 6-(4-hexyloxyphenyl)1,2,3,4-tetrahydroquinoxalin-1-yl, and the like.
The "alkylene" includes a straight chain or branched chain alkylene group having 1 to 12 carbon atoms, for example, in addition to the above-mentioned lower alkylene groups, heptamethylene, octamethylene, nonamethylene, decamethylene, undecamethylene, dodecamethylene, and the like.
The "lower alkoxycarbonyl(lower)alkyl wherein the alkyl moiety may optionally be substituted by hydroxy or an amino having optionally a phenyl(lower)alkoxycarbonyl substituent" includes a straight chain or branched chain alkoxycarbonylalkyl group having 1 to 6 carbon atoms in the
alkoxy moiety, wherein the alkyl moiety is straight chain or branched chain alkyl group having 1 to 6 carbon atoms and has optionaly a substituent selected from a hydroxy group and an amino group having optionally a substituent of a phenylalkoxycarbonyl group wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, 1-hydroxy-1-methoxycarbonylmethyl, 1-methoxycarbonyl-2-hydroxyethyl, 3-hydroxy-3-methoxycarbonylpropyl, 2-hydroxy-4-ethoxycarbonylbutyl, 2-hydroxy-6-propoxycarbonylhexyl, 2-hydroxy-2-pentyloxycarbonylethyl, 1-hydroxy-1-hexyloxycarbonylmethyl, 5-benzyloxycarbonylamino-1-methoxycarbonylpentyl, 5-amino-1-methoxycarbonylpentyl, 3-(2-phenylethoxycarbonylamino)-1-ethoxycarbonylpropyl, 4-amino-1-butyloxycarbonylbutyl, and the like.
The "amino-substituted lower alkanoyl wherein the lower alkanoyl moiety may optionally be substituted by a member selected from a phenyl(lower)alkoxycarbonylamino, hydroxy, a phenyl having optionally a hydroxy substitutent, carbamoyl, imidazolyl and a lower alkylthio, and the amino group may optionally have a substituent selected from a lower alkyl having optionally a hydroxy substitutent, a lower alkenyl, a phenyl(lower)alkyl having optionally a lower alkoxy substituent on the phenyl ring, a lower alkylsulfonyl, a lower alkanoyl, and a phenyl(lower)alkoxycarbonyl" includes an amino-substituted straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms, wherein the alkanoyl moiety may optionally be substituted by
a member selected from phenylalkoxycarbonylammo wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, a hydroxy group, a phenyl group having optionally one to three
hydroxy-substitutents, a carbamoyl group, an imidazolyl group and a straight chain or branched chain alkylthio group having 1 to 6 carbon atoms, and the amino group may
optionally have a substituent selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and having optionally one to three hydroxy-substitutents, a straight chain or branched chain alkenyl group having 2 to 6 carbon atoms, a phenylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and the phenyl ring has optionally one to three substituents of a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, a straight chain or branched chain alkylsulfonyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, and a phenylalkoxycarbonyl wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, aminoacetyl, 3-formylaminopropionyl, acetylaminoacetyl, 2-propionylaminopropionyl, 4-butyrylaminobutyryl, 2,2-dimethyl-3-isobutyrylaminopropionyl, 5-pentanoylaminopentanoyl, 6-tert-butylcarbonylaminohexanoyl, 3-methyl-4-hexanoylaminobutyryl, 4-methylthio-2-acetylaminobutyryl, 3-(imidazol-4-yl)-2-acetylaminopropionyl, 2-acetylaminopropionyl, 3-(4-hydroxyphenyl)-2-benzyloxy
carbonylaminopropionyl, 4-carbamoyl-2-acetylaminobutyryl, 2-acetylaminoisopentanoyl, 5-ethylthio-2-acetylaminopentanoyl, 4-(imidazol-2-yl)-2-propionylaminobutyryl, 6-(2-hydroxyphenyl)-2-butyrylaminohexanoyl, 3-carbamoyl-2-benzyloxycarbonylaminopropionyl, 5-carbamoyl-2- ( 2-phenylethoxycarbonylamino)pentanoyl, 3-(2,4-dihydroxyphenyl)-2-(3-phenylpropoxycarbonylamino)propionyl, 2,5-dibenzyloxycarbonylaminohexanoyl, 3-(4-hydroxyphenyl)-2-aminopropionyl, dimethylaminoacetyl, 3-hydroxy-2-benzyloxycarbonylaminopropionyl, 2-benzyloxycarbonylaminopropionyl, 2-aminopropionyl, 2-aminoisopentanoyl, 2-aminobutyryl, 4-benzyloxycarbonylaminobutyryl, diethylaminoacetyl, 4-acetylaminobutyryl, 4-dimethylaminobutyryl, 2-hydroxyacetyl, ethylaminoacetyl, allylaminoacetyl, benzylaminoacetyl, isopropylaminoacetyl, (N-methyl-N-benzylamino)acetyl, [N-methyl-N-(2-hydroxyethyl)amino]acetyl, [N-methyl-N-(4-ethoxybenzyl)amino]acetyl, 2-benzyloxycarbonylaminoacetyl, methylsulfonylaminoacetyl, (3-methoxybenzyl)aminoacetyl, (N-methyl-N-acetylamino)acetyl, 5-(N-methyl-N-allylamino)pentanoyl, 6-[N-allyl-N-(3,4-dimethoxybenzyl)amino]hexanoyl, and the like.
The "amido-substituted lower alkyl wherein the lower alkyl moiety has optionally a substituent selected from a phenyl having optionally a hydroxy substituent, imidazolyl, carbamoyl and a lower alkylthio, and the amido group may optionally have a lower alkyl substituent"
includes an amido-substituted straight chain or branched chain alkyl group having 1 to 6 carbon atoms wherein the
alkyl moiety have optionally a substituent selected from a phenyl having optionally one to three hydroxy-substituents, an imidazolyl group, a carbamoyl group and a straight chain or branched chain alkylthio group having 1 to 6 carbon atoms, and the amido group may optionally have one or two substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, carbamoylmethyl, 2-carbamoylethyl, 1-carbamoylethyl, 3-carbamoylpropyl, 4-carbamoylbutyl, 5-carbamoylpentyl, 6-carbamoylhexyl, 1,1-dimethyl-2-carbamoylethyl, 2-methyl-3-carbamoylpropyl, methylamidomethyl, 1-ethylamidoethyl, 2-propylamidoethyl, 3-isopropylamidopropyl, 4-butylamidobutyl, 5-pentylamidopentyl, 6-hexylamidohexyl, dimethylamidomethyl, (N-ethyl-N-propylamido)methyl, 2-(N-methyl-N-hexylamido)ethyl, 2-(4-hydroxyphenyl)carbamoylethyl, 1-carbamoylisobutyl, 2-(imidazol-4-yl)-1-carbamoylethyl, 1,3-dicarbamoylpropyl, 3-methylthio-1-carbamoylpropyl, 3-(2-hydroxyphenyl)-1-methylamidopropyl, 4-(2,6-dihydroxyphenyl)-1-(N-methyl-N-hexylamido)butyl, 3-(imidazol-2-yl)-1-propylamidopropyl, 1,4- dicarbamoylbutyl, 2-ethylthio-1-butylamidobutyl, 4-pentylthio-1-hexylamidobutyl, and the like.
The "carboxy ( lower )alkyl" includes a carboxyalkyl group wherein the alkyl moietyl is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, carboxymethyl, 2-carboxyethyl, 1-carboxyethyl, 3-carboxypropyl, 4-carboxybutyl, 5-carboxypentyl, 6-carboxyhexyl, 1,1-dimethyl-2-carboxyethyl, 2-methyl-3-carboxypropyl, and the like.
The "lower alkoxy(lowe )alkyl" includes a straight chain or branched chain alkoxyalkyl group having 1 to 6 carbon atoms in the alkoxy moiety wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, methoxymethyl, 2-ethoxyethyl, 1-methoxyethyl, 3-methoxypropyl, 4-ethoxybutyl, 6propoxyhexyl, 5-isopropoxypentyl, 1,1-dimethyl-2-butoxyethyl, 2-methyl-3-tert-butoxypropyl, 2-pentyloxyethyl, hexyloxymethyl, and the like.
The "amino acid residue which is able to form an amido bond with the amino group to which R4 and R5 bind" includes, for example, alanine residue, N2-arginine residue, N5-arginine residue, N6-arginine residue, N4-asparagine residue, aspartic acid residue, N5-glutamine residue, cysteine residue, glutamic acid residue, glycine residue, histidine residue, isoleucine residue, leucine residue, N2- lysine residue, N6-lysine residue, methionine residue, phenylalanine residue, proline residue, serine residue, threonine residue, tryptophane residue, tyrosine residue, valine residue, and the like.
The "hydroxyimino-substituted lower alkyl" includes a hydroxyimino-substituted straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, hydroxyiminomethyl, 1-hydroxyiminoethyl, 2-hydroxyiminoethyl, 3-hydroxyiminopropyl, 4-hydroxyiminobutyl, 5-hydroxyiminopentyl, 6-hydroxyiminohexyl, 1,1-dimethyl-2-hydroxyiminoethyl, 2-methyl-3-hydroxyiminopropyl, and the like.
The "halogen-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by one to three halogen atoms, for example, trifluoromethoxy, trichloromethoxy, chloromethoxy, bromomethoxy, fluoromethoxy, iodomethoxy, difluoromethoxy, dibromomethoxy, 2-chloroethoxy, 2,2,2-trifluoroethoxy, 2,2,2-trichloroethoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 4,4,4-trichlorobutoxy, 4-fluorobutoxy, 5-chloropentyloxy, 3-chloro-2-methylpropoxy, 6-bromohexyloxy, 5,6-dichlorohexyloxy, and the like.
The "phenyl(lower)alkoxycarbonyl" includes a phenylalkoxycarbonyl wherein the alkoxycarbonyl moietyl is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, benzyloxycarbonyl, 2-phenylethoxycarbonyl, 1-phenylethoxycarbonyl, 3-phenylpropoxycarbonyl, 4-phenylbutoxycarbonyl, 5-phenylpentyloxycarbonyl, 6-phenylhexyloxycarbonyl, 1,1-dimethyl-2-phenylethoxycarbonyl, 2-methyl-3-phenylpropoxycarbonyl, and the like.
The "lower alkoxy(lower)alkoxy which is substituted by one or two substituents selected from hydroxy and an amino being optionally substituted by a lower alkyl" includes an alkoxy-alkoxy group wherein both alkoxy moieties are each a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by one or two substituents selected from hydroxy and an amino being optionally substituted by a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example,
hydroxymethoxymethoxy, 3-(2-hydroxyethoxy)propoxy, 4-(1-hydroxyethoxy)butoxy, 6-(3-hydroxypropoxy)hexyloxy, 5-(2,3-dihydroxypropoxy)pentyloxy, 1,1-dimethyl-2-(4-hydroxybutoxy)ethoxy, 2-methyl-3-(3,4-dihydroxybutoxy)propoxy, 2-(1,1-dimethyl-2-hydroxyethoxy)ethoxy, ( 5-hydroxypentyloxy)methoxy, (6-hydroxyhexyloxy)methoxy, (2-methyl-3-hydroxypropoxy)methoxy, aminomethoxymethoxy, 2-(1-aminoethoxy)ethoxy, 1-(2-aminoethoxy)ethoxy, 3-(3-aminopropoxy)propoxy, 4-(4-aminobutoxy)butoxy, 5-(5-aminorp-entyloxy)pentyloxy, 6- (6-aminohexyloxy)hexyloxy, (1,1-dimethyl-2-aminoethoxy)methoxy, (2-methyl-3-aminopropoxy)methoxy, 1,1-dimethyl-2-(methylaminomethoxy)ethoxy, 2-methyl-3-(ethylaminomethoxy)propoxy, propylaminomethoxymethoxy, 1-(isopropylaminomethoxy)ethoxy, 2-(butylaminomethoxy)ethoxy, 3-(tert-butylaminomethoxy)propoxy, 4-(pentylaminomethoxy)butoxy, 5-(hexylaminomethoxy)pentyloxy, 6-(dimethylaminomethoxy)hexyloxy , 1 , 1-dimethyl-2- ( diethylaminomethoxy ) ethoxy , 2-methyl-3-(dipropylaminomethoxy)propoxy, dibutylaminomethoxymethoxy, 1-(dipentylaminomethoxy)ethoxy, 2-(dihexylaminomethoxy)ethoxy, 3-(N-methyl-N-ethylaminomethoxy)propoxy, 4-(N-methyl-N-propylaminomethoxy)butoxy, 5-(N-methyl-N-butylaminomethoxy)pentyloxy, 6-(N-methyl-N-hexylaminomethoxy)hexyloxy, (1-methylaminoethoxy)methoxy, 1-(2-ethylaminoethoxy)ethoxy, 2-(3-propylaminopropoxy)ethoxy, 3-(4-butylaminobutoxy)propoxy, 4-(1,1-dimethyl-2-pentylaminoethoxy)butoxy, 5-(5-hexylaminopentyloxy)pentyloxy, 6-(6-dimethylaminohexyloxy)hexyloxy, 3-(2-diethylaminoethoxy)propoxy, 4-[1-(N-methyl-N-hexylamino)ethoxy]butoxy, 5-(3-dihexylamino
propoxy)pentyloxy, 6-(4-dibutylaminobutoxy)hexyloxy, 3-[2-(N-methyl-N-pentylamino)ethoxy]propoxy, 5-(2-hydroxy-3-dimethylaminopropoxy)pentyloxy, 5-(2-hydroxy-3-diethylaminopropoxy)pentyloxy, 3-(2-hydroxy-3-diethylaminopropoxy)propoxy, 4-(3-hydroxy-4-methylaminobutoxy)butoxy, 5-(4-hydroxy-5-dimethylaminopentyloxy)pentyloxy, 6-(4-hydroxy-5-methylaminopentyloxy)hexyloxy, and the like.
The "morpholinyl-substituted lower alkoxy which may optionally have a substituent selected from a lower alkyl and oxo" includes a morpholinyl-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which may optionally have one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, and an oxo group, for example, (2-morpholinyl)methoxy, 2-(3-morpholinyl)ethoxy, 1-(3-morpholinyl)ethoxy, 3-(2-morpholinyl)propoxy, 4-(3-morpholinyl)butoxy, 5-(2-morpholinyl)pentyloxy, 6-(3-morpholinyl)hexyloxy, 1,1-dimethyl-2-(3-morpholinyl)ethoxy, 2-methyl-3-(2-morpholinyl)propoxy, 6-(1-methyl-5-oxo-3-morpholinyl)hexyloxy, (1-ethyl-2-morpholinyl)methoxy, 2-(2-oxo-3-morpholinyl)ethoxy, 1-(2-propyl-3-morpholinyl)ethoxy, 3-(3-butyl-2-morpholinyl)propoxy, 4-(5-pentyl-3-morpholinyl)butoxy, 5-(6-hexyl-2-morpholinyl)pentyloxy, 3-(5-oxo-1-propyl-2-morpholinyl)propoxy, 4-(2-oxo-1-butyl-3-morpholinyl)butoxy, 5-(3-oxo-1-pentyl-6-morpholinyl)pentyloxy, 6-(2-bxo-1-hexyl-5-morpholinyl)hexyloxy, and the like.
The "benzimidazolylthio-substituted lower alkoxy"
includes a benzimidazolylthio-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, (benzimidazol-2-yl)thiomethoxy, 1-(benzimidazol-4-yl)thioethoxy, 2-(benzimidazol-5-yl)thioethoxy, 3-(benzimidazol-6-yl)thiopropoxy, 4-(benzimidazol-2-yl) thiobutoxy, 5-(benzimidazol-7-yl)thiopentyloxy, 6-(benzimidazol2-yl)thiohexyloxy, 1,1-dimethyl-2-(benzimidazol-2-yl)thioethoxy, 2-methyl-3-(benzimidazol-2-yl)thiopropoxy, and the like.
The "benzimidazolylsulfinyl-substituted lower alkoxy" includes a benzimidazolylsulfinyl-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, (benzimidazol-2-yl)sulfinylmethoxy, 1-(benzimidazol-4-yl)sulfinylethoxy, 3-(benzimidazol-6-yl)sulfinylpropoxy, 4-(benzimidazol-2-yl)sulfinylbutoxy, 5-(benzimidazol-7-yl)sulfinylpentyloxy, 6-(benzimidazol-2-yl)sulfinylhexyloxy, 1,1-dimethyl-2-(benzimidazol-2-yl)sulfinylethoxy, 2-methyl-3-(benzimidazol2-yl)sulfinylpropoxy, and the like.
The "tetrahydropyranyl-substituted lower alkyl" includes a tetrahydropyranyl-substituted straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, (2-, 3- or 4-tetrahydropyranyl)methyl, 2-(2-, 3- or 4-tetrahydropyranyl)ethyl, 1-(2-, 3- or 4-tetrahydropyranyl)ethyl, 3-(2-, 3- or 4-tetrahydropyranyl)propyl, 4-(2-, 3- or 4-tetrahydropyranyl)butyl, 5-(2-, 3- or 4-tetrahydropyranyl)pentyl, 6-(2-, 3- or 4-tetrahydropyranyl)hexyl, 1,1-dimethyl-2-(2-, 3- or 4-tetrahydropyranyl)ethyl, 2-
methyl-3-(2-, 3- or 4-tetrahydropyranyl)propyl, and the like.
The "5- or 6-membered saturated heterocyclic group which is formed by binding R14 and R15 together with the nitrogen atom to which they bond with being intervened or not with nitrogen, oxygen or sulfur atom" includes, for example, pyrrolidinyl, piperidinyl, piperazinyl, morpholino, thiomorpholino, and the like.
The "heterocyclic group having a substituent selected from carbamoyl, a lower alkyl, a phenyl(lower)alkyl, phenyl and a hydroxy-substituted lower alkyl"
includes the above-mentioned heterocyclic groups which have one to three substituents selected from a carbamoyl group, a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a phenylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a phenyl group and a hydroxy-substituted straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, 4-phenylpiperazinyl, 2-phenylpyrrolidinyl, 4-phenylpiperidinyl, 3-phenylmorpholino, 3-phenylthiomorpholino, 4-benzylpiperazinyl, 3-(2-phenylethyl)pyrrolidinyl, 2-(3-phenylpropyl)pyrrolidinyl, 4-(4-phenylbutyl)piperidinyl, 3-(5-phenylpentyl)morpholino, 2-(6-phenylhexyl)thiomorpholino, 4-methylpiperazinyl, 3,4-dimethylpiperazinyl, 3-ethylpyrrolidinyl, 2-propylpyrrolidinyl, 3,4,5-trimethylpiperidinyl, 4-butylpiperidinyl, 3-pentylmorpholino, 2-hexylthiomorpholino, 4-ethylpiperazinyl, 3-methyl-4-phenylpiperazinyl, 3-ethyl-4-
benzylpiperidinyl, 3-methyl-4-benzylpyrrolidinyl, 3-methyl-5-phenylmorpholino, 3-methyl-5-(2-hydroxyethyl)thiomorpholino, 4-(2-hydroxyethyl)piperazinyl, 2-(hydroxymethyl)pyrrolidinyl, 4-(4-hydroxybutyl)piperidinyl, 2-(5-hydroxypentyl)thiomorpholino, 3-(6-hydroxyhexyl)morpholino, 2-methyl-4-(2-hydroxyethyl)pyrrolidinyl, 2-carbamoylpyrrolidinyl, 3-carbamoylpyrrolidinyl, 4-carbamoylpiperazinyl, 3-carbamoylpiperazinyl, 2-carbamoylpiperazinyl, 4-carbamoylpiperidinyl, 3-carbamoylpiperidinyl, 2-carbamoylpiperidinyl, 3-carbamoylmorpholino, 2-carbamoylthiomorpholino, 2-methyl-3-carbamoylpyrrolidinyl, 3-methyl-4-carbamoylpiperidinyl, 2,6-dimethyl-4-carbamoylpiperazinyl, and the like.
The "amino having optionally a phenyl(lower)alkoxycarbonyl substituent" includes an amino group which may optionally have a substituent of a phenylalkoxycarbonyl group wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, amino, benzyloxycarbonylamino, ( 2-phenylethoxycarbonyl)amino, (1-phenylethoxycarbonyl)amino, (3-phenylpropoxycarbonyl)amino, (4-phenylbutoxycarbonyl)amino, (5-phenylpentyloxycarbonyl)amino, (6-phenylhexyloxycarbonyl)amino, (1,1-dimethyl-2-phenylethoxycarbonyl)amino, ( 2-methyl-3-phenylpropoxycarbonyl)amino, and the like.
The "phenyl having optionally hydroxy substituent" includes a phenyl group having optionally one to three hydroxy-substituents, for example, phenyl, 4-hydroxyphenyl, 3-hydroxyphenyl, 2-hydroxyphenyl, 2,4-dihydroxyphenyl, 3,4-
dihydroxyphenyl, 2,3,4-trihydroxyphenyl, and the like.
The "phenylsulfonyl wherein the phenyl ring may optionally have a substituent selected from a lower alkyl, nitro, and an amino having optionally one or two substituents selected from a lower alkanoyl and lower alkyl" includes a phenylsulfonyl group wherein the phenyl ring may optionally have one to three substitutents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a nitro group, and an amino group having optionally one or two substituents selected from a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms and a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, phenylsulfonyl, 2-methylphenylsulfonyl, 3-methylphenylsulfonyl, 4-methylphenylsulfonyl, 2-ethylphenylsulfonyl, 3-ethylphenylsulfonyl, 4-ethylphenylsulfonyl, 4-isopropylphenylsulfonyl, 4-butylphenylsulfonyl, 2-pentylphenylsulfonyl, 3-hexylphenylsulfonyl, 2,4-dimethylphenyleulfonyl, 3,4-diethylphenylsulfonyl, 3,4,5-trimethylphenylsulfonyl, 4-aminophenylsulfonyl, 3-aminophenylsulfonyl, 2-aminophenylsulfonyl, 3,4-diaminophenylsulfonyl, 2,5-diaminophenylsulfonyl, 2,4,6-triaminophenylsulfonyl, 4-nitrophenylsulfonyl, 3-nitrophenylsulfonyl, 2-nitrophenylsulfonyl, 2,3-dinitrophenylsulfonyl, 2,6-dinitrophenylsulfonyl, 2,4,6-trinitrophenylsulfonyl, 4-acetylaminophenylsulfonyl, 4-dimethylaminophenylsulfonyl, 3-(N-methyl-N-acetylamino)phenylsulfonyl, 2-methyl-4-aminophenylsulfonyl, 3-nitro-4-methylphenylsulfonyl, 2-ethylaminophenylsulfonyl, 2-methyl-
3-diethylaminophenylsulfonyl, and the like.
The "amino-substituted lower alkyl which may optionally have a substituent selected from a lower alkyl and a lower alkanoyl" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by an amino group having optionally one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, aminomethyl, 2-aminoethyl, 1-aminoethyl, 3-aminopropyl, 4-aminobutyl, 5-aminopentyl, 6-aminohexyl, 1,1-dimethyl-2-aminoethyl, 2-methyl-3-aminopropyl, methylaminomethyl, 1-ethylaminoethyl, 2-propylaminoethyl, 3-isopropylaminopropyl, 4-butylaminobutyl, 5-pentylaminopentyl, 6-hexylaminohexyl, dimethylaminomethyl, (N-ethyl-N-propylamino)methyl, 2-(N-methyl-N-hexylamino)ethyl, 2-(acetylamino)ethyl, 3-(acetylamino)propyl, formylaminomethyl, 1-(propionylamino)ethyl, 4-(butyrylamino)butyl, 5-(pentanoylamino)pentyl, 5-(hexanoylamino)hexyl, 2-(N-methylN-acetylamino)ethyl, 1-(N-ethyl-N-acetylamino)ethyl, and the like.
The "piperidinyl having optionally a phenyl(lower)alkyl substituent" includes a piperidinyl which has
optionally a substituent of a phenylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, 4-piperidinyl, 3-piperidinyl, 2-piperidinyl, 1-benzyl-4-piperidinyl, 1-(2-phenylethyl)-3-piperidinyl, 2-(3-phenylpropyl)-5-
piperidinyl, 3-(4-phenylbutyl)-6-piperidinyl, 4-(5-phenylpentyl)-3-piperidinyl, 5-(6-phenylhexyl)-4-piperidinyl, 2-benzyl-4-piperidinyl, 1-(3-phenylpropyl)-4-piperidinyl, and the like.
The "imidazo[4,5-c]pyridylcarbonyl(lower)alkoxy" includes an imidazo[4,5-c]pyridylcarbonylalkoxy group wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, (imidazo[4,5-c]pyridin-2-yl)carbonylmethoxy, 2-(imidazo[4,5-c]pyridin-2-yl)carbonylethoxy, 1-(imidazo[4,5-c]pyridin-4- yl)carbonylethoxy, 3-(imidazo[4,5-c]pyridin-5-yl)carbonylpropoxy, 4-(imidazo[4,5-c]pyridin-7-yl)carbonylbutoxy, 5-(imidazo[4,5-c]pyridin-2-yl)carbonylpentyloxy, 6-(imidazo[4,5-c]pyridin-2-yl)carbonylhexyloxy, 1,1-dimethyl-2-(imidazo[4,5-c]pyridin-2-yl)carbonylethoxy, 2-methyl-3-(imidazo[4,5-c]pyridin-2-yl)carbonylpropoxy, and the like.
The "tri(lower alkyl)ammonium" includes an ammonium group having three of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example,
trimethylammonium, triethylammonium, tripropylammonium, triisopropylammonium, tributylammonium, tri(tert-butyl)ammonium, tripentylammonium, trihexylammonium, dimethylethylammonium, diethylpropylammonium, dimethylbutylammonium, diethylmethylammonium, dimethylhexylammonium, dipropylmethylammonium, dibutylethylammonium, methylethylpropylammonium, methylbutylpentylammonium, and the like.
The "pyridyl(lower)alkyl" include a pyridylalkyl group wherein the alkyl moiety is a straight chain or
branched chain alkyl group having 1 to 6 carbon atoms, for example, (2-pyridyl)methyl, (3-pyridyl)methyl, (4-pyridyl)methyl, 2-(2-pyridyl)ethyl, 1-(3-pyridyl)ethyl, 3-(4-pyridyl)propyl, 4-(2-pyridyl)butyl, 5-(3-pyridyl)pentyl, 6-(4-pyridyl)hexyl, 1,1-dimethyl-2-(2-pyridyl)ethyl, 2-methyl-3-(3-pyridyl)propyl, and the like.
The "lower alkyl which may optionally have a substituent selected from hydroxy and cyano" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which may optionally have one to three substituents selected from a hydroxy group and a cyano group, for example, hydroxymethyl, 2-hydroxyethyl, 1-hydroxyethyl, 3-hydroxypropyl, 2,3-dihydroxypropyl, 4-hydroxybutyl, 1,1-dimethyl-2-hydroxyethyl, 5,5,4-trihydroxypentyl, 5-hydroxypentyl, 6-hydroxyhexyl, 1-hydroxyisopropyl, 2-methyl-3-hydroxypropyl, 2,3-dihydroxyethyl, 3,4-dihydroxybutyl, 5,6-dihydroxyhexyl, cyanomethyl, 2-cyanoethyl, 1-cyanoethyl, 3-cyanopropyl, 4-cyanobutyl, 5-cyanopentyl, 6-cyanohexyl, 1,1-dimethyl-2-cyanoethyl, 2-methyl-3-cyanopropyl, and the like.
The "lower alkynyl" includes a straight chain or branched chain alkynyl group having 2 to 6 carbon atoms, for example, ethynyl, 2-propynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 2-pentynyl, 2-hexynyl, and the like.
The "pyrrolidmylcarbonyl which may optionally be substituted by a phenyl(lower)alkoxycarbonyl on the
pyrrolidine ring" includes a pyrrolidmylcarbonyl which may optionally be substituted by a phenylalkoxycarbonyl group on the pyrrolidine ring wherein the alkoxy moiety is a straight
chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, 1-benzyloxycarbonyl-2-pyrrolidinylcarbonyl, 2-pyrrolidinylcarbonyl, 1-pyrrolidinylcarbonyl, 3-pyrrolidinylearbonyl, 1-(2-phenylethoxycarbonyl)-2-pyrrolidinylcarbonyl, 2-(1-phenylethoxycarbonyl)-1-pyrrolidinylcarbonyl, 3-(3-phenylpropoxycarbonyl)-2-pyrrolidinylcarbonyl, 1-(4-phenylbutoxycarbonyl)-2-pyrrolidinylcarbonyl, 2-(5-phenylpentyloxycarbonyl)-1-pyrrolidinylcarbonyl, 2-(6-phenylhexyloxycarbonyl)-3-pyrrolidinylcarbonyl, and the like.
The "phenyl(lower)alkoxycarbonylamino" includes a phenylalkoxycarbonylammo wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, N-benzyloxycarbonylamino, N-(2-phenylethoxycarbonyl)amino, N-(1-phenylethoxycarbonyl)amino, N-(3-phenylpropoxycarbonyl)amino, N-(4-phenylbutoxycarbonyl)amino, N-(5-phenylpentyloxycarbonyl)amino, N-(6-phenylhexyloxycarbonyl)amino, N-(1,1-dimethyl-2-phenylethoxycarbonyl)amino, N-(2-methyl-3-phenylpropoxycarbonyl)amino, and the like.
The "lower alkyl having optionally a hydroxysubstituent" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which has optionally one to three hydroxy-substituents, for example, in addition to the above-mentioned lower alkyl groups, hydroxymethyl, 2-hydroxyethyl, 1-hydroxyethyl, 3-hydroxypropyl, 2,3dihydroxypropyl, 4-hydroxybutyl, 1,1-dimethyl-2-hydroxyethyl, 5,5,4-trihydroxypentyl, 5-hydroxypentyl, 6-hydroxy
hexyl, 1-hydroxyisopropyl, 2-methyl-3-hydroxypropyl, 2,3-dihydroxybutyl, 3,4-dihydroxyhexyl, 5,6-dihydroxyhexyl, 2,3,4-trihydroxybutyl, and the like.
The "hydroxy-substituted lower alkanoyl" includes a hydroxy-substituted straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms, for example, 2-hydroxyacetyl, 3-hydroxypropionyl, 2-hydroxypropionyl, 4-hydroxybutyryl, 2,2-dimethyl-3-hydroxypropionyl, 5-hydroxypentanoyl, 6-hydroxyhexanoyl, 3-methyl-4-hydroxybutyryl, and the like.
The "lower alkanoyloxy(lower)alkanoyl" includes an alkanoyloxy-substituted alkanoyl wherein both alkanoyl moieties are a straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms, for example, 2-acetyloxyacetyl, 3-propionyloxypropionyl, 2-butyryloxypropionyl, 4-pentanoyloxybutyryl, 2,2-dimethyl-3-hexanoyloxypropionyl, 5-acetyloxypentanoyl, 6-propionyloxyhexanoyl, and the like.
The "phenyl(lower)alkyl wherein the phenyl ring may optionally has a lower alkoxy substituent" includes a phenylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and the phenyl ring has optionally one to three substituents of a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, in addition to the above-mentioned phenyl(lower)alkyl groups, 2-methoxybenzyl, 3-methoxybenzyl, 2-(4-methoxyphenyl)ethyl, 1-(2-ethoxyphenyl)ethyl, 3-(4-isopropoxyphenyl)propyl, 4-(3-pentyloxyphenyl)butyl, 5-(4-hexyloxyphenyl)pentyl, 6-(2-
butyloxyphenyl)hexyl, 3,4-dimethoxybenzyl, 3-ethoxy-4-methoxybenzyl, 2,3-dimethoxybenzyl, 2,6-dimethoxybenzyl, 3,4,5-trimethoxybenzyl, and the like.
The "cycloalkenylcarbonyl" includes a cycloalkenylcarbonyl group having 3 to 8 carbon atoms, for example, cyclopropenylcarbonyl, cyclobutenylcarbonyl, cyclopentenylcarbonyl, cyclohexenylcarbonyl, cycloheptenylcarbonyl, cyclooctenylcarbonyl, and the like.
The "pyrimidylthio-substituted lower alkoxy" includes a pyrimidylthio-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, (2-pyrimidyl)thiomethoxy, 2-(4-pyrimidyl)thioethoxy, 1-(5-pyrimidyl)thioethoxy, 3-(6-pyrimidyl)thiopropoxy, 4-(4-pyrimidyl)thiobutoxy, 5-(2-pyrimidyl)thiopentyloxy, 6-(5-pyrimidyl)thiohexyloxy, 1,1-dimethyl-2-(2-pyrimidyl)thioethoxy, 2-methyl-3-(2-pyrimidyl)thiopropoxy, and the like.
The "pyrimidylsulfinyl-substituted lower alkoxy" includes a pyrimidylsulfinyl-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, (2-pyrimidyl)sulfinylmethoxy, 2-(4-pyrimidyl)sulfinylethoxy, 1-(5-pyrimidyl)sulfinylethoxy, 3-(6-pyrimidyl)sulfinylpropoxy, 4-(4-pyrimidyl)sulfinylbutoxy, 5- (2-pyrimidyl)sulfinylpentyloxy, 6-(5-pyrimidyl)sulfinylhexyloxy, 1,1-dimethyl-2-(2-pyrimidyl)sulfinylethoxy, 2-methyl-3-(2-pyrimidyl)sulfinylpropoxy, and the like.
The "pyrimidylsulfonyl-substituted lower alkoxy" includes a pyrimidylsulfonyl-substituted straight chain or
branched chain alkoxy group having 1 to 6 carbon atoms, for example, (2-pyrimidyl)sulfonylmethoxy, 2-(4-pyrimidyl)sulfonylethoxy, 1-(5-pyrimidyl)sulfonylethoxy, 3-(6-pyrimidyl)sulfonylpropoxy, 4-(4-pyrimidyl)sulfonylbutoxy, 5-(2-pyrimidyl)sulfonylpentyloxy, 6-(5-pyrimidyl)sulfonylhexyloxy, 1,1-dimethyl-2-(2-pyrimidyl)sulfonylethoxy, 2-methyl-3-(2-pyrimidyl)sulfonylpropoxy, and the like.
The "imidazolylthio-substituted lower alkoxy which may optionally have a lower alkyl substituent " includes a imidazolylthio-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which may optionally have a substituent of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms on the imidazolyl group, for example, (2-imidazolyl)thiomethoxy, 2-(4-imidazolyl)thioethoxy, 1-(5-imidazolyl)thioethoxy, 3-(2- imidazolyl) thiopropoxy, 4-(4-imidazolyl)thiobutoxy, 5-(2-imidazolyl)thiopentyloxy, 6-(5-imidazolyl)thiohexyloxy, 1,1-dimethyl-2-(2-imidazolyl)thioethoxy, 2-methyl-3-(2-imidazolyl)thiopropoxy, (4-methyl-2-imidazolyl)thiomethoxy, 2-(5-ethyl-4-imidazolyl)thioethoxy, 1-(4-propyl-5-imidazolyl)thioethoxy, 3-(1-butyl-2-imidazolyl)thiopropoxy, 4-(2-pentyl-4-imidazolyl)thiobutoxy, 5-(1-methyl-2-imidazolyl)thiopentyloxy, 6-(1-hexyl-5-imidazolyl)thiohexyloxy, 1,1- dimethyl-2-(1-ethyl-2-imidazolyl)thioethoxy, 2-methyl-3-(1-propyl-2-imidazolyl)thiopropoxy, and the like.
The "imidazolylsulfonyl-substituted lower alkoxy which may optionally have a lower alkyl substituent" includes a imidazolylsulfonyl-substituted straight chain or
branched chain alkoxy group having 1 to 6 carbon atoms which may optionally have a substituent of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms on the imidazolyl group, for example, (2-imidazolyl)sulfonylmethoxy, 2-(4-imidazolyl)sulfonylethoxy, 1-(5-imidazolyl)sulfonylethoxy, 3-(2-imidazolyl)sulfonylpropoxy, 4-(4-imidazolyl)sulfonylbutoxy, 5-(2-imidazolyl)sulfonylpentyloxy, 6-(5-imidazolyl)sulfonylhexyloxy, 1,1-dimethyl-2-(2-imidazolyl)sulfonylethoxy, 2-methyl-3-(2-imidazolyl)sulfonylpropoxy, (4-methyl-2-imidazolyl)sulfonylmethoxy, 2-(5-ethyl-4-imidazolyl)sulfonylethoxy, 1-(4-propyl-5-imidazolyl)sulfonylethoxy, 3-(1-butyl-2-imidazolyl)sulfonylpropoxy, 4-(2-pentyl-4-imidazolyl)sulfonylbutoxy, 5-(1-methyl-2-imidazolyl)sulfonylpentyloxy, 6-(1-hexyl-5-imidazolyl)sulfonylhexyloxy, 1,1-dimethyl-2-(1-ethyl-2-imidazolyl)sulfonylethoxy, 2-methyl-3-(1-propyl-2-imidazolyl)sulfonylpropoxy, and the like.
The "ammonium-substituted lower alkoxy having three substituents selected from a lower alkyl, a lower alkenyl and oxo" includes an ammonium-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, which have three substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkenyl group having 2 to 6 carbon atoms, and an oxo group, for example, trimethylammoniummethoxy, 2-(triethylammonium)ethoxy, 1-(tripropylammonium)ethoxy, 3-(tributylammonium)propoxy, 4-(tripentylammonium)butoxy, 5-(triethylammonium)pentyloxy, 6-(trihexyl
ammonium)hexyloxy, 1,1-dimethyl-2-(triallylammonium)ethoxy, 2-methyl-3-(tributenylammonium)propoxy, tri(1-methylallyl)ammonium-methoxy, 2-[tri(2-pentenyl)ammonium]ethoxy, 1-[tri(2-hexenyl)ammonium]ethoxy, 3-(N-allyl-N,N-dimethylammonium)propoxy, 4-(N,N-diallyl-N-methylammonium)butoxy, 5-(N-allyl-N-methylamino)pentyloxy N-oxide, 6-(N-allyl-N-ethylamino)hexyloxy N-oxide, 5-(N-allyl-N-methyl-N-ethylammonium)pentyloxy, and the like.
The "phenylthio(lower)alkoxy wherein the phenyl ring may optionally have a substituent selected from nitro and an amino" includes a phenylthioalkoxy wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, and the phenyl ring may
optionally have one to three substituents selected from a nitro group and an amino group, for example, phenylthiomethoxy, 2-phenylthioethoxy, 1-phenylthioethoxy, 3-phenylthiopropoxy, 4-phenylthiobutoxy, 5-phenylthiopentyloxy, 6-phenylthiohexyloxy, 1,1-dimethyl-2-phenylthioethoxy, 2-methyl-3-phenylthiopropoxy, (2-nitrophenyl)thiomethoxy, 2-(3-nitrophenyl)thioethoxy, 1-(4-nitrophenyl)thioethoxy, 3-(2,3-dinitrophenyl)thiopropoxy, 4-(3,4-dinitrophenyl)thiobutoxy, 5-(4-nitrophenyl)thiopentyloxy, 6-(2,6-dinitrophenyl)thiohexyloxy, 1,1-dimethyl-2-(2,4,6-trinitrophenyl)thioethoxy, 2-methyl-3-(4-nitrophenyl)thiopropoxy, (2-aminophenyl)thiomethoxy, 2-(3-aminophenyl)thioethoxy, 1-(4-aminophenyl)thioethoxy, 3-(2,3-diaminophenyl)thiopropoxy, 4-(3,4-diaminophenyl)thiobutoxy, 5-(4-aminophenyl)thiopentyloxy, 6-(2,6-diaminophenyl)thiohexyloxy, 1,1-dimethyl-2-
(2,4,6-triaminophenyl)thioethoxy, 2-methyl-3-(4-aminophenyl)thiopropoxy, and the like.
The "phenylsulfonyl(lower)alkoxy wherein the phenyl ring may optionally have a substituent selected from nitro and an amino having optionally one or two substituents selected from a lower alkanoyl and a lower alkyl" includes a phenylsulfonylalkoxy wherein the alkoxy moiety is a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, and the phenyl ring may optionally have one to three substituents selected from a nitro group and an amino group having opitonally one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, phenylsulfonylmethoxy, 2-phenylsulfonylethoxy, 1-phenylsulfonylethoxy, 3-phenylsulfonylpropoxy, 4-phenylsulfonylbutoxy, 5-phenylsulfonylpentyloxy, 6-phenylsulfonylhexyloxy, 1,1-dimethyl-2-phenylsulfonylethoxy, 2-methyl-3-phenylsulfonylpropoxy, (2-aminophenyl)sulfonylmethoxy, 5-(4-aminophenyl)sulfonylpentyloxy, 2-(4-methylaminophenyl)sulfonylethoxy, 1-(3-ethylaminophenyl)sulfonylethoxy, 3-[2-(N-methyl-N-ethylamino)phenyl]sulfonylpropoxy, 4-[3-(N-methyl-N-hexylamino)phenyl]sulfonylbutoxy, 5-(4-dimethylaminophenyl)sulfonylpentyloxy, 4-dipentylaminophenylsulfonylmethoxy, 2-(2-isopropylaminophenyl)sulfonylethoxy, 1-(3-butylaminophenyl)sulfonylethoxy, 5-(2,4-diaminophenyl)sulfonylpentyloxy, 3-[2,3-bis(dimethylamino)phenyl]sulfonylpropoxy, 4-[3,4-bis-(methylamino)phenyl]sulfonylbutoxy, 5-(2,4,6-triamino
phenyl)sulfonylpentyloxy, 6-[3,4,5-tri(methylamino)phenyl]sulfonylhexyloxy, 5-(4-acetylaminophenyl)sulfonylpentyloxy, 3-[4-(N-methyl-N-acetylamino)phenyl]sulfonylpropoxy, 5-(4-nitrophenyl)sulfonylpentyloxy, 2-(4-nitro-3-methylaminophenyl)sulfonylethoxy, 3-(2,4-dinitrophenyl)sulfonylpropoxy, 4-(2,4,6-trinitrophenyl)sulfonylbutoxy, and the like.
The "pyridylthio-substituted lower alkoxy" includes a pyridylthio-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, (2-pyridyl)thiomethoxy, 2-(3-pyridyl)thioethoxy, 1-(4-pyridyl)thioethoxy, 3-(3-pyridyl)thiopropoxy, 4-(4-pyridyl)thiobutoxy, 5-(2-pyridyl)thiopentyloxy, 5-(4-pyridyl)thiopentyloxy, 6-(3-pyridyl)thiohexyloxy, 1,1-dimethyl-2-(2-pyridyl)thioethoxy, 2-methyl-3-(4-pyridyl)thiopropoxy, and the like.
The "pyridylsulfonyl-substituted lower alkoxy which may optionally have an oxo subsituent on the pyridine ring" includes a pyridylsulfonyl-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which may optionally have an oxo substituent on the pyridine ring, for example, (2-pyridyl)sulfonylmethoxy, 2-(3-pyridyl)sulfonylethoxy, 1-(4-pyridyl)sulfonylethoxy, 3-(3-pyridyl)sulfonylpropoxy, 4-(4-pyridyl)sulfonylbutoxy, 5-(2-pyridyl)sulfonylpentyloxy, 5-(4-pyridyl)sulfonylpentyloxy, 6- ( 3-pyr idyl ) sulfonylhexyloxy , 1 , 1-dimethyl-2- ( 2-pyridyl)sulfonylethoxy, 2-methyl-3-(4-pyridyl)sulfonylpropoxy, 5-(1-oxido-4-pyridyl)sulfonylpentyloxy, (4-oxo-2-pyridyl)sulfonylmethoxy, 2-(1-oxo-3-pyridyl)sulfonylethoxy, 1-(2-oxo-4-pyridyl)sulfonylethoxy, 3-(2-oxo-3-pyridyl)sulfonyl
propoxy, 4-(3-oxo-4-pyridyl)sulfonylbutoxy, 5-(1-oxido-2-pyridyl)sulfonylpentyloxy, 6-(1-oxido-3-pyridyl)sulfonylhexyloxy, and the like.
The "cycloalkylcarbonyl having optionally one to three substituents selected from hydroxy and a lower
alkanoyloxy" includes a cycloalkylcarbonyl having 3 to 8 carbon atoms which has optionally one to three substituents selected from a hydroxy group and a straight chain or branched chain alkanoyloxy group having 2 to 6 carbon atoms, for example, cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, cycloheptylcarbonyl, cyclooctylcarbonyl, 2-hydroxycyclopropylcarbonyl, 3-hydroxycyclobutylcarbonyl, 2-hydroxycyclopentylcarbonyl, 3-hydroxycyclopentylcarbonyl, 2,4-dihydroxycyclopentylcarbonyl, 2-hydroxycyclohexylcarbonyl, 3-hydroxycyclohexylcarbonyl, 4-hydroxycyclohexylcarbonyl, 3,4-dihydroxycyclohexylcarbonyl, 2,4-dihydroxycyclohexylcarbonyl, 2,5-dihydroxycyclohexylcarbonyl, 3,4,5-trihydroxycyclohexylcarbonyl, 3-hydroxycycloheptylcarbonyl, 3,4-dihydroxycycloheptylcarbonyl, 2,3,4-trihydroxycycloheptylcarbonyl, 4-hydroxycyclooctylcarbonyl, 4,5-dihydroxycyclooctylcarbonyl, 4,5,6-trihydroxycyclooctylcarbonyl, 2-acetyloxycyclopropylcarbonyl, 3-propionyloxycyclobutylcarbonyl, 2-butyryloxycyclopentylcarbonyl, 3-pentanoyloxycyclopentylcarbonyl, 2,4- dihexanoyloxycyclopentylcarbonyl, 2-acetyloxycyclohexylcarbonyl, 3-propionyloxycyclohexylcarbonyl, 4-butyryloxycyclohexylcarbonyl, 3,4-diacetyloxycyclohexylcarbonyl, 2,4-diacetyloxycyclohexylcarbonyl, 2,5-diacetyloxycyclohexyl
carbonyl, 3,4,5-triacetyloxycyclohexylcarbonyl, 3,4-diacetyloxy-5-hyroxycyclohexylcarbonyl, 3-pentanoyloxycycloheptylcarbonyl, 3,4-diacetyloxycycloheptylcarbonyl, 2,3,4-tripropionyloxycycloheptylcarbonyl, 4-hexanoyloxycyclooctylcarbonyl, 4,5-dibutyryloxycyclooctylcarbonyl, 4,5,6-triacetyloxycyclooctylcarbonyl, and the like.
The "tetrahydroypyranyl(lower)alkyl wherein the tetrahydroxypyranyl ring may optionally have one to four substituents selected from hydroxy and a lower alkoxy" includes a tetrahydropyranylalkyl wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, and the tetrahydropyranyl ring may optionally have one to four substituents selected from a hydroxy group and a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, (2-tetrahydropyranyl)methyl, 2-(3-tetrahydropyranyl)ethyl, 1-(4-tetrahydropyranyl)ethyl, 3-(2-tetrahydropyranyl)propyl, 4-(3-tetrahydropyranyl)butyl, 5-(4-tetrahydropyranyl)pentyl, 6-(2-tetrahydropyranyl)hexyl, 1,1-dimethyl-2-(3-tetrahydropyranyl)ethyl, 2-methyl-3-(4-tetrahydropyranyl)propyl, (3-hydroxy-2-tetrahydropyranyl)methyl, 2-(2,4-dihydroxy-3-tetrahydropyranyl)ethyl, 1-(2,3,5-trihydroxy-4-tetrahydropyranyl)ethyl, 3-(6-methoxy-2-tetrahydropyranyl)propyl, 4-(4-ethoxy-3-tetrahydropyranyl)butyl, 5-(4,6-dimethoxy-4-tetrahydropyranyl)pentyl, 6-(4,5,6-trimethoxy-2-tetrahydropyranyl)hexyl, 1,1-dimethyl-2-(2-propoxy-3-tetrahydropyranyl)ethyl, 2-methyl-3-(6-butoxy-4-tetrahydropyranyl)propyl, (6-pentyloxy-2-tetrahydropyranyl)methyl, 2-(4-
hexyloxy-3-tetrahydropyranyl)ethyl, 2-(3,4,5-trihydroxy-6-methoxy-2-tetrahydropyranyl)methyl, 1-(3,4,5,6-tetrahydroxy-2-tetrahydropyranyl)ethyl, 3-(3,4,5,6-tetramethoxy-2-tetrahydropyranyl)propyl, and the like.
The "lower alkanoyl substituted by a 5- or 6-membered saturated heterocyclic group selected from pyrrolidinyl, piperazinyl, piperidinyl, and morpholinyl" includes a straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms which is substituted by a 5- or 6-membered saturated heterocyclic group selected from pyrrolidinyl, piperazinyl, piperidinyl, and morpholinyl, for example, 2-(1-pyrrolidinyl)acetyl, 3- ( 2-pyr rol idinyl ) propionyl , 2- ( 3-pyr rolidinyl ) propionyl , 4-(1-pyrrolidinyl)butyryl, 2,2-dimethyl-3-(2-pyrrolidinyl)propionyl, 5-(3-pyrrolidinyl)pentanoyl, 6-(1-pyrrolidinyl)hexanoyl, 2-(1-piperazinyl)acetyl, 3-(2-piperazinyl)propionyl, 2-(3-piperazinyl)propionyl, 4-(1-piperazinyl)butyryl, 2,2-dimethyl-3-(2-piperazinyl)propionyl, 5-(3-piperazinyl)pentanoyl, 6-(1-piperazinyl)hexanoyl, 2-(1-piperidinyl)acetyl, 3-(2-piperidinyl)propionyl, 2-(3-piperidinyl)propionyl, 4-(4-piperidinyl)butyryl, 2,2-dimethyl-3-(1-piperidinyl)propionyl, 5-(2-piperidinyl)pentanoyl, 6-(3-piperidinyl)hexanoyl, 2-(4-morpholinyl)acetyl, 3-(2-morpholinyl)propionyl, 2-(3-morpholinyl)propionyl, 4-(4-morpholinyl)butyryl, 2,2-dimethyl-3-(2-morpholinyl)propionyl, 5-(3-morpholinyl)pentanoyl, 6-(4-morpholinyl)hexanoyl, and the like.
The above "heterocyclic group-substituted lower
alkanoyl which has a substituent selected from a lower alkyl and phenyl" includes the above heterocyclic group-substituted straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms, which has one to three substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, and a phenyl group, for example, 2-(2-methyl-1-pyrrolidinyl)acetyl, 3-(1-ethyl-2-pyrrolidinyl)propionyl, 2-(1-propyl-3-pyrrolidinyl)propionyl, 4-(3-butyl-1-pyrrolidinyl)butyryl, 2, 2-dimethyl-3-(4-pentyl-2-pyrrolidinyl)propionyl, 5-(1-hexyl-3-pyrrolidinyl)pentanoyl, 6-(2,3-dimethyl-1-pyrrolidinyl)hexanoyl, 2-(2,3,4-trimethyl1-pyrrolidinyl) acetyl, 3-(1-phenyl-2-pyrrolidinyl)propionyl, 2-(1-methyl-2-phenyl-3-pyrrolidinyl)propionyl, 2-(4-methyl-1-piperazinyl)acetyl, 2-(4-phenyl-1-piperazinyl)acetyl, 3-(4-ethyl-2-piperazinyl)propionyl, 2-(4-propyl-3-piperazinyl)propionyl, 4-(4-butyl-1-piperazinyl)butyryl, 2,2-dimethyl-3-(4-pentyl-2-piperazinyl)propionyl, 5-(4-hexyl-3-piperazinyl)pentanoyl, 6-(2,4-dimethyl-1-piperazinyl)hexanoyl, 2-(3,4,5-trimethyl-1-piperazinyl)acetyl, 2-(4-phenyl-3-methyl-1-piperazinyl)acetyl, 2-(4-methyl-1-piperidinyl)acetyl, 3-(1-ethyl-2-piperidinyl)propionyl, 2-(1-propyl-3-piperidinyl)propionyl, 4-(1-butyl-4-piperidinyl)butyryl, 2,2-dimethyl-3-(4-pentyl-1-piperidinyl)propionyl, 5-(1-hexyl-2-piperidinyl)pentanoyl, 6-(1-phenyl-3-piperidinyl)hexanoyl, 2-(2,5-dimethyl-4-phenyl-1-piperidinyl)acetyl, 2-(2,3,4-trimethyl-1-piperidinyl)acetyl, 2-(1,2-dimethyl-4-piperidinyl)acetyl, 2-(3-methyl-1-morpholinyl)acetyl, 3-(1-ethyl-2-morpholinyl)propionyl, 2-(1-propyl-3-
morpholinyl)propionyl, 4-(2-butyl-4-morpholinyl)butyryl, 2,2-dimethyl-3-(1-pentyl-2-morpholinyl)propionyl, 5-(2-hexyl-3-morpholinyl)pentanoyl, 6-(3,5-dimethyl-4-morpholinyl)hexanoyl, 2-(2,3,5-trimethyl-4-morpholinyl)acetyl, 2-(3-phenyl-4-morpholinyl)acetyl, 2-(2-methyl-3-phenyl-4-morpholinyl)acetyl, and the like.
The "piperidinylcarbonyl which may optionally have a lower alkanoyl substituent" includes a piperidinylcarbonyl which may optionally have a substituent of a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, (1-piperidinyl)carbonyl, (2-piperidinyl)carbonyl, ( 3-piperidinyl)carbonyl, (4-piperidinyl)carbonyl, (1-acetyl-4-piperidinyl)carbonyl, (4-formyl-1-piperidinyl)carbonyl, ( 3-propionyl-2-piperidinyl)carbonyl, ( 1-butyryl-4-piperidinyl)carbonyl, (1-pentanoyl-4-piperidinyl)carbonyl, (1-hexanoyl-4-piperidinyl)carbonyl, and the like.
The "lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, tertbutoxy, pentyloxy, hexyloxy, and the like.
The "amino having optionally a lower alkyl substituent" includes an amino optionally having one to two straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, amino, methylamino, ethylamino, propyl amino, isopropylamino, butylamino, tert-butylamino, pentylamino, hexylamino, dimethylamino, diethylamino, dipropylamino, dibutylamino, dipentylamino, dihexylamino, N-methyl-N-ethylamino, N-ethyl-N-propylamino, N-methyl-N-
butylamino, N-methyl-N-hexylamino, and the like.
The "lower alkyl which has optionally a substituent selected from a halogen atom and hydroxy" includes a
straight chain or branched chain alkyl group having 1 to 6 carbon atoms which may optionally have 1 to 3 substituents selected from a halogen atom and hydroxy, for example, in addition to the above-mentioned lower alkyl groups, hydroxymethyl, 2-hydroxyethyl, 1-hydroxyethyl, 3-hydroxypropyl, 2,3-dihyroxypropyl, 4-hydroxybutyl, 1,1-dimethyl-2-hydroxyethyl, 5,5,4-trihydroxypentyl, 5-hydroxypentyl, 6-hydroxyhexyl, 1-hydroxyisopropyl, 2-methyl-3-hydroxypropyl,
trifluoromethyl, trichloromethyl, chloromethyl, bromomethyl, fluoromethyl, iodomethyl, difluoromethyl, dibromomethyl, 2-chloroethyl, 2 ,2,2-trifluoroethyl, 2,2,2-trichloroethyl, 3-chloropropyl, 2,3-dichloropropyl, 4,4,4-trichlorobutyl, 4-fluorobutyl, 5-chloropentyl, 3-chloro-2-methylpropyl, 5-bromohexyl, 5,6-dichlorohexyl, and the like.
The "amino having optionally a substituent selected from a lower alkyl and a lower alkanoyl" includes an amino having optionally one or two substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and a st raight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, amino, methylamino, ethylamino, propylamino, isopropylamino, butylamino, tert-butylamino, pentylamino, hexylamino, dimethylamino, diethylamino, dipropylamino, dibutylamino, dipentylamino, dihexylamino, N-methyl-N-ethylamino, N-ethylN-propylamino, N-methyl-N-butylamino, N-methyl-N-hexylamino,
N-methyl-N-acetylamino, N-acetylamino, N-formylamino, N-propionylamino, N-butyrylamino, N-isobutyrylamino, N-pentanoylamino, N-tert-butylcarbonylamino, N-hexanoylamino, N-ethyl-N-acetylamino, and the like.
The "carbamoyl-substituted lower alkoxy" includes a carbamoyl-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms , for example , carbamoylmethoxy , 2-carbamoylethoxy, 1-carbamoylethoxy, 3-carbamoylpropoxy, 4-carbamoylbutoxy, 5-carbamoylpentyloxy, 6-carbamoylhexyloxy, 1,1-dimethyl-2-carbamoylethoxy, 2-methyl-3-carbamoylpropoxy, and the like .
The "hydroxy-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms and having 1 to 3 hydroxy-substitutents, for example, hydroxymethoxy, 2-hydroxyethoxy, 1-hydroxyethoxy, 3-hydroxypropoxy, 2,3-dihydroxypropoxy, 4-hydroxybutoxy, 3,4-dihydroxybutoxy, 1,1-dimethyl-2-hydroxyethoxy, 5-hydroxypentyloxy, 6-hydroxyhexyloxy, 2-metnyl-3-hydroxypropoxy, 2,3,4-trihydroxybutoxy, and the like.
The "lower alkoxycarbonyl-substituted lower alkoxy" includes an alkoxycarbonyl-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, methoxycarbonylmethoxy, 3-methoxycarbonylpropoxy, ethoxycarboxymethoxy, 3-ethoxycarbonylpropoxy, 4-ethoxycarbonylbutoxy, 5-isopropoxycarbonylpentyloxy, 6-propoxycarbonylhexyloxy, 1,1-dimethyl-2-butoxy
carbonylethoxy, 2-methyl-3-tert-butoxycarbonylpropoxy, 2-pentyloxycarbonylethoxy, hexyloxycarbonylmethoxy, and the like.
The "carboxy-substituted lower alkoxy" includes a carboxy-substituted straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, for example, carboxymethoxy, 2-carboxyethoxy, 1-carboxyethoxy, 3-carboxypropoxy, 4-carboxybutoxy, 5-carboxypentyloxy, 6-carboxyhexyloxy, 1,1-dimethyl-2-carboxyethoxy, 2-methyl-3-carboxypropoxy, and the like.
The "phthalimido-substituted lower alkoxy" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by phthalimido group, for example, phthalimidomethoxy, 2-phthalimidoethoxy, 1-phthalimidoethoxy, 3-phthalimidopropoxy, 4-phthalimidobutoxy, 5-phthalimidopentyloxy, 6-phthalimidohexyloxy, 1,1-dimethyl-2-phthalimidoethoxy, 2-methyl-3-phthalimidopropoxy, and the like.
The "5- or 6-membered saturated heterocyclic group which is formed by binding the groups R21 and R22 together with the nitrogen atom to which they bond with or without being intervened with nitrogen or oxygen atom" includes, for example, pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and the like.
The above-mentioned "heterocyclic group having a substituent selected from piperidinyl and a lower alkyl" includes the above-mentioned heterocyclic groups having 1 to 3 substituents selected from piperidinyl and a straight
chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, 4-methylpiperazinyl, 3,4-dimethylpiperazinyl, 3-ethylpyrrolidinyl, 2-propylpyrrolidinyl, 3,4,5-trimethylpiperidinyl, 4-butylpiperidinyl, 3-pentylmorpholino, 4-hexylpiperazinyl, 4-(1-piperidinyl)piperidinyl, 3-(1-piperidinyl)pyrrolidinyl, 3-(1-piperidinyl)-4-methylpiperazinyl, 3-(1-piperidinyl)morpholino, and the like.
The "phenyl(lower)alkanoyl" includes a phenylalkanoyl wherein the alkanoyl moiety is a straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms, for example, phenylacetyl, 3-phenylpropionyl, 2-phenylpropionyl, 4-phenylbutyryl, 2,2-dimethyl-3-phenylpropionyl, 5-phenylpentanoyl, 6-phenylhexanoyl, and the like.
The "cycloalkyl-lower alkanoyl" includes C3-C8 cycloalkyl-alkanoyl group wherein the alkanoyl moiety is a straight chain or branched chain alkanoyl having 2 to 6 carbon atoms, for example, cyclohexylacetyl, 3-cyclopropylpropionyl, 2-cyclopentylpropionyl, 4-cyclohexylbutyryl, 2,2-dimethyl-3-cycloheptylpropionyl, 5-cyclooctylpentanoyl, 6-cyclohexylhexanoyl, and the like.
The "cycloalkylcarbonyl" includes a cycloalkylcarbonyl having 3 to 8 carbon atoms, for example,
cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexylcarbonyl, cycloheptylcarbonyl,
cyclooctylcarbonyl, and the like.
The "phenoxy-lower alkanoyl wherein the phenyl ring has optionally 1 to 3 substituents selected from a lower
alkyl, a lower alkoxy and an amino having optonally a lower alkanoyl substituent" includes a phenoxyalkanoyl group wherein the alkanoyl moiety is a straight chain or branched chain alkanoyl having 2 to 6 carbon atoms and the phenyl ring has optionally 1 to 3 substituents selected from a straight chain or branched chain alkyl having 1 to 6 carbon atoms, a straight chain or branched chain alkoxy having 1 to 6 carbon atoms and an amino having optionally a straight chain or branched chain alkanoyl having 1 to 6 carbon atoms, for example, phenoxyacetyl, 3-phenoxypropionyl, 2-phenoxypropionyl, 4-phenoxybutyryl, 2,2-dimethyl-3-phenoxypropionyl, 5-phenoxypentanoyl, 6-phenoxyhexanoyl, (2-aminophenoxy) acetyl, 3-(4-aminophenoxy)propionyl, (2-methylphenoxy)acetyl, (4-methylphenoxy)acetyl, (3-methylphenoxy)acetyl, (3-methoxyphenoxy)acetyl, ( 3-acetylaminophenoxy)acetyl, 4-(2-propionylaminophenoxy)butyryl, 2,2-dimethyl-3-(4-butyrylaminophenoxy)propionyl, 5-(2-pentanoylaminophenoxy)pentanoyl, 6-(4-hexanoylaminophenoxy)hexanoyl, 3-(2-ethylphenoxy)propionyl, 2-(4-propylphenoxy)propionyl, 4-(4-butylphenoxy)butyryl, 5-(3-pentylphenoxy)pentanoyl, 6-(4-hexylphenoxy)hexanoyl, (2,3-dimethylphenoxy)acetyl, (2,5-dimethylphenoxy)acetyl, (3,4-dimethylphenoxy)acetyl, (3,4,5-trimethylphenoxy)acetyl, 3-(4-ethoxyphenoxy)propionyl, 2-(2-propoxyphenoxy)propionyl, 4-(3-butoxyphenoxy)butyryl, 5-(4-pentyloxyphenoxy)pentanoyl, 6-(4-hexyloxyphenoxy)hexanoyl, (3,4-dimethoxyphenoxy)acetyl, (3,5-dimethoxyphenoxy)acetyl, (2,4-dimethoxyphenoxy)acetyl, (3,4,5-trimethoxyphenoxy)acetyl, (2-acetylamino-4-methylphenoxy)acetyl, (4-acetyl
amino-3-methoxyphenoxy)acetyl, and the like.
The "phthalimido-substituted lower alkanoyl" includes a straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms which is substituted by
phthalimido group, for example, 2-phthalimidoacetyl, 3-phthalimidopropionyl, 2-phthalimidopropionyl, 4-phthalimidobutyryl, 2,2-dimethyl-3-phthalimidopropionyl, 5-phthalimidopentanoyl, 6-phthalimidohexanoyl, 3-methyl-4-phthalimidobutyryl, and the like.
The "lower alkoxycarbonyl-lower alkanoyl" includes an alkoxycarbonyl-alkanoyl group wherein the alkoxy moiety is a straight chain or branched chain alkoxy having 1 to 6 carbon atoms and the alkanoyl moiety is a straight chain or branched chain alkanoyl having 2 to 6 carbon atoms, for example, methoxycarbonylacetyl, 3-methoxycarbonylpropionyl, ethoxycarbonylacetyl, 3-ethoxycarbonylpropionyl, 4-ethoxycarbonylbutyryl, 3-propoxycarbonylpropionyl, 2-methoxycarbonylpropionyl, 6-propoxycarbonylhexanoyl, 5-isopropoxycarbonylpentanoyl, 2,2-dimethyl-3-butoxycarbonylpropionyl, 2-methyl-3-tert-butoxycarbonylpropionyl, pentyloxycarbonylacetyl, hexyloxycarbonylacetyl, and the like.
The "carboxy-lower alkanoyl" includes a carboxyalkanoyl group wherein the alkanoyl moiety is a straight chain or branched chain alkanoyl having 2 to 6 carbon atoms, for example, carboxyacetyl, 3-carboxypropionyl, 2-carboxypropionyl, 4-carboxybutyryl, 2,2-dimethyl-3-carboxypropionyl, 5-carboxypentanoyl, 6-carboxyhexanoyl, and the like.
The "naphthyloxy-lower alkanoyl" includes a
naphthyloxy-alkanoyl group wherein the alkanoyl moiety is a straight chain or branched chain alkanoyl having 2 to 6 carbon atoms, for example, naphtyloxyacetyl, 3-naphtyloxypropionyl, 2-naphtyloxypropionyl, 4-naphthyloxybutyryl, 2,2-dimethyl-3-naphthyloxypropionyl, 5-naphthyloxypentanoyl, 6-naphthyloxyhexanoyl, and the like.
The "phenyl-lower alkoxycarbonyl" includes a phenylalkoxycarbonyl wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, benzyloxycarbonyl, 2-phenylethoxycarbonyl, 1-phenylethoxycarbonyl, 3-phenylpropoxycarbonyl, 4-phenylbutoxycarbonyl, 5-phenylpentyloxycarbonyl, 6-phenylhexyloxycarbonyl, 1,1-dimethyl-2-phenylethoxycarbonyl, 2-methyl-3-phenylpropoxycarbonyl, and the like.
The "phenoxy-lower alkyl" includes a phenoxyalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, phenoxymethyl, 1-phenoxyethyl, 2-phenoxyethyl, 3-phenoxypropyl, 4-phenoxybutyl, 5-phenoxypentyl, 6-phenoxyhexyl, 1,1-dimethyl-2-phenoxyethyl, 2-methyl-3-phenoxypropyl, and the like.
The "phenyl which has optionally 1 to 3
substituents selected from a lower alkyl, a lower alkoxy and a halogen atom" includes a phenyl group which has optionally 1 to 3 substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a
straight chain or branched chain alkoxy group having 1 to 6 carbon atoms and a halogen atom, for example, phenyl, 2-methoxyphenyl, 3-methoxyphenyl, 4-methoxyphenyl, 2-ethoxyphenyl, 3-ethoxyphenyl, 4-ethoxyphenyl, 4-isopropoxyphenyl, 4-pentyloxyphenyl, 2,4-dimethoxyphenyl, 4-hexyloxyphenyl, 3,4-dimethoxyphenyl, 3-ethoxy-4-methoxyphenyl, 2,3-dimethoxyphenyl, 3,4-diethoxyphenyl, 2,5-dimethoxyphenyl, 2,6-dimethoxyphenyl, 3,5-dimethoxyphenyl, 3,4-dipentyloxyphenyl, 3,4,5-trimethoxyphenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2-fluorophenyl, 3-fluorophenyl, 4fluorophenyl, 2-bromophenyl, 3-bromophenyl, 4-bromophenyl, 2-iodophenyl, 3-iodophenyl, 4-iodophenyl, 3,4-dichlorophenyl, 3,5-dichlorophenyl, 2,6-dichlorophenyl, 2,3- dichlorophenyl, 2,4-dichlorophenyl, 3,4-difluorophenyl, 3,5- dibromophenyl, 3,4,5-trichlorophenyl, 2-methoxy-3-chlorophenyl, 2-methylphenyl, 3-methylphenyl, 4-methylphenyl, 2- ethylphenyl, 3-ethylphenyl, 4-ethylphenyl, 4-isopropylphenyl, 3-butylphenyl, 4-pentylphenyl, 4-hexylphenyl, 3,4- dimethylphenyl, 3,4-diethylphenyl, 2,4-dimethylphenyl, 2,5-dimethylphenyl, 2,6-dimethylphenyl, 3,4,5-trimethylphenyl, 3-chloro-4-methylphenyl, 3-methoxy-4-methyl-5-iodophenyl, 3,4-dimethoxy-5-bromophenyl, 3,5-diiodo-4-methoxyphenyl, and the like.
The "amino-lower alkyl having optionally a lower alkyl substituent" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by an amino group having optionally 1 to 2 substituents of a straight chain or branched chain alkyl
group having 1 to 6 carbon atoms, for example, aminomethyl, 2-aminoethyl, 1-aminoethyl, 3-aminopropyl, 4-aminobutyl, 5-aminopentyl, 6-aminohexyl, 1,1-dimethyl-2-aminoethyl, 2-methyl-3-aminopropyl, methylaminomethyl, 1-ethylaminoethyl, 2-propylaminoethyl, 3-isopropylaminopropyl, 4-butylaminobutyl, 5-pentylaminopentyl, 6-hexylaminohexyl, dimethylaminomethyl, (N-ethyl-N-propylamino)methyl, 2-(N-methyl-N-hexylamino)ethyl, and the like.
The "5- or 6-membered saturated heterocyclic group which is formed by binding the groups R24 and R25 together with the nitrogen atom to which they bond with or without being intervened with nitrogen or oxygen atom" includes, for example, pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and the like.
The above-mentioned "heterocyclic group navir.g a substituent selected from a lower alkyl, a lower alkoxycarbonyl and piperidinyl" includes the above-mentioned heterocyclic groups having 1 to 3 substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkoxycarbonyl having 1 to 6 carbon atoms and piperidinyl, for example, in addition to the above-mentioned heterocyclic groups having a substituent selected from a lower alkyl and piperidinyl, 4-methoxycarbonylpiperazinyl, 4-ethcxycarbonylpiperidinyl, 3-propoxycarbonylpyrrolidinyl, 2-pentyloxycarbonylmorpholino, 4-hexyloxycarbonylpiperidinyl, 4-ethoxycarbonyl-3-methylpiperidinyl, 3-methyl-4-ethoxycarbonylpiperazinyl, and the like.
The "5- or 6-membered saturated heterocyclic group which is formed by binding the groups R29 and R30 together with the nitrogen atom to which they bond with or without being intervened with nitrogen or oxygen atom" includes, for example, pyrrolidinyl, piperidinyl, piperazinyl, morpholino, and the like.
The above-mentioned "heterocyclic group having a lower alkyl substituent" includes the above-mentioned heterocyclic groups having 1 to 3 substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, 4-methylpiperazinyl, 3,4-dimethylpiperazinyl, 2-ethylpyrrolidinyl, 2-propylpyrrolidinyl, 3,4,5-trimethylpiperidinyl, 4-butylpiperidinyl, 3-pentylmorpholino, 4-hexylpiperazinyl, and the like.
The heterocyclic ring in the formula (2) includes tetrahydroquinolyl, 2,3,4,5-tetrahydro-1H-benzazepinyl, 1,2,3,4,5,6-hexahydrobenzazocinyl, 1,2-dihydroquinolyl, 2,3-dihydro-1H-benzazepinyl, 1,2,3,4-tetrahydrobenzazocinyl, and the like.
The heterocyclic ring in the formula (2) wherein the carbon atom in the group of the formula: -(CH2)t- or -CH=CH-(CH2)v- for W is replaced by oxygen atom, sulfur atom, sulfinyl group, sulfonyl group, or a group of the formula: -NR28- ( R28 is hydrogen atom or a lower alkyl) includes a heterocylic group wherein the carbon atom in the group of the formula: -(CH2)t- or -CH=CH-(CH2)v- for W is replaced by oxygen atom, sulfur atom, sulfinyl group, sulfonyl group, or a group of the formula: -NR28- (R28 is
hydrogen atom or a straight chain or branched chain alkyl having 1 to 6 carbon atoms), for example, 3,4-dihydro-2H-1,4-benzoxazinyl, 1,2,3,5-tetrahydro-4,1-benzoxazepinyl, 1,2,3,4-tetrahydroquinoxalinyl, 1,2,3,4,5,6-hexahydro-1,5-benzodiazocinyl, 5-methyl-1,2,3,4,5, 6-hexahydro-1,5-benzodiazocinyl, 4-methyl-1,2,3,4-tetrahydroquinoxalinyl,
1,2,3,4-tetrahydro-5,1-benzoxazepinyl, 3,4-dihydro-2H-1,4-benzothiazinyl, 2,3,4,5-tetrahydro-1,5-benzothiazepinyl, 1,2,3,5-tetrahydro-4,1-benzothiazepinyl, 4-ethyl-1,2,3,4- tetrahydroquinoxalinyl, 4-propyl-1,2,3,4-tetrahydroquinoxalinyl, 4-butyl-1,2,3,4-tetrahydroquinoxalinyl, 4-pentyl-1 , 2 , 3 , 4-tetrahydroquinoxalinyl , 4-hexyl-1 , 2 , 3 , 4-tetrahydroquinoxalinyl, 2,3,4,5-tetrahydro-1H-1,4-benzodiazepinyl, 4-methyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepinyl, 4-ethyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepinyl, 4-propyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepinyl, 4-butyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepinyl, 4-pentyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepinyl, 4-hexyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepinyl, 2,3,4,5-tetrahydro-1H-1,5-benzodiazepinyl, 5-methyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepinyl, 5-ethyl2,3,4,5-tetrahydro-1H-1,5-benzodiazepinyl, 5-propyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepinyl, 5-butyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepinyl, 5-pentyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepinyl, 5-hexyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepinyl, 3,4-dihydro-1-oxo-2H-1,4-benzothiazepinyl, 3,4-dihydro-1,1-dioxo-2H-1,4-benzothiazepinyl, 1-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepinyl,
1,1-dioxo-2,3,4,5-tetrahydro-1,5-benzothiazepinyl, 4-oxo-1,2,3,5-tetrahydro-4,l-benzothiazepinyl, 4,4-dioxo-l, 2,3,5tetrahydro-4,l-benzothiazepinyl, and the like.
The "halogen-substituted lower alkanoyl" includes a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms which has 1 to 3 substituents of a halogen atom, for example, 2,2,2-trifluoroacetyl, 2,2,2-trichloroacetyl, 2-chloroacetyl, 2-bromoacetyl, 2-fluoroacetyl, 2-iodoacetyl, 2,2-difluoroacetyl, 2,2-dibromoacetyl, 3,3,3-trifluoropropionyl, 3,3,3-trichloropropionyl, 3-chloropropionyl, 2,3-dichloropropionyl, 4,4,4-trichlorobutyryl, 4-fluorobutyryl, 5-chloropentanoyl, 3-chloro-2-methylpropionyl, 6-bromohexanoyl, 5,6-dibromohexanoyl, and the like.
The "aminocarbonyl-lower alkoxy having a lower alkyl substituent" includes a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by an aminocarbonyl group having 1 to 2
substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, methylaminocarbonylmethoxy, 1-ethylaminocarbonylethoxy, 2-propylaminocarbonylethoxy, 3-isopropyIaminocarbonyIpropoxy, 4-butyIaminocarbonylbutoxy, 5-pentylaminocarbonylpentyloxy, 6-hexylaminocarbonylhexyloxy, dimethylammocarbonylmethoxy, 3-diethylaminocarbonylpropoxy, diethylaminocarbonyImethoxy, (N-ethyl-N-propylamino)carbonylmethoxy, 2- (N-methyl-N-hexylamino) carbonylethoxy, and the like.
The "carbamoyl-lower alkyl" includes a carbamoyl-
substituted straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, carbamoylmethyl, 2-carbamoylethyl, 1-carbamoylethyl, 3-carbamoylpropyl, 4-carbamoylbutyl, 5-carbamoylpentyl, 6-carbamoylhexyl, 1,1-dimethyl-2-carbamoylethyl, 2-methyl-3-carbamoylpropyl, and the like.
The "amino-lower alkanoyl having optionally a lower alkyl substituent" includes a straight chain or branched chain alkanoyl having 2 to 6 carbon atoms which is
substituted by an amino group having optionally 1 to 2 substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, 2-aminoacetyl, 3-aminopropionyl, 2-aminopropionyl, 4-aminobutyryl, 5-aminopentanoyl, 6-aminohexanoyl, 2,2-dimethyl-3-aminopropionyl, 2-methyl-3-aminopropionyl, 2-methylaminoacetyl, 2-ethylaminopropionyl, 3-propylaminopropionyl, 3-isopropylaminopropionyl, 4-butylaminobutyryl, 5-pentylaminopentanoyl, 6-hexylaminohexanoyl, 2-dimethylaminoacetyl, 2-diethylaminoacetyl, 2-(N-ethyl-N-propylamino)acetyl, 3-(N-methyl-N-hexylamino)propionyl, and the like.
The "amino-lower alkyl having optionally a lower alkanoyl substituent" includes a straight chain or branched chain alkyl having 1 to 6 carbon atoms which is substituted by an amino group having optionally a substituent of a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, aminomethyl, 2-aminoethyl, 1-aminoethyl, 3-aminopropyl, 4-aminobutyl, 5-aminopentyl, 6-aminohexyl, 1,1-dimethyl-2-aminoethyl, 2-methyl-3-amino-
propyl, acetylaminomethyl, 1-acetylaminoethyl, 2-propionylaminoethyl, 3-isopropionylaminopropyl, 4-butyrylaminobutyl, 5-pentanoylaminopentyl, 6-hexanoylaminohexyl, formylaminomethyl, and the like.
The "anilinocarbonyl having optionally a lower alkyl substituent on the phenyl ring" includes an
anilinocarbonyl group having optionally 1 to 3 substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms on the phenyl ring, for example, anilinocarbonyl, 2-methylanilinocarbonyl, 3-methylanilinocarbonyl, 4-methylanilinocarbonyl, 2-ethylanilinocarbonyl, 3-ethylanilinocarbonyl, 4-ethylanilinocarbonyl, 4-isopropylanilinocarbonyl, 3-butylanilinocarbonyl, 4-pentylanilinocarbonyl, 4-hexylanilinocarbonyl, 3,4-dimethylanilinocarbonyl, 3,4-diethylanilinocarbonyl, 2,4-dimethylanilinocarbonyl, 2,5-dimethylanilinocarbonyl, 2,6-dimethylanilinocarbonyl, 3,4,5-trimethylanilinocarbonyl, and the like.
The "phenylsulfonyl which has optionally a substituent selected from a halogen and a lower alkyl on the phenyl ring" includes a phenylsulfonyl group which has optionally 1 to 3 substitutents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and a halogen atom, for example, phenylsulfonyl, 2-chlorophenylsulfonyl, 3-chlorophenylsulfonyl, 4-chlorophenylsulfonyl, 2-fluorophenylsulfonyl, 3-fluorophenylsulfonyl, 4-fluorophenylsulfonyl, 2-bromophenylsulfonyl, 3-bromophenylsulfonyl, 4-bromophenylsulfonyl, 2-iodophenylsulfonyl, 3-iodophenylsulfonyl, 4-iodophenylsulfonyl, 3,4-
dichlorophenylsulfonyl, 3,5-dichlorophenylsulfonyl, 2,6-dichlorophenylsulfonyl, 2,3-dichlorophenylsulfonyl, 2,4-dichlorophenylsulfonyl, 3,4-difluorophenylsulfonyl, 3,5-dibromophenylsulfonyl, 3,4,5-trichlorophenylsulfonyl, 2-ethyl-3-chlorophenylsulfonyl, 2-methylphenylsulfonyl, 3-methylphenylsulfonyl, 4-methylphenylsulfonyl, 2-ethylphenylsulfonyl, 3-ethylphenylsulfonyl, 4-ethylphenylsulfonyl, 4-isopropylphenylsulfonyl, 3-butylphenylsulfonyl, 4-pentylphenylsulfonyl, 4-hexylphenylsulfonyl, 3,4-dimethylphenylsulfonyl, 3,4-diethylphenylsulfonyl, 2,4-dimethylphenylsulfonyl, 2,5-dimethylphenylsulfonyl, 2 ,6-dimethylphenylsulfonyl, 2,4,6-trimethylphenylsulfonyl, 3,4,5-trimethylphenylsulfonyl, 3-chloro-4-methylphenylsulfonyl, 4-methyl-5- iodophenylsulfonyl, 3,4-dimethyl-5-bromophenylsulfonyl, 3,5-diiodo-4-methylphenylsulfonyl, and the like.
The "phthalimido-substituted lower alkyl" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by phthalimido croup, for example, phthalimidomethyl, 2-phthalimidoethyl, 1-phthalimidoethyl, 3-phthalimidopropyl, 4-phthalimidobutyl, 5-phthalimidopentyl, 6-phthalimidohexyl, 1,1-dimethyl-2-phthalimidoethyl, 2-methyl-3-phthalimidopropyl, and the like.
The "lower alkynyl" includes a straight chair, or branched chain alkynyl having 2 to 6 carbon atoms, for example, ethynyl, 2-propynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 2-pentynyl, 2-hexynyl, and the like.
The "benzoyl which has optionally a halogen
substituent on the phenyl ring" includes a benzoyl group which has optionally 1 to 3 substituents of a halogen atom on the phenyl ring, for example, benzoyl, 2-chlorobenzoyl, 3-chlorobenzoyl, 4-chlorobenzoyl, 2-fluorobenzoyl, 3-fluorobenzoyl, 4-fluorobenzoyl, 2-bromobenzoyl, 3-bromobenzoyl, 4-bromobenzoyl, 2-iodobenzoyl, 3-iodobenzoyl , 4-iodobenzoyl , 3 , 4-dichlorobenzoyl , 3 , 5-dichlorobenzoyl, 2 , 6-dichlorobenzoyl, 2,3-dichlorobenzoyl, 2,4-dichlorobenzoyl, 3,4-difluorobenzoyl, 3,5-dibromobenzoyl, 3,4,5-trichlorobenzoyl, and the like.
The "amino-lower alkoxy having optionally a substituent selected from a lower alkyl and a lower
alkanoyl" include a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms which is substituted by an amino group having optionally 1 to 2 substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, aminomethoxy, 2-aminoethoxy, 1-aminoethoxy, 3-aminopropoxy, 4-aminobutoxy, 5-aminopentyloxy, 6-aminohexyloxy, 1,1-dimethyl-2-aminoethoxy, 2-methyl-3-aminopropoxy, acetylaminomethoxy, 1-acetylaminoethoxy, 2-propionylaminoethcxy, 3-isopropionylaminopropoxy, 4-butyrylaminobutoxy, 5-pentanoylaminopentyloxy, 6-hexanoylaminohexyloxy, formylaminomethoxy, methylaminomethoxy, 1-ethylaminoethoxy, 2-propylaminoethoxy, 3-isopropylaminopropoxy, 4-butylaminobutoxy, 5-pentylaminopentyloxy, 6-hexylaminohexyloxy, dimethylaminomethoxy, (N-ethyl-N-propylamino)methoxy, 2-(N-
methyl-N-hexylamino)ethoxy, and the like.
The "benzoyloxy which has optionally a halogen substituent on the phenyl ring" includes a benzoyloxy group which has optionally 1 to 3 substituents of a halogen atom on the phenyl ring, for example, benzoyloxy, 2-chlorobenzoyloxy, 3-chlorobenzoyloxy, 4-chlorobenzoyloxy, 2-fluorobenzoyloxy, 3-fluorobenzoyloxy, 4-fluorobenzoyloxy, 2-bromobenzoyloxy, 3-bromobenzoyloxy, 4-bromobenzoyioxy, 2-iodobenzoyloxy, 3-iodobenzoyloxy, 4-iodobenzoyloxy, 3,4-dichlorobenzoyloxy, 3,5-dichlorobenzoyloxy, 2,6-dichlorobenzoyloxy, 2 ,3-dichlorobenzoyloxy, 2,4-dichlorobenzoyloxy, 3,4-difluorobenzoyloxy, 3,5-dibromobenzoyloxy, 3,4,5-trichlorobenzoyloxy, and the like.
The "lower alkanoyloxy-substituted lower alkyl" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by a
straight chain or branched chain alkanoyloxy group having 2 to 6 carbon atoms, for example, acetyloxymethyl, 2-propionyloxyethyl, 1-butyryloxyethyl, 3-acetyloxypropyl, 4-acetyloxybutyl, 4-isobutyryloxybutyl, 5-pentanoyloxypentyl, 6acetyloxyhexyl, 6-tert-butylcarbonyloxyhexyl, 1,1-dimethyl2-hexanoyloxyethyl, 2-methyl-3-acetyloxypropyl, and the like.
The "lower alkylsulfonyloxy-lower alkyl" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by a straight chain or branched chain alkylsulfonyloxy group having 1 to 6 carbon atoms, for example, methylsulfonyloxymethyl, 1-ethyl-
sulfonyloxyethyl, 2-propylsulfonyloxyethyl, 3-isopropylsulfonyloxypropyl, 4-butylsulfonyloxybutyl, 5-pentylsulfoyloxypentyl, 6-hexylsulfonyloxyhexyl, 1,1-dimethyl-2-methylsulfonyloxyethyl, 2-methyl-3-ethylsulfonyloxypropyl, and the like.
The "azido-lower alkyl" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by an azido group, for example, azidomethyl, 1-azidoethyl, 2-azidoethyl, 3-azidopropyl, 4-azidobutyl, 5-azidopentyl, 6-azidohexyl, 1,1-dimethyl-2-azidoethyl, 2-methyl-3-azidopropyl, and the like.
The "lower alkanoyloxyimino" includes a straight chain or branched chain alkanoyloxyimino group having 1 to 6 carbon atoms, for example, formyloxyimino, acetyloxyimino, propionyloxyimino, butyryloxyimino, isobutyryloxyimino, pentanoyloxyimino, tert-butylcarbonyloxyimino, hexanoyloxyimino , and the like .
The "lower alkylidene" includes a straight chain or branched chain alkylidene group having 1 to 6 carbon atoms, for example, methylidene, ethylidene, propylidene,
isopropylidene, butylidene, pentylidene, hexylidene, and the like.
The "oxiranyl-substituted lower alkyl" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by oxiranyl group, for example, oxiranylmethyl, 1-oxiranylethyl, 2-oxiranylethyl, 3-oxiranylpropyl, 4-oxiranylbutyl, 5-oxiranylpentyl, 6-oxiranylhexyl, 1,1-dimethyl-2-oxiranylethyl, 2-methyl-3-
oxiranylpropyl, and the like.
The "lower alkyl having 1 to 2 substituents selected from a lower alkoxy, hydroxy and an amino having optionally a lower alkyl substituent" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and having 1 to 2 substituents selected from a straight chain or branched chain alkoxy group having 1 to 6 carbon atoms, hydroxy and an amino having optionally a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, methoxymethyl, 1-ethoxyethyl, 2-propoxyethyl, 3-isopropoxypropyl, 4-butoxybutyl, 5-pentyloxypentyl, 6-hexyloxyhexyl, 1,1-dimethyl-2-methoxyethyl, 2-methyl-3-ethoxypropyl, 3-methoxy-2-hydroxypropyl, hydroxymethyl, 2-hydroxyethyl, 1-hydroxyethyl, 3-hydroxypropyl, 2,3-dihydroxyethyl, 4-hydroxybutyl, 3,4-dihydroxybutyl, 1,1-dimethyl-2-hydroxyethyl, 5 , 6-dihydroxyhexyl, 5-hydroxypentyl, 6-hydroxyhexyl, 6-(N-ethyl-N-methylamino)-5-methoxyhexyl, 2-methyl-3-hydroxypropyl, aminomethyl, 1-aminoethyl, 2-aminoethyl, 3-aminopropyl, 4-aminobutyl, 5-aminopentyl, 6-aminohexyl, 1,1-dimethyl-2-aminoethyl, 2-methyl-3-aminopropyl, methylaminomethyl, ethylaminomethyl, propylaminomethyl, isopropylaminomethyl, butylaminomethyl, tert-butylaminomethyl, pentylaminomethyl, hexylaminomethyl, dimethylaminomethyl, diethylaminomethyl, dipropylaminomethyl, dibutylaminomethyl, dipentylaminomethyl, dihexylaminomethyl, N-methyl-N-ethylaminomethyl, N-methyl-Npropylaminomethyl, N-methyl-N-butylaminomethyl, N-methyl-N-hexylaminomethyl, 1-methylaminoethyl, 2-ethylaminoethyl, 3-
propylaminopropyl, 4-butylaminobutyl, 1,1-dimethyl-2-pentylaminoethyl, 5-hexylaminopentyl, 6-dimethylaminohexyl, 4- dimethylaminobutyl, 2-diethylaminoethyl, 1-(N-methyl-N-hexylamino)ethyl, 3-dihexylaminopropyl, 6-diethylaminohexyl, 4-dibutylaminobutyl, 2-(N-methyl-N-pentylamino) ethyl, 2-hydroxy-3-diethylaminopropyl, 3-hydroxy-4-methylaminobutyl, 5-hydroxy-6-diethylaminohexyl, 4-hydroxy-5-dimethylaminopentyl, 4-hydroxy-5-methylaminopentyl, 4-hydroxy-5-diethylaminopentyl, 5-hydroxy-6-ethylaminohexyl, 5-hydroxy-6-isopropylaminohexyl, 5-hydroxy-6-aminohexyl, and the like.
The "aminocarbonyloxy having optionally a lower alkyl substituent" includes an aminocarbonyloxy group having optionally 1 to 2 substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, aminocarbonyloxy, methylaminocarbonyloxy, ethylaminocarbonyloxy, propylaminocarbonyloxy, isopropylaminocarbonyloxy, butylammocarbonyloxy, tert-butylaminocarbonyloxy, pentylaminocarbonyloxy, hexylaminocarbonyloxy,
dimethylaminocarbonyloxy, diethylaminocarbonyloxy, dipropylaminocarbonyloxy, dibutylaminocarbonyloxy, dipentylaminocarbonyloxy, dihexylaminocarbonyloxy, N-methyl-N-ethylaminocarbonyloxy, N-ethyl-N-propylaminocarbonyloxy, N-methyl-N-butylaminocarbonyloxy, N-methyl-N-hexylaminocarbonyloxy, and the like.
The "lower alkanoyloxy having optionally a halogen substituent" includes a straight chain or branched chain alkanoyloxy group having 1 to 6 carbon atoms which has optionally 1 to 3 substituents of a halogen atom, for
`xample, in addition to the above-mentioned lower alkanoyloxy groups, 2,2,2-trifluoroacetyloxy, 2,2,2-trichloroacetyloxy, 2-chloroacetyloxy, 2-bromoacetyloxy, 2-fluoroacetyloxy, 2-iodoacetyloxy, 2,2-difluoroacetyloxy, 2,2-dibromoacetyloxy, 3,3,3-trifluoropropionyloxy, 3,3,3-trichloropropionyloxy, 3-chloropropionyloxy, 2,3-dichloropropionyloxy, 4,4,4-trichlorobutyryloxy, 4-fluorobutyryloxy, 5-chloropentanoyloxy, 3-chloro-2-methylpropionyloxy, 6-bromohexanoyloxy, 5,6-dibromohexanoyloxy, and the like.
The "amino-lower alkyl having optionally a substituent selected from a lower alkyl and a lower
alkanoyl" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by an amino group having optionally 1 to 2 substituents selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, for example, aminomethyl, 2-aminoethyl, 1-aminoethyl, 3-aminopropyl, 4-aminobutyl, 5-aminopentyl, 6-aminohexyl, 1,1-dimethyl-2-aminoethyl, 2-methyl-3-aminopropyl, acetylaminomethyl, 1-acetylaminoethyl, 2-propionylaminoethyl, 3-isopropionylaminopropyl, 4-butyrylaminobutyl, 5-pentanoylaminopentyl, 6-hexanoylaminohexyl, formylaminomethyl, methylaminomethyl, 1-ethylaminoethyl, 2-propylaminoethyl, 3-isopropylaminopropyl, 4-butylaminobutyl, 5-pentylaminopentyl, 6-hexylaminohexyl, dimethylaminomethyl, (N-ethyl-N-propylamino)methyl, 2-(N- methyl-N-hexylamino)ethyl, and the like.
The "amino-lower alkanoyloxy having optionally a
lower alkyl substituent" includes a straight chain or branched chain alkanoyloxy having 2 to 6 carbon atoms which is substituted by an amino group having optionally 1 to 2 substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, 2-aminoacetyloxy, 3-aminopropionyloxy, 2-aminopropionyloxy, 4aminobutyryloxy, 5-aminopentanoyloxy, 6-aminohexanoyloxy, 2,2-dimethyl-3-aminopropionyloxy, 2-methyl-3-aminopropionyloxy, 2-methylaminoacetyloxy, 2-ethylaminopropionyloxy, 3-propylaminopropionyloxy, 3-isopropylaminopropionyloxy, 4butylaminobutyryloxy, 5-pentylaminopentanoyloxy, 6-hexylaminohexanoyloxy, 2-dimethylaminoacetyloxy, 2-diethylaminoacetyloxy, 2-(N-ethyl-N-propylamino)acetyloxy, 3-(N-methylN-hexylamino)propionyloxy, and the like.
The "pyridyl-lower alkyl" includes a pyridylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, (4-pyridyl)methyl, 1-(3-pyridyl)ethyl, 2-(2-pyridyl)ethyl, 3-(2-pyridyl)propyl, 4-(3-pyridyl)butyl, 5-(4-pyridyl)pentyl, 6-(2-pyridyl)hexyl, 1,1-dimethyl-2-(3-pyridyl)ethyl, 2-methyl-3-(4-pyridyl)propyl, and the like.
The "5- or 6-membered saturated heterocyclic group which is formed by binding the groups R33 and R34 together with the nitrogen atom to which they bond with or without being intervened with nitrogen, oxygen or sulfur atom" includes, for example, pyrrolidinyl, piperidinyl,
piperaz inyl , morpholino , thiomorpholino , and the like .
The above "heterocyclic group which has a
substituent selected from oxo, a lower alkyl, a lower alkanoyl and carbamoyl" includes the above heterocyclic groups which have 1 to 3 substituents selected from oxo, a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, a straight chain or branched chain alkanoyl group having 1 to 6 carbon atoms, and carbamoyl group, for example, 4-methylpiperazinyl, 3,4-dimethylpiperazinyl, 3-ethylpyrrolidinyl, 2-propylpyrrolidinyl, 3,4,5-trimethylpiperidinyl, 4-butylpiperidinyl, 3-pentylmorpholino, 4-hexylpiperazinyl, 2-methylthiomorpholino, 4-acetylpiperazinyl, 2-propanoylmorpholino, 3-butyrylthiomorpholino, 3-pentanoylpyrrolidinyl, 4-hexanoylpiperidinyl, 3-methyl-4-acetylpiperazinyl, 2-carbamoylpyrrolidinyl, 4-carbamoylpiperazinyl, 3-carbamoylthiomorpholino, 2-carbamoylmorpholino, 3-carbamoylpiperidinyl, 1-oxothiomorpholino, 1,1-dioxothiomorpholino, and the like.
The "aminocarbonyl having optionally a lower alkyl substituent" includes an aminocarbonyl group having
optionally 1 to 2 substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, aminocarbonyl, methylaminocarbonyl, ethylaminocarbonyl, propylaminocarbonyl, isopropylaminocarbonyl, butylaminocarbonyl, tert-butylaminocarbonyl, pentylaminocarbonyl, hexylaminocarbonyl, dimethylaminocarbonyl,
diethylaminocarbonyl, dipropylaminocarbonyl, dibutylaminocarbonyl, dipentylaminocarbonyl, dihexylaminocarbonyl, N-methyl-N-ethylaminocarbonyl, N-ethyl-N-propylaminocarbonyl, N-methyl-N-butylaminocarbonyl, N-methyl-N-hexylamino
c1rbonyl, and the like.
The "cyano-substituted lower alkyl" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by cyano group, for example, cyanomethyl, 2-cyanoethyl, 1-cyanoethyl, 3-cyanopropyl, 4-cyanobutyl, 5-cyanopentyl, 6-cyanohexyl, 1,1-dimethyl-2-cyanoethyl, 2-methyl-3-cyanopropyl, and the like.
The "lower alkoxycarbonyl-substituted lower alkyl" includes an alkoxycarbonyl-substituted straight chain or branched chain alkyl group having 1 to 6 carbon atoms wherein the alkoxycarbonyl moiety is a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, methoxycarbonylmethyl, 3-methoxycarbonylpropyl, ethoxycarboxymethyl, 3-ethoxycarbonylpropyl, 4-ethoxycarbonylbutyl, 5-isopropoxycarbonylpentyl, 6-propoxycarbonylhexyl, 1,1-dimethyl-2-butoxycarbonylethyl, 2-methyl-3-tert-butoxycarbonylpropyl, 2-pentyloxycarbonylethyl, hexyloxycarbonylmethyl, and the like.
The "carboxy-substituted lower alkyl" includes a carboxy-substituted alkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, carboxymethyl, 2-carboxyethyl, 1-carboxyethyl, 3-carboxypropyl, 4-carboxybutyl, 5-carboxypentyl, 6-carboxyhexyl, 1,1-dimethyl-2-carboxyethyl, 2-methyl-3-carboxypropyl, and the like.
The "tetrahydropyranyloxy-substituted lower alkyl" includes a tetrahydropyranyloxy-substituted straight chain or branched chain alkyl group having 1 to 6 carbon atoms,
for example, (2-tetrahydropyranyl)oxymethyl, 2-(3-tetrahydropyranyl)oxyethyl, 1-(4-tetrahydropyranyl)oxyethyl, 3-(2-tetrahydropyranyl)oxypropyl, 4-(3-tetrahydropyranyl)oxybutyl, 5-(4-tetrahydropyranyl)oxypentyl, 6-(2-tetrahydro¬pyranyl)oxyhexyl, 1,1-dimethyl-2-(3-tetrahydropyranyl)oxyethyl, 2-methyl-3-(4-tetrahydropyranyl)oxypropyl, and the like.
The "piperidinyl having optionally a phenyl-lower alkyl substituent" includes a piperidinyl which has
optionally a substituent of a phenylalkyl group wherein the alkyl moiety is a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, piperidinyl, 1-benzyl-4-piperidinyl, 1-(2-phenylethyl)-3-piperidinyl, 1-(1-phenylethyl)-2-piperidinyl, 1-(3-phenylpropyl)-4-piperidinyl, 1-(4-phenylbutyl)-4-piperidinyl, 1-(5-phenylpentyl)-4-piperidinyl, 1-(6-phenylhexyl)-4-piperidinyl, 1- (1,1-dimethyl-2-phenylethyl)-3-piperidinyl, 1-(2-methyl-3-phenylpropyl)-2-piperidinyl, and the like.
The "imidazolyl-substituted lower alkanoyl" includes an imidazolyl-substituted alkanoyl group wherein the alkanoyl moiety is a straight chain or branched chain alkanoyl group having 2 to 6 carbon atoms, for example, (1- imidazolyl)acetyl, 3-(2-imidazolyl)propionyl, 2-(4-imidazolyl)propionyl, 4-(1-imidazolyl)butyryl, 2,2-dimethyl-3-(2-imidazolyl)propionyl, 5-(4-imidazolyl)pentanoyl, 6-(1-imidazolyl)hexanoyl, and the like.
The "amino-lower alkanoyl having optionally a substituent selected from a lower alkyl and a lower alkoxy
carbonyl" includes a straight chain or branched chain alkanoyl having 2 to 6 carbon atoms which is substituted by an amino group having optionally 1 to 2 substituents
selected from a straight chain or branched chain alkyl group having 1 to 6 carbon atoms and a straight chain or branched chain alkoxycarbonyl group having 1 to 6 carbon atoms, for example, 2-aminoacetyl, 3-aminopropionyl, 2-aminopropionyl, 4-aminobutyryl, 5-aminopentanoyl, 6-aminohexanoyl, 2,2-dimethyl-3-aminopropionyl, 2-methyl-3-aminopropionyl, 2-methylaminoacetyl, 2-ethylaminopropionyl, 3-propylaminopropionyl, 3-isopropylaminopropionyl, 4-butylaminobutyryl, 5-pentylaminopentanoyl, 6-hexylaminohexanoyl, 2-dimethylaminoacetyl, 2-diethylaminoacetyl, 2-(N-ethyl-N-propylamino)acetyl, 3-(N-methyl-N-hexylamino)propionyl, 2-methoxycarbonylaminoacetyl, 2-ethoxycarbonylaminoacetyl, 3-propoxycarbonylaminopropionyl, 4-butoxycarbonylaminobutyryl, 2-tert-butoxycarbonylaminoacetyl, 5-pentyloxycarbonylaminopentanoyl, 6-hexyloxycarbonylaminohexanoyl, 2-(N-methyl-N-tert-butoxycarbonylamino)acetyl, and the like.
The "aminocarbonyl-lower alkyl having a lower alkyl substituent" includes a straight chain or branched chain alkyl group having 1 to 6 carbon atoms which is substituted by an aminocarbonyl group having 1 to 2 substituents of a straight chain or branched chain alkyl group having 1 to 6 carbon atoms, for example, methylaminocarbonylmethyl, 1-ethylaminocarbonylethyl, 2-propylaminocarbonylethyl, 3-isopropylaminocarbonylpropyl, 4-butylaminocarbonylbutyl, 5-pentylaminocarbonylpentyl, 6-hexylaminocarbonylhexyl,
dimethylaminocarbonylmethyl, 3-diethylaminocarbonylpropyl, diethylaminocarbonylmethyl, (N-ethyl-N-propylamino)carbonylmethyl, 2-(N-methyl-N-hexylamino)carbonylethyl, and the like.
The "amino-substituted lower alkoxy having optionally a lower alkyl substituent" includes an aminosubstituted straight chain or branched chain alkoxy having 1 to 6 carbon atoms wherein the amino group has optionally 1 to 2 substituents of a straight chain or branched chain alkyl having 1 to 6 carbon atoms, for example, aminomethoxy, 2-aminoethoxy, 1-aminoethoxy, 3-aminopropoxy, 4-aminobutoxy, 5-aminopentyloxy, 6-aminohexyloxy, 1,1-dimethyl-2-aminoethoxy, 2-methyl-3-aminopropoxy, methylaminomethoxy, 1-ethylaminoethoxy, 2-propylaminoethoxy, 3-isopropylaminopropoxy, 4-butylaminobutoxy, 5-pentylaminopentyloxy, 6-hexylaminohexyloxy, dimethylaminomethoxy, (N-methyl-N-propylamino)methoxy, 2-(N-methyl-N-hexylamino)ethoxy, and the like.
The active ingredients of the present oxytocin antagonists of the present invention can be easily prepared by a conventional method, for example, the carbostyril derivatives of the formula (1) can be prepared, for example, by the method dislcosed in Japanese Patent First Publication (Kokai) No. 173870/1991, and the benzohetrocyclic compounds of the formula (2) can be prepared, for example, by the method disclosed in European Patent No. 450097.
Among the active compounds (1) and (2) of this invention, the compounds having an acidic group can easily
be converted into salts by treating with a pharmaceutically acceptable basic compound. The basic compound includes, for example, metal hydroxides such as sodium hydroxide,
potassium hydroxide, lithium hydroxide, calcium hydroxide, etc., alkali metal carbonates or hydrogen carbonates such as sodium carbonate, sodium hydrogen carbonate, etc., alkali metal alcoholates such as sodium methylate, potassium ethylate, etc. Besides, among the active compounds (1) and (2) of this invention, the compounds having a basic group can easily be converted into acid addition salts thereof by treating with a pharmaceutically acceptable acid. The acid includes, for example, inorganic acids such as sulfuric acid, nitric acid, hydrochloric acid, hydrobromic acid, etc., and organic acids such as acetic acid, p-toluenesulfonic acid, ethanesulfonic acid, oxalic acid, maleic acid, citric acid, succinic acid, benzoic acid, etc. Among the active compounds (1) and (2) of the invention, the compounds having an ammonium group can be converted into a salt thereof with a pharmaceutically acceptable halogen anion (e.g. chlorine anion, bromine anion, fluorine anion, or iodine anion). These salts are useful as an active ingredient of the present oxytocin antagonist as like as the compounds (1) and (2) in the free form.
In addition, the active compounds (1) and (2) of this invention include stereoisomers and optical isomers, and these isomers are also useful as the active ingredient in this invention.
The active compounds (2) of the present oxytocin
antagonst obtained by the method disclosed in European
Patent No. 450097 can easily be isolated and purified by a conventional isolation method. The isolation methods are, for example, distillation method, recrystallization method, column chromatography, ion exchange chromatography, gel chromatography, affinity chromtography, preparative thin layer chromatography, extraction with a solvent, and the like.
The compounds of the formulae (1), (2) and their salts are useful as an oxytocin antagonist and are used in the form of a conventional pharmaceutical preparation. The preparation is prepared by using conventional dilutents or carriers such as fillers, thickening agents, binders, wetting agents, disintegrators, surfactants, lubricants, and the like. The pharmaceutical preparations may be selected from various forms in accordance with the desired utilities, and the representative forms are tablets, pills, powders, solutions, suspensions, emulsions, granules, capsules, suppositories, injections (solutions, suspensions, etc.), and the like. In order to form in tablets, there are used conventional carriers such as vehicles (e.g. lactose, white sugar, sodium chloride, glucose, urea, starches, calcium carbonate, kaolin, crystalline cellulose, silicic acid, etc.), binders (e.g. water, ethanol, propanol, simple syrup, glucose solution, starch solution, gelatin solution,
carboxymethyl cellulose, shellac, methyl cellulose,
potassium phosphate, polyvinylpyrrolidone, etc.),
disintegrators (e.g. dry starch, sodium arginate, agar
powder, laminaran powder, sodium hydrogen carbonate, calcium carbonate, polyoxyethylene sorbitan fatty acid esters, sodium laurylsulfate, stearic monoglyceride, starches, lactose, etc.), disintegration inhibitors (e.g. white sugar, stearin, cacao butter, hydrogenated oils, etc.), absorption promoters (e.g. quaternary ammonium base, sodium laurylsulfate, etc.), wetting agents (e.g. glycerin, starches, etc.), adsorbents (e.g. starches, lactose, kaolin, bentonite, colloidal silicates, etc.), lubricants (e.g. purified talc, stearates, boric acid powder, polyethylene glycol, etc.), and the like. Moreover, the tablets may also be in the form of a conventional coated tablet, such as sugarcoated tablets, gelatin-coated tablets, enteric coated tablets, film coating tablets, or double or multiple layer tablets. In the preparation of pills, the carriers include conventional vehicles (e.g. glucose, lactose, starches, cacao butter, hydrogenated vegetable oils, kaolin, talc, etc.), binders (e.g. gum arable powder, tragacanth powder, gelatin, ethanol, etc.), disintegrators (e.g. laminaran, agar, etc.), and the like. In the preparation of
suppositories, the carriers include conventional vehicles, for example, polyethylene glycol, cacao oils, higher
alcohols, higher alcohol esters, gelatin, semi-synthetic glycerides, and the like. Capsules can be prepared by charging a mixture of the active compound of this invention with the above carriers into hard gelatin capsules or soft capsules in a usual manner. In the preparation of injections, the solutions, emulsions or suspendions are steri
lized and are preferably made isotonic with the blood. In the preparation of these solutions, emulsions and
suspensions, there are used conventional diluents, such as water, ethyl alcohol, macrogol, propylene glycol,
ethoxylated isostearyl alcohol, polyoxylated isostearyl alcohol, polyoxyethylene sorbitan fatty acid esters, and the like. In this case, the pharmaceutical preparations may also be incorporated with sodium chloride, glucose, or glycerin in an amount sufficient to make them isotonic, and may also be incorporated with conventional solubilizers, buffers, anesthetizing agents. Besides, the pharmaceutical preparations may optionally be incorporated with coloring agents, preservatives, perfumes, flavors, sweeting agents, and other medicaments, if required.
The amount of the active compounds of the formulae (1) and (2) of this invention (active ingredient) to be incorporated into the oxytocin antagonist of the present invention is not specified but may be selected from a broad range, but usually, it is preferably in the range of about 1 to 70 % by weight, more preferably about 5 to 50 % by weight.
The oxytocin antagonist of the present invention may be administered in any method, and suitable method for administration may be determined in accordance with types of the preparations, ages, sexes and other conditions of the patients, the degree of severity of diseases, and the like. For instance, tablets, pills, solutions, suspensions, emulsions, granules and capsules are administered orally.
The injections are intraveneously administered alone or together with a conventional auxiliary liquid (e.g. glucose, amino acid solutions), and further are optionally administered alone in intramuscular, intracutaneous, subcutaneous, or intraperitoneal route, if required. Suppositories are administered in intrarectal route.
The dosage of the oxytocin antagonist of the present invention may be selected in accordance with the usage, ages, sexes and other conditions of the patients, the degree of severity of the diseases, and the like, but is usually in the range of about about 0.6 to 50 mg of the active compound (1) or (2) per 1 kg of body weight of the patient per day. The active compound is preferably
contained in an amount of about 10 to 1000 mg per the dosage unit.
Best Mode for Carrying Out the Invention
The present invention is illustrated by the following Preparations of oxytocin antagnist, and
Experiments of the activities of the active compounds (1) and (2) of the present invention.
Preparation 1
Film coated tablets are prepared from the following components.
Components Amount
1-[1-(4-Dimethylaminobenzoyl)-4-piperidinyl]-3,4-dihydrocarbostyril 150 g
Avicel (tradename of microcrystalline cellulose,
manufactured by Asahi Chemical Industry
Co., Ltd., Japan) 40 g
Corn starch 30 g
Magnesium stearate 2 g
Hydroxypropyl methylcellulose 10 g
Polyethylene glycol-6000 3 g
Castor oil 40 g
Ethanol 40 g
The active component of the present invention, Avicel, corn starch and magnesium stearate are mixed and kneaded and the mixture is tabletted using a conventional pounder (R 10 mm) for sugar coating. The tablets thus obtained are coated with a film coating agent consisting of hydroxypropyl methylcellulose, polyethylene glycol-6000, castor oil and ethanol to give film coated tablets.
Preparation 2
Tablets are prepared from the following components
Components Amount
1-[1-(2-Methoxy-4-ethoxybenzoyl)-4-piperidinyl]-3,4-dihydrocarbostyril 150 g
Citric acid 1.0 g
Lactose 33.5 g
Dicalcium phosphate 70.0 g
Pullonic F-68 30.0 g
Sodium laurylsulfate 15.0 g
Polyvinylpyrrolidone 15.0 g
Polyethylene glycol (Carbowax 1500) 4.5 g
Polyethylene glycol (Carbowax 6000) 45.0 g
Corn starch 30.0 g
Dry sodium stearate 3.0 g
Dry magnesium stearate 3.0 g
Ethanol q.s.
The active compound of the present invention, citric acid, lactose, dicalcium phosphate, Pullonic F-68 and sodium laurylstearate are mixed. The mixture is screened with No. 60 screen and is granulated with an alcohol
solution containing polyvinylpyrrolidone, carbowax 1500 and 6000. If required, an alcohol is added thereto so that the powder mixture is made a paste-like mass. Corn starch is added to the mixture and the mixture is continuously mixed to form uniform particles. The resulting particles are passed through No. 10 screen and entered into a tray and then dried in an oven at 100°C for 12 to 14 hours. The dried particles are screened with No. 16 screen and thereto are added dry sodium laurylsulfate and dry magnesium
stearate, and the mixture is tabletted to form the desired shape.
The core tablets thus prepared are vanished and dusted with talc in order to guard from wetting.
Undercoating is applied to the core tablets. In order to administer the tablets orally, the core tablets are vanished several times. In order to give round shape and smooth surface to the tablets, further undercoating and coating with lubricant are applied thereto. The tablets are further coated with a coloring coating material until the desired colored tablets are obtained. After drying, the coated tablets are polished to obtain the desired tablets having uniform gloss.
Preparation 3
An injection preparation is prepared from the following components.
Components Amount
7-Fluoro-1-[1-(2,4-dimethoxybenzoyl)-4-piperidinyl]-3,4-dihydrocarbostyril 5 g
Polyethylene glycol (molecular weight: 4000) 0 . 3 9
Sodium chloride 0 . 9 g
Polyoxyethylene sorbitan monooleate 0 . 4 g
Sodium metabisulfite 0 . 1 g
Methyl-paraben 0 . 18 g
Propyl-paraben 0 . 02 g
Distilled water for injection 10 . 0 ml
The above parabens, sodium metabisulfite and sodium chloride are dissolved in distilled water of half volume of the above with stirring at 80°C. The solution thus obtained is cooled to 40°C, and the active compound of this invention and further polyethylene glycol and polyoxyethylene sorbitan monooleate are dissolved in the above solution. To the solution is added distilled water for injection to adjust to the desired volume, and the solution is sterilized by filtering with an appropriate filter paper to give an injection preparation.
Preparation 4
Film coated tablets are prepared from the following components.
Components Amount
4-Methylamino-1-[4-(3,5-dichlorobenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 150 g
Avicel (tradename of microcrystalline cellulose,
manufactured by Asahi Chemical Industry
Co., Ltd., Japan) 40 g
Corn starch 30 g
Magnesium stearate 2 g
Hydroxypropyl methylcellulose 10 g
Polyethylene glycol-6000 3 g
Castor oil 40 g
Ethanol 40 g
The active component of the present invention, Avicel, corn starch and magnesium stearate are mixed and kneaded and the mixture is tabletted using a conventional pounder (R 10 mm) for sugar coating. The tablets thus obtained are coated with a film coating agent consisting of hydroxypropyl methylcellulose, polyethylene glycol-6000, castor oil and ethanol to give film coated tablets.
Preparation 5
Tablets are prepared from the following components.
Components Amount 1-[4-(N-Butylanilinoacetylamino)benzoyl]¬
2,3,4,5-tetrahydroy-1H-benzazepine 150 g
Citric acid 1.0 g
Lactose 33.5 g
Dicalcium phosphate 70.0 g
Pullonic F-68 30.0 g
Sodium laurylsulfate 15.0 g
Polyvinylpyrrolidone 15.0 g
Polyethylene glycol (Carbowax 1500) 4.5 g
Polyethylene glycol (Carbowax 6000) 45.0 g
Corn starch 30.0 g
Dry sodium stearate 3.0 g
Dry magnesium stearate 3.0 gEthanol q.s.
The active compound of the present invention, citric acid, lactose, dicalcium phosphate, Pullonic F-68 and sodium laurylstearate are mixed. The mixture is screened with No. 60 screen and is granulated with an alcohol
solution containing polyvinylpyrrolidone, carbowax 1500 and 6000. If required, an alcohol is added thereto so that the powder mixture is made a paste-like mass. Corn starch is added to the mixture and the mixture is continuously mixed to form uniform particles. The resulting particles are passed through No. 10 screen and entered into a tray and then dried in an oven at 100°C for 12 to 14 hours. The dried particles are screened with No. 16 screen and thereto are added dry sodium laurylsulfate and dry magnesium
stearate, and the mixture is tabletted to form the desired shape.
The core tablets thus prepared are vanished and dusted with talc in order to guard from wetting.
Undercoating is applied to the core tablets. In order to administer the tablets orally, the core tablets are vanished several times. In order to give round shape and smooth surface to the tablets, further undercoating and coating with lubricant are applied thereto. The tablets are further coated with a coloring coating material until the desired
colored tablets are obtained. After drying, the coated tablets are polished to obtain the desired tablets having uniform gloss.
Preparation 6
An injection preparation is prepared from the following components.
Components Amount
4-Methyl-1-[4-(2,3-dimethylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 5 g
1H-1,4-benzodiazepine
Polyethylene glycol (molecular weight: 4000) 0.3 g
Sodium chloride 0.9 g
Polyoxyethylene sorbitan monooleate 0.4 g
Sodium metabisulfite 0.1 g
Methyl-paraben 0.18 g
Propyl-paraben 0.02 g
Distilled water for injection 10.0 ml
The above parabens, sodium metabisulfite and sodium chloride are dissolved in distilled water of half volume of the above with stirring at 80°C. The solution thus obtained is cooled to 40°C, and the active compound of this invention and further polyethylene glycol and polyoxyethylene sorbitan monooleate are dissolved in the above solution. To the solution is added distilled water for injection to adjust to the desired volume, and the solution is sterilized by filtering with an appropriate filter paper to give an injection preparation.
Pharmacological Test
Oxytocin Receptor Binding Assay
Uterin muscle is taken out from a rat which has previously been injected subcutaneously with diethylstilbestrol the day before, and homogenized, which is used as a membrane preparation. The membrane preparation (0.2 mg), [3H]-oxytocin (100000 dpm, 10-9M), a test compound (10-9 - 10-5 M) are inclubated at 25°C for one hour in 100 mM , Tris-HCl buffer (pH=8.0, 250 yl) containing 5 mM MgCl2, 1 mM MEDTA and 0.1 % BSA. The mixture is filtered through the glass filter (GF/F) so as to separate the membrane
preparation combining with [3H]-oxytocin, and then, washed twice with the buffer (5 ml). This glass filter is put into a vial and mixted with Aquasole (liquid scintillation cocktail). The amount of [3H]-oxytocin combining with the membrane is measured by liquid scintillation counter. The rate of the inhibitory effect of the test compound is estimated according to the following equation.
Inhibitory Rate (%) = 100 - [ ( C^B ) / ( CQ-3 ) ] x 100
C1: The amount of [3H]-oxytocin combining with the
membrane in the presence of a test compound (known amount).
C0: The amount of [3H]-oxytocin combining with the
membrane in the absence of a test compound.
B: The amount of [3H]-oxytocin combining with the
membrane in the presence of the excess amount of oxytocin (5 × 10-6 M).
The results are expressed as IC50 values, which is
the concentration of the test compound required to achieve the inhibitory effect in the rate of 50 %.
The results are shown in the following Tables 1 and 2.
Test compounds
The compounds of the formula (1);
1-1: 1-{1-[4-{6-Aminohexyloxy)benzoyl]-4-piperidinyl}- 3,4-dihydrocarbostyril
1-2: 1-{1-[4-(6-Acetylaminohexyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-3: 1-{1-[4-(6-Methylsulfonylaminohexyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-4: 1-{1-[4-(7-Hydroxy-8-diethylaminooctyloxy)benzoyl]- 4-piperidinyl}-3,4-dihydrocarbostyril
1-5: 1-{1-(4-[6-(4-Methyl-1-piperazinyl)hexyloxy]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril 1-6: 1-{1-(4-[6-[N-Methyl-N-(2-(2-pyridyl)ethyl)amino)hexyloxy]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril
1-7: 1-{1-[4-(6-Dimethylaminohexyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-8: 1-{1-[4-(6-(1-Pyrrolidinyl)hexyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-9: 1-{1-[4-(7-(1-Pyrrolidinyl)octyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-10: 1-{1-[4-(7-(4-Methyl-1-piperazinyl)octyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-11: 1-{1-[4-(4-Acetylaminobutyloxy)benzoyl]-4-
piperidinyl}-3,4-dihydrocarbostyril
1-12: 1-{1-[4-(6-Diethylamino-5-hydroxyhexyloxy)benzoyl]- 4-piperidinyl}-3,4-dihydrocarbostyril
1-13: 1-{1-[4-(6-Dimethylamino-5-hydroxyhexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-14: 1-{1-[4-(4-(4-Benzyl-1-piperazinyl)butoxy)benzoyl]- 4-piperidinyl}-3,4-dihydrocarbostyril
1-15: 1-{1-[4-(4-(1-Piperazinyl)butoxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-16: 1-{1-[4-[4-(1-Piperazinyl)carbonyloxybutoxy]benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-17: 1-{1-[4-[5-Hydroxy-6-(4-benzyl-1-piperazinyl)hexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-18: 1-{1-[4-(5-Hydroxy-6-[N-methyl-N-(2-hydroxy-2- phenylethyl)amino]hexyloxy)benzoyl]-4-piperidinyl}- 3,4-dihydrocarbostyril
1-19: 1-{1-[4-(6[2(S)-Hydroxymethyl-1-pyrrolidinyl]-5- hydroxy)hexyloxy)benzoyl]-4-piperidinyl}-3,4- dihydrocarbostyril
1-20: 1-{1-[4-(5-Hydroxy-6-(3,4-dimethoxybenzylamino)hexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril
1-21: 1-{1-[4-(5-Hydroxy-6-(4-benzyl-1-piperidino)hexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-22: 1-{1-(4-[4-(4-Piperidinylcarbonylamino)butoxy)benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril 1-23: 1-{1-[4-(5-Methoxy-6-diethylmethylammoniumhexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril
iodide
1-24: 1-{1-[4-(Allylaminobutoxy)benzoyl]-4-piperidinyl}- 3,4-dihydrocarbostyril
1-25: 1-{1-[4-(5-Hydroxy-6-(allylaminohexyloxy)benzoyl]- 4-piperidinyl}-3,4-dihydrocarbostyril
1-26: 1-{1-[4-[3-(4-Benzoyl-1-piperazinyl)propoxy]benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-27: 1-[1-{4-[3-(4-Anilinocarbonyl-1-piperazinyl)propoxy]benzoyl}-4-piperidinyl]-3,4-dihydrocarbostyril
1-28: 1-{1-[4-(3-Phenylsulfonylaminopropoxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-29: 1-{1-[4-(4-Hydroxy-5-(1-pyrrolidinyl)pentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-30: 1-{1-[4-(4-Hydroxy-5-(l-piperidinyl)pentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-31: 1-{1-[4-(4-Hydroxy-5-(4-morpholino)pentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-32: 1-{1-[4-(3-Diethylaminopropoxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-33: 1-{1-[4-(3-Hydroxy-4-diethylaminobutoxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-34: 1-{1-[4-Anilinooxycarbonyl]-4-piperidinyl}-3,4- dihydrocarbostyril
1-35: 1-{1-[4-Benzoylaminophenoxycarbonyl]-piperidinyl}- 3,4-dihydrocarbostyril
1-36: 1-{1-[4-(5-Hydroxypentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-37: 1-{1-[4-(4-Carbamoylmethylaminocarbonylbutoxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-38: 1-{1-[4-(5-Carbamoyloxypentyloxy)benzoyl]-4- piperidinyl]-3,4-dihydrocarbostyril
1-39: 5,7-Difluoro-1-[1-(2-methoxy-4-ethoxybenzoyl)-4- piperidinyl]-3,4-dihydrocarbostyril
1-40: 1-{1-[4-(5-[(1S)-1,3-Dicarbamoyl]propylaminocarbonylpentyloxy)benzoyl]-4-piperidinyl}-3,4- dihydrocarbostyril
1-41: 1-[1-(2-Hydroxy-4-ethoxybenzoyl)-4-piperidinyl]-7- fluoro-3,4-dihydrocarbostyril
1-42: 5-Methyl-1-[1-(2-methoxy-4-ethoxybenzoyl)-4- piperidinyl]-3,4-dihydrocarbostyril
1-43: 1-{1-(4-[5-(1-Imidazolyl)pentyloxy]benzoyl)-4- piperidinyl}-3,4-dihydrocarbostyril
1-44: 5-Methyl-1-{1-[4-(3-acetylaminopropoxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-45: 1-{1-[4-(2-Propionyloxy)benzoyl]-4-piperidinyl}- 3,4-dihydrocarbostyril
1-46: 1-{1-[ 4-(4-Carboxybutoxy)benzoyl]-4-piperidinyl}- 3,4-dihydrocarbostyril
1-47: 1-{1-[4-(5-Carbamoylpentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-48: 1-{1-[4-(3-Carbamoylpropylamino)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-49: 1-{1-[4-(5-Hydroxypentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-50: 1-{1-[4-(5-Acetylaminopentyloxy)benzoyl]-4-
piperidinyl}-3,4-dihydrocarbostyril
1-51: 1-[1-(4-Methoxyanilinocarbonyl)-4-piperidinyl]-3,4- dihydrocarbostyril
1-52: 1-[1-(4-Ethoxybenzoyl)-4-piperidinyl]carbostyril 1-53: 6,7-Difluoro-1-[1-(2-methoxy-4-ethoxybenzoyl)-4- piperidinyl]-3,4-dihydrocarbostyril
1-54: 1-[1-{4-[4-(1-Pyrrolyl)butoxy]benzoyl}-4- piperidinyl]-3,4-dihydrocarbostyril
1-55: 1-[1-{4-[3-(4-Methyl-1-piperazinyl)propoxy]benzoyl}-4-piperidinyl]-3,4-dihydrocarbostyril dioxalate
1-56: 1-(1-[4-{5-[(1S)-1-Carbamoyl-2-(4-hydroxyphenyl)]ethylaminocarbonylpentyloxy}benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-57: 7-Fluoro-1-(1-benzoyl-4-piperidinyl)carbostyril 1-58: 7-Fluoro-1-[1-(2,4-dimethoxybenzoyl)-4-piperidinyl]carbostyril
1-59: 1-{1-[4-{5-[(1S)-1-Carbamoyl-3-(methylthio)]propylaminocarbonylpentyloxy}benzoyl]-4-piperidinyl}-3,4- dihydrocarbostyril
1-60: 1-{1-[4-(5-(2-Hydroxy-3-diethylaminopropoxy)pentyloxy)benzoyl]-4-piperidinyl}-3,4- dihydrocarbostyril
1-61: 1-{1-[4-(5-(3-Dimethylaminopropyl)aminocarbonylpentyloxy)benzoyl]-4-piperidinyl}-3,4- dihydrocarbostyril
1-62: 1-{1-[4-(5-(1-Benzyl-4-piperidinyl)aminocarbonylpentyloxy)benzoyl]-4-piperidinyl}-3,4-
dihydrocarbostyril
1-63: 1-{1-[4-(5-Hydroxy-6-(1-pyrrolidinyl)hexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-64: 1-{1-[4-(5-(4-Piperidinyl)aminocarbonylpentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-65: 1-{1-[4-(5-(1-Pyrrolidinyl)pentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-66: 1-{1-[4-(5,6-Dihydroxyhexyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-67: 1-{1-(4-[5-Hydroxy-6-{3-methoxybenzylamino)hexyloxy]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril 1-68: 1-{1-(4-[3-((1S)-1-Aminoethylcarbonylamino)propoxy]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril
1-69: 5,7-Dimethyl-1-[1-(2-methoxy-4-ethoxybenzoyl)-4- piperidinyl]-3,4-dihydrocarbostyril
1-70: 1-{1-(4-[5-(2-Imidazolylsulfonyl)pentyloxy]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril 1-71: 1-{1-(4-[5-Hydroxy-6-[N-methyl-N-(2-(2-pyridyl)ethyl)amino]hexyloxy]benzoyl)-4-piperidinyl}-3,4- dihydrocarbostyril
1-72: 1-{1-(4-[5-(2-(4-Methyl-1-piperazinyl)acetylamino)pentyloxy]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril
1-73: 1-{1-(4-[5-(l-Oxo-4-pyridylsulfonyl)pentyloxy]benzoyl-4-piperidinyl}-3,4-dihydrocarbostyril 1-74: 1-{1-(4-[5-(3-Hydroxy-1-piperidino)pentyloxy]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril
1-75: 1-{1-(4-[5-(4-Dimethylaminophenylsulfonyl)pentyloxy]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril 1-76: 1-{1-[4-(5-(4-Dimethylaminobenzoylamino)pentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-77: 1-{1-(4-[5-(2-(2-Hydroxyethyl)-1-piperazinyl)pentyloxy]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril
1-78: 1-{1-(4-[5-(N,N-(2-Hydroxyethyl)amino]pentyloxy]benzoyl-4-piperidinyl}-3,4-dihydrocarbostyril
1-79: 1-{1-[4-(5-Hydroxy-6-(1-piperidinyl)hexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-80: 5-Hydroxy-1-{1-[4-(3-acetylaminopropoxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-81: 1-{1-[2-Methoxy-4-(4-carbamoylbutoxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-82: 1-{1-[4-(5-(2-Methyl-1-piperidinyl)pentyloxy]benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-83: 5-Acetoxy-1-[1-(2-methoxy-4-ethoxybenzoyl)-4- piperidinyl]-3,4-dihydrocarbostyril
1-84: 1-{1-[4-[(5-Isopropylamino)pentyloxy]benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-85: 1-{1-(4-[2,4-Di-(5-(l-pyrrolidinyl)pentyloxy)]benzoyl)-4-piperidinyl}-3,4-dihydrocarbostyril 1-86: 1-{1-[4-(5-Dimethylaminopentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-87: 1-{1-[2-Methoxy-4-(4-thiomorpholinocarbonylbutyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-88: 1-{1-(2-Methoxy-4-[4-(l-oxo-4-thiomorpholino)
carbonylbutyloxybenzoyl]-4-piperidinyl}-3,4- dihydrocarbostyril
1-89: 1-{1-(2-Methoxy-4-[1,1-dioxo-4-thiomorpholino)carbonylbutyloxybenzoyl)-4-piperidinyl}-3,4- dihydrocarbostyril
1-90: 1-{1-[4-(5-tert-Butylaminopentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-91: 1-{1-[4-(5-(2-Propynylamino)pentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-92: 1-{1-[4-(6-Hydroxy-7-diethylamino)heptyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-93: 1-{1-[4-(5-Cyclopropylaminopentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-94: 1-{1-[4-(5-Tricyclo[3.3.1.1]decanylmethylaminopentyloxy)benzoyl]-4-piperidinyl}-3,4- dihydrocarbostyril
1-95: 1-{1-[5-[3-(3-Azaspiro(5,5)undecanyl)]-(5-phenylspiro-4-(1-piperidinyl)pentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-96: 1-{1-[4-(5-Butylaminopentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-97: 1-{1-[4-(5-Cyclohexylaminopentyloxy)benzoyl]-4- piperidinyl}-3,4-dihydrocarbostyril
1-98: 1-{1-[4-(5-Tricyclo[3.3.1.1]decanylaminopentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril 1-99 1-{1-[4-(3-Acetylaminopropoxy)benzoyl]-4- piperidinyl}-3,4-dihydroca.bostyril
The compounds of the formula (2);
2-1: 3-Methyl-1-[4-(2-methylbenzoylamino)benzoyl]¬
1,2,3,4-tetrahydroquinoline
2-2: 5-Methyl-1-[4-(2-methylbenzoylamino)benzoyl]¬
2,3,4,5-tetrahydro-1H-benzazepine
2-3: 5-Hydroxymethyl-7-chloro-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-4: 4-Hydroxy-1-[4-(2-methylbenzoylamino)benzoyl]¬
1,2,3,4-tetrahydroquinoline
2-5: 4-Hydroxy-1-[4-(2-methylbenzoylamino)benzoyl]¬
2,3,4,5-tetrahydro-1H-benzazepine
2-6: 5-Hydroxy-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-7: 5-Hydroxy-6-methyl-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-8: 4-Methyl-5-hydroxy-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-9: 5-Hydroxy-7-chloro-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-10: 5-Hydroxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-11: 5-Hydroxy-7-chloro-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-12: 5-Hydroxy-7-chloro-1-{4-[2-(2-methylphenyl)acetylamino]benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine 2-13: 5-Hydroxy-7-chloro-1-[3-methoxy-4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-14: 5-Hydroxy-1-[2-chloro-4-(2,4-dichlorobenzoylamino)-
benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
2-15: 5-Oxo-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydao-1H-benzazepine
2-16: 4-Oxo-1- [4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-17: 5-Oxo-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-18: 5-Oxo-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]2,3,4,5-tetrahydro-1H-benzazepine
2-19: 5-Hydroxy-6-methyl-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-20: 5-Acetyloxy-1-[4-(2-methylbenzoylamino)benzoyl]¬
2,3,4,5-tetrahydro-1H-benzazepine
2-21: 4-Dimethylaminomethyl-1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-22: 5-Aminomethyl-1-[4-(2-methylbenzoylamino)benzoyl]¬
2,3,4,5-tetrahydro-1H-benzazepine
2-23: 5-Formylaminomethyl-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-24: 5-Acetyloxymethyl-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-25: 5-Methylsulfonyloxymethyl-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-26: 1-[2-Chloro-4-(2-methylbenzoylamino)benzoyl]¬
2,3,4,5-tetrahydro-1H-benzazepine-5-spiro-2'- oxirane
2-27: 5-Methylaminocarbonyloxy-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
2-28: 5-Carbamoyloxy-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-29: 5-Dimethylaminocarbonyloxy-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-30: 5-Carboxymethoxy-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-31: 5-(4-Dimethylaminobutoxy)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-32: 5-(3-Aminopropoxy)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-33: 5-(2-Dimethylaminoethoxy)-7-fluoro-1-[3-methoxy-4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine hydrochloride
2-34: 5-(3-Phthalimidopropoxy)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-35: 5-Hydroxyimino-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-36: 5-Acetyloxyimino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-37: 5-Methylidene-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-38: 5-Methylidene-1-[4-(2-methylbenzoylamino)benzoyl]¬
2,3,4,5-tetrahydro-1H-benzazepine
2-39: Potassium {1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepin-5-yl}imino-O-sulfonate
2-40: 5-(2-Dimethylaminoacetyloxy)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
2-41: 5-(2-Dimethylaminoacetyloxy)-7-fluoro-1-[2-methoxy- 4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-42: 5-(2-Dimethylaminoacetyloxy)-7-chloro-1-[4-(2- chlorobenzoylamino)-2-methoxybenzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-43: 5-(2-Dimethylaminoacetyloxy)-7-chloro-1-[3-methoxy- 4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-44: 5-(2-Dimethylaminoacetyloxy)-7-chloro-1-[3-chloro- 4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-45: 5-(2-Dimethylaminoacetyloxy)-7-chloro-1-{2-methoxy- 4-[(2-methylphenyl)acetylamino)]benzoyl}-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-46: 5-(4-Dimethylaminobutyryloxy)-7-chloro-1-[2- methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-47: 5-(2-Dimethylaminoacetyloxy)-7-fluoro-1-[2-chloro- 4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-48: 5-(2-Dimethylaminoacetyloxy)-7-chloro-1-[2-methyl- 4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-49: 5-(2-Aminoacetyloxy)-7-chloro-1-[3-methoxy-4-(2- chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine hydrochloride
2-50: 5-(2-Aminoacetyloxy)-7-chloro-1-[3-chloro-4-(2-
methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine hydrochloride
2-51: 5-(2-Aminoacetyloxy)-7-fluoro-1-[2-chloro-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine hydrochloride
2-52: 5-(2-Aminoacetyloxy)-7-chloro-1-[2-methyl-4-(2- chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine hydrochloride
2-53: 5-Carbamoylmethoxy-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-54: 5-Dimethylaminocarbonylmethoxy-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-55: 5-Carbamoylmethylaminocarbonylmethoxy-7-chloro-1- [4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-56: 5-(4-Methyl-1-piperazinylcarbonylmethoxy)-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-57: 5-Amino-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-58: 3-Dimethylamino-1-[4-(3,5-dichlorobenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-59: 4-Methylamino-1-[4-(2-methylbenzoylamino)benzoyl]¬
1,2,3,4-tetrahydroquinoline
2-60: 4-Dimethylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-61: 3-Dimethylamino-1-[3-methoxy-4-(2-methylbenzoyl
amino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-62: 5-(N-Methyl-N-ethylamino)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-63 5-Dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-64 5-Dimethylamino-1- 2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3 4,5-tetrahydro-1H-benzazepine 2-65: 5-Dimethylamino-1- 3-ethoxy-4-(2-methylbenzoylamino)benzoyl]-2,3 4,5-tet rahydro-1H-benzazepine 2-66 5 -Dimethylamino-1- 3-hydroxy-4-(2-methylbenzoylamino)benzoyl]-2,3 4,5-tetrahydro-1H-benzazepine 2-67 5-Dimethylamino-1- 3-benzyloxy-4-(2-methylbenzoylamino)benzoyl]-2,3 4,5-tetrahydro-1H-benzazepine 2-68: 5-Dimethylamino-1- 2-ethoxy-4-(2-methylbenzoylamino)benzoyl]-2,3 4,5-tetrahydro-1H-benzazepine 2-69 5-Dimethylamino-1- 3-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3 4,5-tetrahydro-1H-benzazepine 2-70: 5-Dimethylamino-1- 2-fluoro-4-(2-methylbenzoylamino)benzoyl]-2,3 4,5-tetrahydro-1H-benzazepine 2-71: 5-Dimethylamino-1- 3-fluoro-4-(2-methylbenzoylamino)benzoyl]-2,3 4,5-tetrahydro-1H-benzazepine 2-72: 5-Dimethylamino-1- 3-methoxy-4-(2,3-dimethylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-73 5-Dimethylamino-1-[4-(2-methylanilinocarbonyl)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-74 5-Dimethylamino-1-[3-hydroxy-4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
2-75: 3-Hydroxy-4-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-l,2,3,4-tetrahydroquinoline 2-76: 4-Methyl-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-77: 5-Methylamino-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-78: 5-Methylamino-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-79: 5-Methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-80: 5-Propylamino-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-81: 5-Ethylamino-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-82: 5-Allylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-83: 5-Acetylamino-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-84: 5-(N-Acetyl-N-methylamino)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-85: 5-Cyclopropylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-86: 5-(2-Dimethylaminoethylamino)-1-[2-chloro-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-87: 5-(3-Dimethyl-2-hydroxypropylamino)-1-[4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-88: 5-(2,3-Dihydroxypropylamino)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-89: 5-[N-(3-Hydroxypropyl)-N-methylamino]-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-90: 5-Benzoylamino-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-91: 5-(N-Cyanomethyl-N-methylamino)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-92: 5-(N-Carbamoylmethyl-N-methylamino)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-93: 5-[N-(3-[1-Tetrahydropyranyloxy]propyl)-N-methyl]amino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-94: 5-[N-(3-Acetyloxypropyl)-N-methyl]amino-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-95: 5-(1-Benzyl-4-piperidinyl)amino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-96: 3-(4-Methyl-1-piperazinyl)-1-[4-(2,3-dimethylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-97: 3-(1-Pyrrolidinyl)-1-[4-(2,3-dimethylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-98: 5-Hydroxy-5-hydroxymethyl-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-
benzazepine
2-99: 5-Hydroxy-5-hydroxymethyl-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-100: 5-Hydroxymethyl-5-N-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-101: 5-Hydroxy-5-(N-methylamino)methyl-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-102: 5-Hydroxy-5-methyl-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-103: 5-(N-Ethoxycarbonylmethyl-N-methylamino)-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-104: 1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,5- tetrahydro-4,1-benzoxazepine
2-105: 1-[4-(2-Methylbenzoylamino)benzoyl]-1,2,3,4- tetrahydro-5,1-benzoxazepine
2-106: 4-Methyl-1-[4-(2-methylbenzoylamino)benzoyl]- 1,2,3,4-tetrahydroquinoxaline
2-107: 4-Methyl-1-[4-(3,5-dichlorobenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-1,4-benzodiazepine 2-108: 5-Methyl-1-(4-benzoylaminobenzoyl]-2,3,4,5- tetrahydro-1H-1,5-benzodiazepine
2-109: 5-Isopropyl-1-[4-(2,3-dimethylbenzoylarnino)benzoyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine 2-110: 1-[4-(2-methylbenzoylamino)benzoyl]-1,2-dihydroquinoline
2-111 : 5- [ 2- ( 4-Morpholino)acetyloxy ] -7-chloro-1- [ 2- methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-112: 5-(2-Isopropylaminoacetyloxy)-7-chloro-1-[2- methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-113: 5-(1,5-Diaminopentylcarbonyloxy)-7-chloro-1-[2- methoxy-4-{2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-114: 5-(3-Aminopropionyloxy)-7-chloro-1-[2-methoxy-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine hydrochloride
2-115: 5-(4-Dimethylaminobutyryloxy)-7-chloro-1-[3- methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-116: 5-(1,5-Diaminopentylearbonyloxy)-7-chloro-1-[3- methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-117: 5-(3-Aminopropionyloxy)-7-fluoro-1-[2-chloro-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine hydrochloride
2-118: 5-Formyloxy-7-chloro-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-119: 5-Dimethylaminocarbonylmethyl-7-chloro-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-120: 1-[4-[3-Methylphenylsulfonylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-121: 1-[4-(2-Methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-122: 1-[4-(4-Methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-123: 1-[4-(2,3-Dimethylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-124: 1-[4-(2-Chlorobenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-125: 1-[4-(2-Bromobenzoylamino)benzoyl] -2,3,4,5- tetrahydro-1H-benzazepine
2-126: 1-[4-(2-Methoxybenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-127: 1-(4-Cyclohexylcarbonylaminobenzoyl)-2,3,4,5- tetrahydro-1H-benzazepine
2-128: 1-[4-(2-Carbamoylmethoxybenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-129: 1-{4-[2-(6-Isopropylaminohexyloxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine 2-130: 1-[4-(2-(N-Phenyl-N-ethynylamino)acetylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-131: 1-[4-(2-(N-Phenyl-N-methylamino)acetylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-132: 1-[(2-(4-Phenylamino)acetylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-133: 1-[{4-(2-[N-Phenyl-N-(2-acetyloxy)ethoxy]amino)acetylamino}benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-134: 1-{[4-{2-(2-Acetylaminophenoxy)acetylamino]
benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine
2-135: 1-[4-(3-Fluorobenzoylamino)benzoyl]-1,2,3,4- tetrahydroquinoline
2-136: 1-[4-Tricyclo[3.3.1.1]decanylearbonylaminobenzoyl]- 1,2,3,4-tetrahydroquinoline
2-137: 1-(4-Benzylcarbonylaminobenzoyl)-1,2,3,4-tetrahydroquinoline
2-138: 1-[4-(2-Furoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-139: 1-[4-(3-Thenoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-140: 1-[4-(3-Ethoxybenzoylamino)benzoyl]-1,2,3,4- tetrahydroquinoline
2-141: 7-Chloro-1-[4-(3-hydroxybenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-142: 7-Chloro-1-[4-(3-acetyloxybenzoylamino)benzoyl]¬
2,3,4,5-tetrahydro-1H-benzazepine
2-143: 7-Chloro-1-[4-(2-carbamoylmethoxybenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-144: 7-Chloro-1-{3-[2-(2-dimethylaminoethoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride
2-145: 7-Chloro-1-{4-[2-[4-isopropylaminobutoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine 2-146: 1-[4-(2-Methylbenzoylamino)benzoyl]-1,2,3,4,5,6- hexahydrobenzazocine
2-147: 1-[4-(2-Methoxybenzoylamino)benzoyl]-1,2,3,4,5,6- hexahydrobenzoazocine
2-148: 6-Methyl-1-[4-(3,4-dichlorobenzoylamino)benzoyl]¬
1,2,3,4-tetrahydroquinoline
2-149: 1-[4-(3-Methylbenzoylamino)benzoyl]perhydroquinoline
2-150: 1-[4-(2-Methylbenzoylamino)benzoyl]-1,2,3,4- tetrahydroquinoline
2-151: 1-[4-(4-Methoxycarbonylbenzoylamino)benzoyl]¬
1,2,3,4-tetrahydroquinoline
2-152: 1-[4-(2-Nitrobenzoylamino)benzoyl]-1,2,3,4- tetrahydroquinoline
2-153: 1-(4-Isobutyrylaminobenzoyl)-1,2,3,4-tetrahydroquinoline
2-154: 1-[4-(2,3-Dimethylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-155: 4-Methyl-1-[4-cyclohexylcarbonylaminobenzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-156: 3-Methyl-1-[4-(2-methylbenzoylamino)benzoyl]¬
1,2,3,4-tetrahydroquinoline
2-157: 2-Methyl-1-(4-benzoylaminobenzoyl)-1,2,3,4- tetrahydroquinoline
2-158: 1-{4-[4-(6-(1-Piperidyl)hexyloxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine 2-159: 1-[4-(2-Chloro-4-aminobenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-160: 3-Dimethylaminocarbonyl-1-[4-(3,5-dichlorobenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-161: 1-{4-[2-(4-Methoxyanilino)acetylamino]benzoyl}- 2,3,4,5-tetrahydro-1H-benzazepine
2-162: 1-{4-[2-(2-(4-Morpholino)ethoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine 2-163: 1-{4-[2-(4-Hydroxybutoxy)benzoylamino]benzoyl}- 2,3,4,5-tetrahydro-1H-benzazepine
2-164: 1-{4-(2-Diethylaminocarbonylmethoxybenzoylamino)benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine 2-165: 1-{4-(2-[N-(1-(2-Propyl)), N-(phenyl)amino]acetylamino)benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine 2-166: 4-Isopropyl-1-{4-(2,3-dimethylbenzoylamino)benzoyl}-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine 2-167: 1-{4-[4-(2-Diethylaminoacetyl-1-piperidinyl)carbonylamino]benzoyl}-2,3,4,5-tetrahydro-1H- benzazepine hydrochloride
2-168: 5-Methoxy-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-169: 5-Ethoxycarbonylmethoxy-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-170: 5-Hydroxymethyl-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-171: 1-[4-(2-Methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine-5-spiro-2'-oxirane
2-172: 5-[N-Methyl,N-(2-hydroxy-3-diethylaminopropyl)]amino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-173: 5-[N-ethyl,N-n-propyl)amino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-174: 5-(4-MorpholinocarbonyImethoxy)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-
benzazepine
2-175: 5-(4-Thiomorpholinocarbonylmethoxy)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-176: 5-(Anilinocarbonylamino)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-177: 5-Isobutylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-178: 5-Formylamino-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-179: 5-(1-Oxothiomorpholinocarbonylmethoxy)-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-180: 5-Methylaminocarbonylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-181: 5-(1-Pyrrol)-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-182: 5-[(2S)-2-Carbamoyl-(1-pyrrolidinyl)]carbonylmethoxy-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-183: 5-Carbamoylmethylaminocarbonylmethoxy-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-184: 5-[(1,1-Dioxothiomorpholino)carbonylmethoxy]-1-[4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-185: 5-[(4-Acetyl-1-piperazinyl)carbonylmethoxy]-1-[4- {2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-
1H-benzazepine
2-186: 7-Chloro-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-187: 5-Ethoxycarbonylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-188: 5-(2-Methylamino)acetylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-189: 5-[N-Methyl,N-(2-hydroxyethyl)aminocarbonylmethoxy]-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-190: 5-Dimethylamino-1-[4-(2-methylbenzoyloxy)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-191: 2-[N-Methyl-N-{1-[4-(2-methylbenzoylamino)benzoyl]-
2,3,4,5-tetrahydro-1H-benzazepin-5-yl}amino]acetic acid potassium salt
2-192: 5-(2-[N-Methyl,N-(l-imidazol)]acetylamino)-1-[4-(2- methylaminobenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-193: 5-Dimethylamino-1-[4-(2-dimethylaminobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine2-194: 5-(2-Aminoacetylamino)-1-[4-(2-methylaminobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-195: 5-[2- (1-Imidazol)acetylamino]-1-[4-(2-methylaminobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-196: 8-Chloro-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-197: 8-Chloro-5-methylamino-1-[4-(2-methylbenzoylamino)
benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
2-198: 5-(2-tert-Butoxycarbonylamino)acetylamino)-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-199: 6-Chloro-5-hydroxy-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-200: 6-Chloro-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-201: 7-Chloro-5-cyclopropylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-202: 9-Chloro-5-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-203: 9-Chloro-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-204: 5-Dimethlamino-1-[4-(2-methylbenzylearbonylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-205: 6-Methylamino-1-[4-(2-methylbenzoylamino)benzoyl]- 1,2,3,4,5,6-hexahydrobenzazocine
2-206: 7-Chloro-5-methylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-207: 7-Chloro-5-dimethylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-208: 7-Chloro-5-cyclopropylamino-1-[3-methoxy-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-209: 7-Methoxy-5-oxo-1-[4-(2-methylbenzoylamino)
benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
2-210: 7-Methyl-5-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-211: 7-Methyl-5-cyclopropylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-212: 7-Methyl-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-213: 7-Methoxy-5-oxo-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-214: 7-Methoxy-5-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-215: 7-Bromo-5-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-216: 7-Chloro-5-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-217: 7-Chloro-5-cyclopropylamino-1-[2-chloro-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-218: 7-Chloro-5-dimethylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-219: 7-Methyl-5-(N-methyl,N-ethyl)amino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-220: 7-Bromo-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
2-221: 7-Methoxy-5-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-222: 7-Methoxy-5-methylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-223: 7-Methoxy-5-dimethylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-224: 7-Methyl-5-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-225: 7-Methoxy-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-226: 7-Methyl-5-cyclopropylamino-1-[2-chloro-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-227: 7-Chloro-5-allylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-228: 7-Chloro-5-dimethylamino-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-229: 6-Methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4,5,6-hexahydrobenzazocine 2-230: 7-Methoxy-5-dimethylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-231: 7-Methoxy-5-cyclopropylamino-1-[2-chloro-4-(2-
methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-232: 7-Chloro-5-ethylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-233: 7-Methoxy-5-cyclopropyl-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-234: 7-Dimethylamino-5-oxo-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-235: 8-Chloro-6-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-l,2,3,4,5,6-hexahydrobenzazocine
2-236: 7-Methoxy-5-cyclopropylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-237: 7-Methoxy-5-hydroxy-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-238: 6-Chloro-4-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-239: 7-Dimethylamino-5-methylamino-1-[2-chloro-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-240: 7-Methyl-5-dimethylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-241: 7-Dimethylamino-5-hydroxy-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-
benzazepine
2-242: 6-Chloro-4-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-243: 7-Chloro-5-methylamino-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-244: 7-Chloro-5-dimethylamino-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-245: (+)-5-Dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride
2-246: (-)-5-Dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine hydrochloride
2-247: 7-Chloro-5-cyclopropylamino-1-[2-methyl-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-248: 7-Methyl-5-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-249: 8-Methoxy-6-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4,5,6-hexahydrobenzazocine
2-250: 7-Methoxy-5-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-251: 6-Methoxy-4-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-252: 7-Fluoro-5-cyclopropylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-253: 7-Fluoro-5-cyclopropylamino-1-[2-chloro-4-(2- methylbenzoylamino)benzoyl] -2,3,4,5-tetrahydro-1H- benzazepine
2-254: 7-Fluoro-5-cyclopropyl-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-255: 6-Methoxy-4-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-256: 7-Methoxy-4-dimethylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-257: 7-Methyl-5-methylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-258: 7-Methyl-5-dimethylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-259: 6-Chloro-4-methylamino-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-260: 7-Chloro-5-dimethylamino-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-261: 7-Fluoro-5-methylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-262: 7-Fluoro-5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-263: 7-Fluoro-5-dimethylamino-1-[2-chloro-4-(2-methyl
benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-264: 7-Chloro-5-allylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-265: 7-Chloro-5-(N-methyl,N-allyl)amino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-266: 7-Fluoro-5-dimethylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-267: 7-Methoxy-5-methylamino-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-268: 7-Methoxy-5-dimethylamino-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-269: 6-Methyl-4-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-270: 6-Chloro-4-methylamino-3-methyl-1-[4-(2-methylbenzoylamino)benzoyl]-l,2,3,4-tetrahydroquinoline 2-271: 4-Methylamino-3-methyl-1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-272: 6-Chloro-4-methylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-273: 6-Chloro-4-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-274: 6-Chloro-4-dimethylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-275: 6-Methyl-4-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-276: 6-Methyl-4-dimethylamino-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-277: 6-Chloro-4-dimethylamino-3-methyl-1-[2-chloro-4-(2- methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline
2-278: 4-Dimethylamino-3-methyl-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-1,2,3,4-tetrahydroquinoline 2-279: 8-Chloro-6-methylamino-1-[4-(2-methylbenzoylamino)benzoyl]-1,2,3,4,5,6-hexahydrobenzazocine 2-280: 7-Chloro-5-allylamino-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-281: 7-Chloro-5-(N-methyl,N-ethyl)amino-1-[3-methoxy-4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-282: 7-Chloro-5-(N-methyl,N-allyl)amino-1-[3-methoxy-4- (2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-283: 7-Fluoro-5-hydroxy-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-284: 7-Fluoro-5-hydroxy-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-285: 7-Fluoro-5-hydroxy-1-[3-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-286: 5-Dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl] -2 , 3 ,4,5-tetrahydro-1H-benzazepine
2-287: 5-Chloro-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-288: 7-Methoxy-5-methylidene-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydrc-1H- benzazepine
2-289: 7-Chloro-4-methyl-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine 2-290: 4-Methyl-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-l,4-benzodiazepine 2-291: 7-Methoxy-5-hydroxymethyl-5-hydroxy-1-[2-chloro-4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-292: 7-Methoxy-5-methylamino-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-293: 7-Methoxy-5-hydroxy-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydrc-1H- benzazepine
2-294: 7-Fluoro-5-[2-(4-methyl-1-piperazinyl)ethoxy]-1-[2- methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-295: 7-Chloro-1-{2-methoxy-4-[2-(4-[4-methyl-1- piperazinyl]butoxy)benzoylamino]benzoyl}-2,3,4,5- tetrahydro-1H-benzazepine
2-296: 7-Chloro-5-(2-(isopropylamino)ethoxy)-1-[2-methyl- 4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-297: 7-Chloro-5-(4-methyl-1-piperazinyl)carbonyImethyl-
1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine hydrochloride 2-298: 7-Chloro-1-{3-methoxy-4-[2-(2-dimethylaminoethoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H- benzazepine
2-299: 7-Chloro-5-(4-methyl-1-piperidinyl)carbonylmethyl- 1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine hydrochloride
2-300: 7-Chloro-5-(2-dimethylaminoethyl)-1-[2-methoxy-4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine hydrochloride
2-301: 7-Chloro-4-hydroxy-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-302: 7-Chloro-1-[2-chloro-4-(2-acetyloxybenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-303: 7-Chloro-1-[2-chloro-4-(2-hydroxybenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-304: 7-Chloro-1-[2-methyl-4-(2-hydroxybenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-305: 7-Fluoro-5-[(4-dimethylamino-1-piperidino)carbonylmethyl]-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-306: 7-Fluoro-5-(1-piperidinocarbonyImethyl)-1-[2- methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
2-307: 7-Chloro-5-[(1-methyl-4-piperidinyl)aminocarbonylmethoxy]-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
hydrochloride
2-308: 7-Chloro-5-(2-acetylaminoethyl)-1-[2-methoxy-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-309: 7-Chloro-5-dimethylaminocarbonylmethyl-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-310: 7-Chloro-5-carbamoylmethyl-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-311: 7-Chloro-5-[(4-methyl-1-piperazinyl)carbonylmethoxy]-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-312: 7-Fluoro-5-[(4-acetylamino-1-piperidino)carbonylmethyl]-1-[4-(2-methylbenzoylamino)benzoyl]- 2,3,4,5-tetrahydro-1H-benzazepine
2-313: 7-Chloro-5-[(4-acetylamino-1-piperidino)carbonylmethyl]-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-314: 5-[(4-Acetylamino-1-piperidino)carbonyImethyl]-7- fluoro-1-[2-methoxy-4-(2-bromomethylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-315: 7-Chloro-1-[2-chloro-4-(2-carbamoylmethoxybenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-316: 7-Chloro-1-{2-chloro-4-[2-(2-dimethylaminoethoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H- benzazepine
2-317: 7-Chloro-1-{2-chloro-4-[2-(4-dimethylaminobutoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H-
benzazepine
2-318: 7-Chloro-1-{2-chloro-4-[2-(4-isopropylaminobutoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H- benzazepine
2-319: 7-Chloro-1-{2-methyl-4-(2-carbamoylmethoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H-benzazepine 2-320: 7-Chloro-5-(2-hydroxyethyl)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-321: 7-Chloro-5-(2-hydroxyethyl)-1-[4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-322: 7-Chloro-5-(2-hydroxyethoxy)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-323: 7-Chloro-5-(2-hydroxyethoxy)-1-[4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-324: 7-Chloro-5-(2-dimethylaminoethyl)-1-[4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-325: 7-Chloro-5-(2-chloroethyl)-1-[4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-326: 7-Chloro-5-(2-dimethylaminoethyl)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-327: 7-Chloro-5-(2-isopropylaminoethyl)-1-[4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-328: 7-Chloro-5-(2-isopropylaminoethyl)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-329 : 7-Chloro-5- ( 2-tert-butylaminoethyl ) -1- [ 4- ( 2-chlorobenzoylamino)benzoylJ-2,3,4,5-tetrahydro-1H- benzazepine
2-330: 7-Chloro-5-(2-tert-butylaminoethyl)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-331: 7-Chloro-5-(2-isopropylaminoethoxy)-1-[4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-332: 7-Chloro-5-(2-isopropylaminoethoxy)-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-333: 7-Chloro-5-(2-tert-butylaminoethoxy)-1-[4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-334: 7-Chloro-4-methylamino-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-335: 7-Chloro-4-dimethylamino-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-336: 7-Chloro-5-(2-dimethylaminoethyl)-1-[2-methyl-4-(2- chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-337: 7-Chloro-5-(2-diethylaminoethyl)-1-[2-methyl-4-(2- chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-338: 7-Chloro-5-(2-isopropylaminoethyl)-1-[2-methyl-4-
(2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-339: 7-Chloro-5-(2-tert-butylaminoethyl)-1-[2-methyl-4- (2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-340: 7-Chloro-5-(2-dimethylaminoethoxy)-1-[3-methoxy-4- (2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-341: 7-Chloro-5-(2-diethylaminoethoxy)-1-[3-methoxy-4- (2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-342: 7-Chloro-5-(2-isopropylaminoethoxy)-1-[3-methoxy-4- (2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-343: 7-Chloro-5-(2-diethylaminoethoxy)-1-[3-methoxy-4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-344: 7-Chloro-5-(2-isopropylaminoethoxy)-1-[3-methoxy-4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-345: 7-Chloro-5-(2-tert-butylethoxy)-1-[3-methoxy-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-346: 7-Chloro-5-(2-diethylaminoethyl)-1-[2-methoxy-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-347: 7-Chloro-5-(2-isopropylaminoethyl)-1-[2-methoxy-4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-
1H-benzazepine
2-348: 7-Chloro-5-(2-tert-butylaminoethyl)-1-[2-methoxy-4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-349: 7-Chloro-5-(2-diethylaminoethyl)-1-[2-methoxy-4-(2- chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-350: 7-Chloro-5-(2-isopropylaminoethyl)-1-[2-methoxy-4- (2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-351: 7-Chloro-5-(2-tert-butylaminoethyl)-1-[2-methoxy-4- (2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-352: 7-Chloro-1-[2-methoxy-4-(3-hydroxybenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-353: 7-Chloro-1-[3-methoxy-4-(2-hydroxybenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-354: 7-Chloro-1-[3-methoxy-4-(2-carbamoylmethoxybenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-355: 7-Chloro-1-{3-methoxy-4-[2-(2-dimethylaminoethoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H- benzazepine
2-356: 7-Chloro-1-{3-methoxy-4-[2-(2-isopropylaminoethoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H- benzazepine
2-357: 7-Chloro-1-{3-methoxy-4-[2-(4-dimethylaminobutoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H- benzazepine
2-358: 7-Chloro-1-{3-methoxy-4-[2-(4-isopropylaninobutoxy)benzoylamino]benzoyl}-2,3,4,5-tetrahydro-1H- benzazepine
2-359: 7-Chloro-4-hydroxy-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-360: 7-Chloro-5-(2-aminoethyl)-1-[2-methoxy-4-(2- methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine hydrochloride
2-361: 7-Chloro-4-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-362: 7-Chloro-1-[2-methyl-4-(2-acetyloxybenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-363: 7-Chloro-5-carbamoylmethoxy-1-[2-methyl-4-(2- chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-364: 7-Fluoro-5-(2-diethylaminoethyl)-1-[2-methyl-4-(2- chlorobenzoylamino)benzoyl}-2,3,4,5-tetrahydro-1H- benzazepine
2-365: 7-Fluoro-5-(2-isopropylaminoethyl)-1-[2-methyl-4- (2-chlorobenzoylamino)benzoyl}-2,3,4,5-tetrahydro- 1H-benzazepine
2-366: 7-Fluoro-5-(2-tert-butylaminoethyl)-1-[2-methyl-4- (2-chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-367: 7-Chloro-5-(2-ethylaminoethoxy)-1-[2-methoxy-4-(2- chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-368: 7-Chloro-5-(2-acetylaminoethoxy)-1-[2-methoxy-4-(2-
chlorobenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H- benzazepine
2-369: 7-Chloro-5-(2-isopropylaminoethoxy)-1-[2-methoxy-4- (2-bromobenzoylamino)benzoyl]-2,3,4,5-tetrahydro- 1H-benzazepine
2-370: 7-Chloro-5-methoxy-1-[2-methoxy-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine 2-371: 7-Chloro-5-{N-methyl,N-[2-(2-pyridyl)ethyl]aminocarbonylmethoxy-1-[2-trifluoromethyl-4-(2-methylbenzoylamino)benzoyl] -2,3,4,5-tetrahydro-1H- benzazepine
2-372: 7-Chloro-5-[2-(N-ethyl,N-butylamino)ethoxy]-1-[2- methoxy-4-(2-chlorobenzoylamino)benzoyl]-2,3,4,5- tetrahydro-1H-benzazepine
Table 1 (*): Inhibitory Rate (%) at 10-5 M
Test IC 50 Test IC50
Comp. Comp.
No. (μM) No. (μM)
1-1 7.60 1-2 5.63
1-3 4.37 1-4 3.96
1-5 8.38 1-6 4.57
1-7 7. 66 1-8 8.23
1-9 4.89 1-10 4.09
1-11 5.05 1-12 3.55
1-13 4. 75 1-14 43.8 (*)
1-15 6.18 1-16 6.03
1-17 4.32 1-18 23.3 (*)
1-19 5.10 1-20 7.13
1-21 5.10 1-22 4.32
1-23 4.99 1-24 22.7 (*)
1-25 7.14 1-26 24.2 (*)
1-27 13.6 (*) 1-28 5.55
1-29 7.24 1-30 24.6 (*)
1-31 33.8 (*) 1-32 28.7 (*)
1-33 14.6 (*) 1-34 10.8 (*)
1-35 32.4 (*) 1-36 4.45
1-37 1.91 1-38 4.38
1-39 0.85 1-40 2.92
1-41 7.70 1-42 4.54
1-43 4.14 1-44 8.28
1-45 9.24 1-46 40.1 (*)
1-47 3.28 1-48 24.5 (*)
1-49 7.85 1-50 8.59
1-51 40.1 (*) 1-52 6.85
1-53 72.7 1-54 47.4 (*)
Test IC50 Test IC50
Comp. Comp.
No. (μM) No. (μM)
1-55 45.7 (*) 1-56 2.92 1-57 30.3 (*) 1-58 43.8 (*) 1-59 3.19 1-60 4.29 1-61 5.08 1-62 5.13 1-63 5.73 1-64 4.55 1-65 6.86 1-66 45.8 (*) 1-67 6, 80 1-68 49.7 (*) 1-69 41.4 (*) 1-70 2.93 1-71 3. 42 1-72 5.82 1-73 2.85 1-74 7.39 1-75 44.10 (*) 1-76 43.3 (*) 1-77 3.29 1-78 5.16 1-79 8.74 1-80 6.62 1-81 1.89 1-82 4.69 1-83 1.91 1-84 5.54 1-85 15.7 (*) 1-86 8.21 1-87 9. 85 1-88 2.45 1-89 6.73 1-90 5.75 1-91 7.05 1-92 2.32 1-93 5.13 1-94 7.44 1-95 4.02 1-96 3.10 1-97 3.87 1-98 7.13 1-99 4.6
Table 2 (*): Inhibitory Rate (%) at 10-5 M
(**): Inhibitory Rate (%) at 10 -6 M
Test IC50 Test IC 50
Comp. Comp.
No. (μM) No. (μM)
2-1 4.01 2-2 1.55
2-3 0.22 2-4 21.3 (*)
2-5 1.57 2-6 1.26
2-7 25.0 (*) 2-8 0.52
2-9 0.23 2-10 3.07
2-11 0.34 2-12 0.60
2-13 0.23 2-14 42.0 (*)
2-15 15.3 (*) 2-16 5.30
2-17 43.2 (*) 2-18 37.8 (*)
2-19 14.8 (*) 2-20 5.20
2-21 27.2 (*) 2-22 3.89
2-23 0.72 2-24 2.49
2-25 2.82 2-26 8.89
2-27 7.25 2-28 7.61
2-29 37.1 (*) 2-30 8.10
2-31 1.83 2-32 2.55
2-33 1.12 2-34 4.04
2-35 41.1 (*) 2-36 35.9 (*)
2-37 6.64 2-38 1.50
2-39 27.9 (*) 2-40 1.38
2-41 0.48 2-42 0.07
2-43 0.55 2-44 4.29
2-45 0.23 2-46 0.07
2-47 8.35 2-48 3.64
2-49 0.55 2-50 2.93
2-51 4.79 2-52 2.70
2-53 5.81 2-54 2.92
Test IC50 Test IC50
Comp. Comp.
No. (μM) No. (μM)
2-55 0.38 2-56 1.83
2-57 8.79 2-58 3.82
2-59 22.8 (*) 2-60 5.01
2-61 22.7 (*) 2-62 37.9 (*)
2-63 5.30 2-64 12.0 (*)
2-65 33.9 (*) 2-66 16.8 (*)
2-67 28.5 (*) 2-68 16.9 (*)
2-69 31.2 (*) 2-70 5.19
2-71 6.07 2-72 26.3 (*)
2-73 8.93 2-74 22.9 (*)
2-75 32.0 (*) 2-76 1.55
2-77 6.10 2-78 10.3 (*)
2-79 19.6 (*) 2-80 8.39
2-81 22.4 (*) 2-82 27.5 (*)
2-83 30.1 (*) 2-84 7.92
2-85 40.3 (*) 2-86 37.3 (*)
2-87 5.55 2-88 2.37
2-89 2.58 2-90 26.5 (*)
2-91 8.62 2-92 2.47
2-93 5.38 2-94 3.19
2-95 5.56 2-96 9.19
2-97 3.81 2-98 16.6 (*)
2-99 44.2 (*) 2-100 21.8 (*)
2-101 14.6 (*) 2-102 3.48
2-103 3.03 2-104 7.61
2-105 33.7 (*) 2-106 32.4 (*)
2-107 3.57 2-108 5.84
2-109 8.75 2-110 36.9 (*)
Test IC50 Test IC50
Comp. Comp.
No. (μM) No. (μM)
2-111 0.05 2-112 0.05
2-113 0.11 2-114 0.03
2-115 0.46 2-116 1.26
2-117 6.02 2-118 0.55
2-119 0.62 2-120 3.33
2-121 1.18 2-122 9.61
2-123 1.24 2-124 1.29
2-125 0.88 2-126 7.34
2-127 1.02 2-128 46.4 (*)
2-129 45.0 (*) 2-130 8.42
2-131 2.05 2-132 8.29
2-133 4.16 2-134 46.9 (*)
2-135 19.0 2-136 10.0 (*)
2-137 11.4 (*) 2-138 16.2 (*)
2-139 8.97 2-140 19.0 (*)
2-141 2.41 2-142 3.29
2-143 5.76 2-144 8.26
2-145 8.54 2-146 3.15
2-147 13.2 (*) 2-148 7.02
2-149 4.83 2-150 3.33
2-151 10.9 (*) 2-152 21.7 (*)
2-153 8.96 2-154 7.93
2-155 2.54 2-156 4.01
2-157 13.8 (*) 2-158 23.7 (*)
2-159 6.73 2-160 49.3 (*)
2-161 6.32 2-162 30.7 (*)
2-163 22.2 (*) 2-164 23.3 (*)
2-165 8.42 2-166 8.75
2-167 25.2 (*) 2-168 1.60
Test IC50 Test IC50
Comp. Comp.
No. (μM) No. (μM)
2-169 1.76 2-170 0.96
2-171 1.90 2-172 5.34
2-173 43.4 (*) 2-174 1.78
2-175 1.24 2-176 21.1 (*)
2-177 24.1 (*) 2-178 9.26
2-179 2.63 2-180 28.6 (*)
2-181 14.2 {*) 2-182 1.34
2-183 2.09 2-184 2.40
2-185 1.47 2-186 1.44
2-187 10.1 (*) 2-188 41.7 (*)
2-189 2.36 2-190 34.2 (*)
2-191 15.6 (*) 2-192 7.71
2-193 7.60 2-194 26.7 (*)
2-195 53.4 (*) 2-196 8.93
2-197 44.1 (*) 2-198 46.0 (*)
2-199 31.1 (*) 2-200 38.1 (*)
2-201 1.17 2-202 4.45
2-203 6.00 2-204 47.4 (*)
2-205 38.2 (*) 2-206 1.58
2-207 3.07 2-208 3.19
2-209 17.8 (*) 2-210 2.71
2-211 3.49 2-212 1.44
2-213 36.1 (*) 2-214 5.06
2-215 0.49 2-216 4.76
2-217 48.8 (*) 2-218 8.58
2-219 3.78 2-220 1.35
2-221 2.32 2-222 3.37
2-223 4.53 2-224 45.6 (*)
Test IC50 Test IC50
Comp. Comp.
No. (μM) No. (μM)
2-225 1.76 2-226 9.19
2-227 47.4 (*) 2-228 40.4 (*)
2-229 34.4 (*) 2-230 4.17
2-231 5.39 2-232 42.8 (*)
2-233 5.27 2-234 22.2 (*)
2-235 2.86 2-236 3.05
2-237 2.40 2-238 2.47
2-239 15.8 (*) 2-240 7.83
2-241 18.1 (*) 2-242 44.5 (*)
2-243 3.19 2-244 16.4 (*)
2-245 20.2 (*) 2-246 2.60
2-247 9.78 2-248 43.1
2-249 1.76 2-250 41.1 (*)
2-251 11.6 (*) 2-252 5.56
2-253 33.7 (*) 2-254 6.09
2-255 3.21 2-256 29.5 (*)
2-257 5.82 2-258 5.86
2-259 25.0 (*) 2-260 26.8 (*)
2-261 8.34 2-262 5.68
2-263 49.8 (*) 2-264 0.83
2-265 7.32 2-266 6.68
2-267 9.46 2-268 35.0 (*)
2-269 45.1 (*) 2-270 0.26
2-271 2.17 2-272 9.46
2-273 3.20 2-274 10.5 (*)
2-275 4.47 2-276 32.8 (*)
2-277 26.0 C) 2-278 18.8 (*)
2-279 1.18 2-280 3.92
Test IC50 Test IC50
Comp. Comp.
No. (μM) No. (μM)
2-281 36.9 (*) 2-282 35.9 (*) 2-283 1.18 2-284 3.43 2-285 0.94 2-286 1.81 (*) 2-287 1.17 2-288 3.62 2-289 2.41 2-290 7.58 2-291 33.8 (*) 2-292 46.0 (*) 2-293 89.7 (*) 2-294 1.64 2-295 3.69 2-296 2.18 2-297 1.85 2-298 47.3 (*) 2-299 0.36 2-300 0.97 2-301 0.12 2-302 29.6 (*) 2-303 14.4 (*) 2-304 17.7 (*) 2-305 0.22 2-306 0.09 2-307 1.94 2-308 0.09 2-309 0.25 2-310 0.28 2-311 0.10 2-312 1.22 2-313 0.13 2-314 0.10 2-315 4.44 2-316 3.52 2-317 6.75 2-318 8.01 2-319 3.58 2-320 0.22 2-321 0.30 2-322 0.23 2-323 0.25 2-324 1.76 2-325 27.6 (*) 2-326 0.61 2-327 0.37 2-328 0.35 2-329 0.45 2-330 0.33 2-331 0.30 2-332 0.38 2-333 0.52 2-334 0.35 2-335 0.14 2-336 7.54
Test IC50 Test IC50
Comp. Comp.
No. (μM) No. (μM)
2-337 4.23 2-338 7.55
2-339 5.41 2-340 0.57
2-341 0.49 2-342 0.62
2-343 0.60 2-344 1.87
2-345 2.50 2-346 0.33
2-347 0.64 2-348 0.66
2-349 0.51 2-350 0.43
2-351 0.86 2-352 0.72
2-353 31.6 (*) 2-354 4.52
2-355 9.50 2-356 9.23
2-357 0.57 2-358 5.18
2-359 0.08 2-360 0.45
2-361 1.37 2-362 24.2 (*)
2-363 4.00 2-364 4.49
2-365 4.40 2-366 9.29
2-367 0.10 2-368 0.21
2-369 88.8 (**) 2-370 0.78
2-371 1.93 2-372 0.88
Claims (46)
1. An oxytocin antagonist which comprises as an active ingredient a carbostyril derivative of the formula (1):
wherein R1 is hydrogen atom; nitro; a lower alkoxy; a lower alkoxycarbonyl; a lower alkyl; a halogen atom; an amino having optionally one or two substituents selected from a lower alkanoyl, a lower alkyl, benozyl and a phenyl(lower)alkoxycarbonyl; hydroxy; cyano; carboxy; a lower alkanoyloxy; or hydrazinocarbonyl,
q is an integer of 1 to 3, and
R is a group of the formula: or
wherein R2 is hydrogen atom; a lower alkoxycarbonyl; a phenoxycarbonyl wherein the phenyl ring may optionally be substituted by one to three substituents selected from nitro and an amino having optionally one or two substituents selected from a lower alkanoyl, a lower alkyl and benzoyl; a phenyl(lower)alkenylcarbonyl; a phenyl(lower)alkanoyl wherein the lower alkanoyl moiety may optionally be
substituted by an amino having optionally a lower
alkoxycarbonyl substituent; an alkanoyl; an alkenylcarbonyl; a phenylsulfonyl wherein the phenyl ring may optionally be substituted by a lower alkoxy; a group of the formula:
-CONR8R9 (wherein R8 and R9 are the same or different and are each hydrogen atom or a phenyl which may optionally have one to three substituents selected from a lower alkoxy, a lower alkyl, a halogen atom, an amino having optionally one or two substituents selected from a lower alkyl and a lower alkanoyl, and nitro); a heterocyclic group-substituted carbonyl wherein the heterocyclic group may optionally have one to three substituents selected from a phenyl(lower)alkoxycarbonyl, a phenyl(lower)alkoxy, oxo, a lower alkyl, and a lower alkylenedioxy; a group of the formula:
naphthylcarbonyl; a thienyl(lower)alkanoyl; a tricyclo[3.3.1.1]decanyl(lower)alkanoyl; tricyclo[3.3.1.1]decanylcarbonyl; or a group of the formula: (wherein p is 0 or an integer of 1 to 3,
and R13 is hydroxy; an alkoxy; an alkoxy which has one or two substituents selected from hydroxy, a lower alkanoyloxy, a tri(lower)alkylammonium, a lower alkoxy, and a group of the formula: -NR14R15 [wherein R14 and R15 are the same or different and are each hydrogen atom, a lower alkyl, a hydroxy-substituted lower alkyl, a lower alkanoyl, a tetrahydropyranyl(lower)alkyl, phenyl, a phenyl(lower)alkyl (wherein the alkyl moiety may optionally be substituted by hydroxy and the phenyl ring may optionally be substituted by a lower alkoxy), or a pyridyl(lower)alkyl; or R14 and R15 may bind with the nitrogen atom to which they bond to form a 5- or 6-membered, saturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom
(wherein the heterocyclic group may optionally be
substituted by a member selected from carbamoyl, a lower alkyl, a phenyl(lower)alkyl, phenyl and a hydroxy-substituted lower alkyl)]; a carboxy-substituted alkoxy; a halogen-substituted lower alkoxy; a lower alkoxycarbonyl-substituted alkoxy; a lower alkanoyloxy-substituted lower alkoxy; a lower alkenyloxy-substituted lower alkoxy; a lower alkoxy(lower)alkoxy; a lower alkylsulfonyloxy-substituted lower alkoxy; a benzoyloxy-substituted lower alkoxy;
tricyclo[3.3.1.1]decanyl-substituted lower alkoxy; a lower alkoxy(lower)alkoxy which is substituted by one or two substituents selected from hydroxy and an amino being optionally substituted by a lower alkyl; a morpholinyl-substituted lower alkoxy which may optionally be substituted by a lower alkyl or oxo; a benzimidazolylthio-substituted lower alkoxy; a benzimidazolylsulfinyl-substituted lower alkoxy; a group of the formula: -O-A-(E)ℓ-NR 4R5 (wherein A is an alkylene, 2. is an integer of 0 or 1, E is a group of the formula: -CO- or -OCO-, R4 and R5 are the same or different and are each hydrogen atom; a lower alkyl which may optionally be substituted by hydroxy or cyano; a lower alkenyl; a lower alkynyl; a phenyl(lower)alkyl; a lower alkanoyl which may optionally have one to three substituents of a halogen atom; a benzoyl wherein the phenyl ring may optionally be substituted by a member selected from nitro and an amino having optionally one or two substituents selected from a lower alkyl, a lower alkanoyl and a
phenyl(lower)alkoxycarbonyl; phenyl; a lower alkoxycarbonyl; a lower alkoxycarbonyl(lower)alkyl wherein the lower alkyl moiety may optionally be substituted by hydroxy or an amino having optionally a phenyl(lower)alkoxycarbonyl substituent; an amido having optionally a lower alkyl substituent; a pyrrolidinyl-substituted carbonyl wherein the pyrrolidinyl ring may optionally be substituted by a phenyl(lower)alkoxycarbonyl; an amino-substituted lower alkanoyl wherein the lower alkanoyl moiety may optionally be substituted by a member selected from phenyl(lower)alkoxycarbonylamino, hydroxy, a phenyl having optionally a hydroxy substitutent, carbamoyl, imidazolyl and a lower alkylthio, and the amino group may optionally have a substituent selected from a lower alkyl having optionally a hydroxy substitutent, a lower alkenyl, a phenyl (lower )alkyl having optionally a lower alkoxy substituent on the phenyl ring, a lower
alkylsulfonyl, a lower alkanoyl, and a phenyl(lower)alkoxycarbonyl; a hydroxy-substituted lower alkanoyl; a lower alkanoyloxy(lower)alkanoyl; a lower alkylsulfonyl; a
phenylsulfonyl wherein the phenyl ring may optionally be substituted by a lower alkyl, nitro or an amino having optionally one or two substituents selected from a lower alkyl and a lower alkanoyl; an amido-substituted lower alkyl wherein the lower alkyl moiety have optionally a substituent selected from a phenyl having optionally a hydroxy substituent, imidazolyl, carbamoyl and a lower alkylthio, and the amido group may optionally have a lower alkyl substituent; an amino-substituted lower alkyl which may optionally substituted by a lower alkyl or a lower alkanoyl; anilinocarbonyl; a piperidinyl which may optionally be substituted by a phenyl(lower)alkyl; a cycloalkyl, a cycloalkenylcarbonyl; a cycloalkylcarbonyl which may optionally have one to three substituents selected from hydroxy and a lower alkanoyloxy; a tetrahydropyranyl-substituted lower alkyl wherein the tetrahydropyranyl ring may optionally have one to four substituents selected from hydroxy and a lower alkoxy; a lower alkanoyl which is substituted by a 5- or 6-membered saturated heterocyclic group selected from
pyrrolidinyl, piperazinyl, piperidinyl and morpholinyl wherein the heterocyclic group have optionally a substituent selected from a lower alkyl and phenyl; a piperidinylsubstituted carbonyl which may optionally be substituted by a lower alkanoyl; a lower alkanoyloxy(lower)alkyl; a
pyridyl-substituted lower alkyl; or an amino acid residue which can form an amido group with its amino group, or R4 and R5 may bind together with the nitrogen atom to which they bond to form a 5- or 6-membered, saturated or
unsaturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom, wherein the heterocyclic group may optionally be substituted by a member selected from a phenyl having optionally a subsituent selected from a lower alkoxy and a halogen atom, oxo, hydroxy, a lower alkenyl, carboxy, a phenyl(lower)alkyl having optionally a hydroxy substituent on the lower alkyl moiety, a lower alkanoyl, a lower alkyl having optionally a hydroxy substituent, benzoyl, an amido having optionally a lower alkyl substituent, anilinocarbonyl, a benzoyl(lower)alkyl, a lower alkylsulfonyl, piperidinyl, pyrimidinyl, pyridyl, and a lower alkoxycarbonyl); a carbamoyloxy-substituted lower alkoxy; a lower alkylthio-substituted lower alkoxy; a lower alkylsulfonyl-substituted lower alkoxy; a lower alkylsulfinyl-substituted lower alkoxy; an alkenyloxy; phenoxy; a lower alkanoyloxy; a lower alkylsulfonyloxy; a lower alkynyloxy; a phenyl(lower)alkoxy; a cycloalkyl; a cycloalkyloxy; a cycloalkenyloxy; imidazo[4,5-c]pyridyl-carbonyl(lower)alkoxy; a group of the
formula: -(B)ℓNR6R7 (wherein ℓ is as defined above, B is a lower alkylene or a group of -CO-, and R6 and R7 are the same or different and are each hydrogen atom, a lower alkyl, a lower alkanoyl having optionally one to three halogen substituents, a carboxy (lower )alkyl, a lower alkoxycarbonyl, a lower alkoxycarbonyl(lower)alkyl, a lower alkenyl, an amido-substituted lower alkyl having optionally a lower alkyl substituent, or a phenyl(lower)alkoxycarbonyl, or R6 and R7 may bind together with nitrogen atom to which they bond to form a 5- or 6-membered, saturated or unsaturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom, wherein the heterocyclic group may optionally have a substituent selected from a lower alkoxycarbonyl, a lower alkyl, a lower alkylthio, and oxo); nitro; a halogen atom; a lower alkylsulfonyl; a lower alkyl which may optionally have one to three substituents selected from a halogen atom, hydroxy, phenyl and a lower alkoxy; a cyano-substituted lower alkoxy; an oxiranylsubstituted lower alkoxy; a phthalimido-substituted alkoxy; an amidino-substituted lower alkoxy, a pyrrolyl-substituted lower alkoxy; cyano; a lower alkoxycarbonyl; amidino;
carbamoyl; carboxy; a lower alkanoyl; benzoyl; a lower alkoxycarbonyl(lower)alkyl; a carboxy(lower)alkyl; a lower alkoxy(lower)alkyl; a lower alkanoyloxy(lower)alkyl;
hydroxyimino-substituted lower alkyl; phenyl; a lower alkylthio; a lower alkylsulfinyl; a lower alkenyl having optionally a hydroxy substituent; a lower alkylenedioxy, a lower alkylsilyl; a pyrimidylthio-substituted lower alkoxy; a pyrimidylsulfinyl-substituted lower alkoxy; a pyrmidylsufonyl-substituted lower alkoxy; an imidazolylthio-substituted lower alkoxy which may optionally have a lower alkyl substituent; an imidazolylsulfonyl-substituted lower alkoxy which may optionally have a lower alkyl substituent; an ammonium-lower alkoxy having three substituents selected from lower alkyl, lower alkenyl and oxo; a phenylthio-substituted lower alkoxy wherein the phenyl ring may
optionally have a substituent selected from nitro and amino; a phenylsulfonyl-substituted lower alkoxy wherein the phenyl ring may optionally have a substituent selected from nitro and an amino having optionally one or two substituents selected from a lower alkanoyl and lower alkyl; a
pyridylthio-substituted lower alkoxy; or a pyridylsuflonyl-substituted lower alkoxy wherein the pyridyl ring may optionally be substituted by oxo), n is an integer of 1 or 2, m is 0 or an integer of 1 to 3, R is a lower alkyl, R10 is a group of the formula: -(CO)ℓ -NR11R12 (wherein a is as defined above and R 11 and R19 are the same or different and are each hydrogen atom, a lower alkyl, a phenyl(lower)alkyl, a lower alkenyl, a benzoyl which may optionally have a lower alkoxy substituent, tricyclo[3.3.1.1]decanyl, a phenyl which may optionally have a lower alkoxy substituent, or a
cycloalkyl, or R 11 and R19 may bind together with the nitrogen atom to which they bond to form a saturated or unsaturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom, wherein the heterocyclic group may optionally have a substituent
selected from a benzoyl, a lower alkanoyl, a phenyl(lower)alkyl and a phenyl which may optionally be substituted by a lower alkoxy or a lower alkanoyl), the bond between 3- and 4-positions of the carbostyril ring is single bond or double bond, provided that when R1 is hydrogen atom and the ℓ in the formula: -(CO)ℓ-NR11R12 is O, R11 and R12 are not simultaneously hydrogen atom, or a pharmaceutical acceptable salt thereof, or a benzoheterocyclic compound of the formula (2): wherein R16 is hydrogen atom, a halogen atom, a lower alkyl, an amino having optionally a lower alkyl substituent, or a lower alkoxy,
R17 is hydrogen atom, a halogen atom, a lower alkoxy, a phenyl(lower)alkoxy, hydroxy, a lower alkyl, an amino having optionally a lower alkyl substituent, a
carbamoyl-substituted lower alkoxy, an amino-substituted lower alkoxy having optionally a lower alkyl substituent, or a benzoyloxy which has optionally a halogen substituent on the phenyl ring,
R18 is a group of the formula: -NR19R20 or a group of the formula: -CONR26R27,
R19 is hydrogen atom, a benzoyl which has optionally a halogen substituent on the phenyl ring, or a lower alkyl,
R 20 is a group of the formula:
[wherein R31 is a halogen atom; a lower alkyl which has optionally a substituent selected from a halogen atom and hydroxy; hydroxy; a lower alkoxy; a lower alkanoyloxy; a lower alkylthio; a lower alkanoyl; carboxy; a lower
alkoxycarbonyl; cyano; nitro; an amino which has optionally a substituent selected from a lower alkyl and a lower alkanoyl; phenyl; a cycloalkyl; a lower alkanoyloxy-substituted lower alkoxy; a carboxy-substituted lower alkoxy; a halogen-substituted lower alkoxy; a carbamoyl-substituted lower alkoxy; a hydroxy-substituted lower alkoxy; a lower alkoxycarbonyl-substituted lower alkoxy; a phthalimido-substituted lower alkoxy; an aminocarbonyl-lower alkoxy having a lower alkyl substituent; or a group of the formula: -0-F-N21R22 (F is a lower alkylene, and R21 and R22 are the same or different and are each hydrogen atom, a lower alkyl having optionally a hydroxy substituent, a lower alkanoyl, or benzoyl, or R 21 and R22 may bind together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with nitrogen or oxygen atom wherein the heterocyclic group has optionally a substituent selected from piperidinyl and a lower alkyl); and r is an integer of 0 to 3], a phenyl-lower alkoxycarbonyl, a lower alkanoyl, a phenyl-lower alkanoyl, a cycloalkyl-lower alkanoyl, a cycloalkylcarbonyl, tricyclo[3.3.1.1]decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-lower alkanoyl wherein the phenyl ring has
optionally 1 to 3 substituents selected from a lower alkyl, a lower alkoxy and an amino having optionally a lower alkanoyl substituent, a phthalimido-substituted. lower alkanoyl, a lower alkoxycarbonyl-lower alkanoyl, a carboxylower alkanoyl, a naphthyloxy-lower alkanoyl, a halogen-substituted lower alkanoyl, a group of the formula: (wherein R23 is hydrogen atom, a lower
alkyl, a phenyl-lower alkoxycarbonyl, a carbamoyl-lower alkyl, an amino-lower alkanoyl having optionally a lower alkyl substituent, or a lower alkanoyl), an anilinocarbonyl which has optionally a lower alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionally a substituent selected from a halogen atom and a lower alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: -CO-G-(CO)s-NR24R25 (wherein G is a lower alkylene, s is an integer of 0 or 1, and R24 and R25 are the same or different and are each hydrogen atom, a lower alkyl having optionally a hydroxy substituent, a cycloalkyl, a phenyl-lower alkyl, a lower alkanoyl, a lower alkenyl, a phenoxy- lower alkyl, a phenyl which has optionally 1 to 3
substituents selected from an amino-lower alkyl having optionally a lower alkanoyl substituent, a lower alkyl, a lower alkoxy and a halogen atom, a phthalimido-substituted lower alkyl, an amino-lower alkyl having optionally a lower alkanoyl substituent, a lower alkynyl, or an amino-lower alkyl having optionally a lower alkyl substituent, or R24 and R 25 may bind together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with nitrogen or oxygen atom wherein the heterocylic group has optionally a substituent selected from a lower alkyl, a lower
alkoxycarbonyl and piperidinyl),
R26 is hydrogen atom or a lower alkyl,
R27 is a cycloalkyl, or a phenyl which has optionally 1 to 3 substituents selected from a lower alkoxy, a lower alkyl and a halogen atom,
W is a group of the formula: -(CH2)t~ (t is an integer of 3 to 5), or a group of the formula:
-CH=CH-(CH2)v- (v is an integer of 1 to 3), the carbon atom of these groups: -(CH2)t- and -CH=CH-(CH2)v- being optionally replaced by oxygen atom, sulfur atom, sulfinyl, sulfonyl, or a group of the formula: -NR28- (R28 is hydrogen atom, a cycloalkyl, or a lower alkyl), and further said -(CH2)t- and -CH=CH-(CH2)v- groups having optionally 1 to 3 substituents selected from a lower alkyl having optionally a hydroxy substituent, a lower alkoxycarbonyl, carboxy, hydroxy, oxo, a lower alkanoyloxy having optionally a halogen substituent, an amino-lower alkyl having optionally a substituent selected from a lower alkyl and a lower alkanoyl, a lower alkanoyloxy-substituted lower alkyl, a lower alkyl sulfonyloxy-lower alkyl, an azido-lower alkyl, a group of the formula: -OCH2-, an aminocarbonyloxy having optionally a lower alkyl substituent, a lower alkoxy, a lower alkoxycarbonyl-substituted lower alkoxy, a carboxy-substituted lower alkoxy, an aminocarbonyl-lower alkoxy having optionally a lower alkyl substituent, an amino-lower alkoxy having optionally a substituent selected from a lower alkyl and a lower alkanoyl, a phthalimido-substituted lower alkoxy, hydroxyimino, a lower alkanoyloxy-imino, a lower alkylidene, a halogen atom, azido, sulfoxyimino, a group of the formula: is hydrogen atom or a lower alkyl), hydrazino, pyrrolyl, an amino-lower alkanoyloxy having optionally a lower alkyl substituent, a group of the formula: -O-F-CO-NR33R34 (F is as defined above, and R33 and R34 are the same or different and are each hydrogen atom, a lower alkyl, a carbamoyl-substituted lower alkyl, a hydroxy-substituted lower alkyl, or a pyridyl-lower alkyl, or R 33 and R34 may bind together with nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with nitrogen, oxygen or sulfur atom wherein the heterocyclic group has optionally a substituent selected from oxo, a lower alkyl, a lower alkanoyl, and carbamoyl), or a group of the formula: -(CO)s- NR29N30 (wherein s is as defined above, and R29 and R30 are the same or different and are each hydrogen atom, a lower alkyl, a lower alkenyl, a lower alkanoyl, a cycloalkyl, an oxiranyl-substituted lower alkyl, a lower alkyl having optionally 1 to 2 substituents selected from a lower alkoxy, hydroxy and an amino having optionally a lower alkyl
substituent, a phenyl-lower alkyl, a pyridyl-lower alkyl, a lower alkylsulfonyl, benzoyl, a lower alkoxycarbonyl, anilinocarbonyl, an aminocarbonyl having optionally a lower alkyl substituent, a cyano-substituted lower alkyl, a lower alkoxycarbonyl-substituted lower alkyl, a carbamoylsubstituted lower alkyl, a carboxy-substituted lower alkyl, a tetrahydropyranyloxy-substituted lower alkyl, a lower alkanoyloxy-substituted lower alkyl, a piperidinyl having optionally a phenyl-lower alkyl substituent on the
piperidinyl ring, a halogen-substituted lower alkanoyl, an imidazolyl-substituted lower alkanoyl, an amino-lower alkanoyl having optionally a substituent selected from a lower alkyl and a lower alkoxycarbonyl, an aminocarbonyl-lower alkyl having optionally a lower alkyl substituent, or a phenyl-lower alkoxycarbonyl, or R29 and R30 may bind together with nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with nitrogen or oxygen, wherein the heterocyclic group may optionally have a substituent
selected from a lower alkyl, a phenyl-lower alkyl and a lower alkanoyl, or a pharmaceutical acceptable salt thereof, in admixture with a pharmaceutically acceptable carrier or diluent.
2. The oxytocin antagonist according to claim 1, wherein the active ingredient is a carbostyril derivative of the formula (1) as set forth in claim 1, or a
pharmaceutically acceptable salt thereof.
3. The oxytocin antagonist according to claim 1, wherein the active ingredient is a benzoheterocyclic
compound of the formula (2) as set forth in claim 1 or a pharmaceutically acceptable salt thereof.
4. The oxytocin antagonist according to claim 2, wherein R is a group of the formula:
in which R2, R3, m and n are the same as defined above.
5. The oxytocin antagonist according to claim 2, wherein R is a group of the formula:
in which R10 is the same as defined above.
6. The oxytocin antagonist according to claim 4, wherein R2 is a group of the formula: in which R 13 and p are the same as defined above.
7. The oxytocin antagonist according to claim 4, wherein R2 is hydrogen atom; a lower alkoxycarbonyl; a phenoxycarbonyl wherein the phenyl ring may optionally be substituted by one to three substituents selected from nitro and an amino having optionally one or two substituents selected from a lower alkanoyl, a lower alkyl and benzoyl; a phenyl(lower)alkenylcarbonyl; a phenyl(lower)alkanoyl wherein the lower alkanoyl moiety may optionally be
substituted by an amino having optionally a lower alkoxycarbonyl substituent; an alkanoyl; an alkenylcarbonyl; a phenylsulfonyl wherein the phenyl ring may optionally be substituted by a lower alkoxy; a group of the formula:
-CONR8R9 (wherein R8 and R9 are the same or different and are each hydrogen atom or a phenyl which may optionally have one to three substituents selected from a lower alkoxy, a lower alkyl, a halogen atom, an amino having optionally one or two substituents selected from a lower alkyl and a lower alkanoyl, and nitro); a heterocyclic group-substituted carbonyl wherein the heterocyclic group may optionally have one to three substituents selected from a phenyl(lower)alkoxycarbonyl, a phenyl(lower)alkoxy, oxo, a lower alkyl, and a lower alkylenedioxy); a group of the formula:
naphthylcarbonyl; a thienyl(lower)alkanoyl; a tricyclo[ 3.3.1.1]decanyl(lower)alkanoyl, or tricyclo[3.3.1.1]decanylcarbonyl.
8. The oxytocin antagonist according to claim 6, wherein R13 is a group of the formula: -O-A- ( E ) -NR4R5 ( in which A, E, ℓ, R4 and R5 are the same as defined above), and p is an integer of 1 to 3.
9. The oxytocin antagonist according to claim 6, wherein R13 is an alkoxy which has one or two substituents selected from hydroxy, a lower alkanoyloxy, a tri(lower)alkylammonium, a lower alkoxy, and a group of the formula: -NR14R15 [wherein R14 and R15 are the same or different and are each hydrogen atom, a lower alkyl, a hydroxy-substituted lower alkyl, a lower alkanoyl, a tetrahydropyranyl(lower)alkyl, phenyl, a phenyl(lower)alkyl (wherein the alkyl moiety may optionally be substituted by hydroxy and the phenyl ring may optionally be substituted by a lower alkoxy), or a pyridyl(lower)alkyl; or R14 and R15 may bind together with the nitrogen atom to which they bond to form a 5- or 6-membered, saturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom
(wherein the heterocyclic group may optionally be
substituted by a member selected from carbamoyl, a lower alkyl, a phenyl(lower)alkyl, phenyl and a hydroxy-substituted lower alkyl)], and p is an integer of 1 to 3.
10. The oxytocin antagonist according to claim 6, wherein R 13 is hydroxy; an alkoxy; a carboxy-substituted alkoxy; a halogen-substituted lower alkoxy; a lower alkoxycarbonyl-substituted alkoxy; a lower alkanoyloxy-substituted lower alkoxy; a lower alkenyloxy-substituted lower alkoxy; a lower alkoxy(lower)alkoxy; a lower alkylsulfonyloxy-substituted lower alkoxy; a benzoyloxy-substituted lower alkoxy; tricyclo[3.3.1.1]decanyl-substituted lower alkoxy; a lower alkoxy(lower)alkoxy which is substituted by one or two substituents selected from hydroxy and an amino being optionally substituted by a lower alkyl; a morpholinyl-substituted lower alkoxy which may optionally be substituted by a lower alkyl or oxo; a benzimidazolylthio-substituted lower alkoxy; a benzimidazolylsulfinyl-substituted lower alkoxy; a carbamoyloxy-substituted lower alkoxy; a lower alkylthio-substituted lower alkoxy; a lower alkylsulfonyl-substituted lower alkoxy; a lower alkylsulfinyl-substituted lower alkoxy; an alkenyloxy; phenoxy; a lower alkanoyloxy; a lower alkylsulfonyloxy; a lower alkynyloxy; a phenyl(lower)alkoxy; a cycloalkyl; a cycloalkyloxy; a cycloalkenyloxy; imidazo-[4,5-c]pyridyl-carbonyl(lower)alkoxy; a group of the formula: -(B)ℓNR6R7 (wherein ℓ, is as defined above, B is a lower alkylene or a group of -CO-, and R6 and R7 are the same or different and are each hydrogen atom, a lower alkyl, a lower alkanoyl having optionally one to three halogen substituents, a carboxy(lower)alkyl, a lower al.koxycarbonyl, a lower alkoxycarbonyl(lower)alkyl, a lower alkenyl, an amido-substituted lower alkyl having optionally a lower alkyl substituent, or a phenyl(lower)alkoxycarbonyl, or R6 and R7 may bind together with nitrogen atom to which they bond to form a 5- or 6-membered, saturated or unsaturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom, wherein the heterocyclic group may optionally have a substituent selected from a lower alkoxycarbonyl, a lower alkyl, a lower alkylthio, or oxo); nitro; a halogen atom; a lower alkylsulfonyl; a lower alkyl which may optionally have one to three substituents selected from a halogen atom, hydroxy, phenyl and a lower alkoxy; a cyano-substituted lower alkoxy; an oxiranylsubstituted lower alkoxy; a phthalimido-substituted alkoxy; an amidino-substituted lower alkoxy, a pyrrolyl-substituted lower alkoxy; cyano; a lower alkoxycarbonyl; amidino;
carbamoyl; carboxy; a lower alkanoyl; benzoyl; a lower alkoxycarbonyl (lower) alkyl; a carboxy(lower)alkyl; a lower alkoxy(lower)alkyl; a lower alkanoyloxy(lower)alkyl;
hydroxyimino-substituted lower alkyl; phenyl; a lower alkylthio; a lower alkylsulfinyl; a lower alkenyl having optionally a hydroxy substituent; a lower alkylenedioxy, a lower alkylsilyl; a pyrimidylthio-substituted lower alkoxy; a pyrimidylsulfinyl-substituted lower alkoxy; a pyrmidylsufonyl-substituted lower alkoxy; an imidazolylthio-substituted lower alkoxy which may optionally have a lower alkyl substituent; an imidazolylsulfonyl-substituted lower alkoxy which may optionally have a lower alkyl substituent; an ammonium-lower alkoxy having three substituents selected from lower alkyl, lower alkenyl and oxo; a phenylthio-substituted lower alkoxy wherein the phenyl ring may
optionally have a substituent selected from nitro and amino; a phenylsulfonyl-substituted lower alkoxy wherein the phenyl ring may optionally have a substituent selected from nitro and an amino having optionally one or two substituents selected from a lower alkanoyl and lower alkyl; a
pyridylthio-substituted lower alkoxy; or a pyridylsuflonyl-substituted lower alkoxy wherein the pyridyl ring may optionally be substituted by oxo.
11. The oxytocin antagonist according to claim 8, wherein ℓ is 0.
12. The oxytocin antagonist according to claim 11, wherein R4 and R5 are the same or different and each
hydrogen atom, a lower alkanoyl which may optionally have one to three substituents of a halogen atom.
13. The oxytocin antagonist according to claim 11, wherein R4 and R may bind together with the nitrogen atom to which they bond to form a 5- or 6-membered, saturated or unsaturated heterocyclic group which may be intervened or not with nitrogen, oxygen or sulfur atom, in which the heterocyclic group may optionally be substituted by a member selected from a phenyl having optionally a subsituent selected from a lower alkoxy and a halogen atom, oxo, hydroxy, a lower alkenyl, carboxy, a phenyl(lower)alkyl having optionally a hydroxy substituent on the lower alkyl moiety, a lower alkanoyl, a lower alkyl having optionally a hydroxy substituent, benzoyl, an amido having optionally a lower alkyl substituent, anilinocarbonyl, a benzoyl(lower)alkyl, a lower alkylsulfonyl, piperidinyl, pyrimidinyl, pyridyl, and a lower alkoxycarbonyl.
14. The oxytocin antagonist according to claim 13, wherein the 5- or 6-membered, saturated or unsaturated heterocyclic group which is formed by binding the groups R4 and R5 together with the nitrogen atom to which they bond and may be intervened or not with nitrogen, oxygen or sulfur atom is pyrrolidinyl, piperidinyl, piperazinyl, morpholino, thiomorpholino, pyrrolyl, pyrazoly, imidazolyl,
imidazolidinyl, 1,2,4-triazolyl, 1,2,3,4-tetrazolyl, pyrrolinyl, imidazolinyl, pyrazolinyl, pyrazolidinyl, oxazolinyl, oxazolidinyl, isoxazolinyl, isoxazolidinyl, thiazolinyl, thiazolidinyl, isothiazolinyl or
isothiazolidinyl.
15. The oxytocin antagonist according to any one of claim 12 and 14, wherein R1 is hydrogen atom or a halogen atom, and the bond between 3-position and 4-position is single bond.
16. The oxytocin antagonist according to claim 2, wherein the active ingredient is a compound selected from 1-{1-[4-(3-acetylaminopropoxy)benzoyl]-4-piperidinyl}-3,4- dihydrocarbostyril, 1-{1-[4-(4-acetylaminobutoxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril, 1-{1-[4-(5-acetylaminopentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril, 1-{1-[4-(3-carbamoyloxypropoxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril, 7-fluoro-1-{1-[4-(3-acetylaminopropoxy)benzoyl]-4-piperidinyl}-3, 4-dihydrocarbostyril, 1-{1-[4-[5-(1-pyrrolidinyl)pentyloxy]benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril, 1-{1-[4-(6-diethylamino-5-hydroxyhexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril, 1-{1-[4-[5-hydroxy-6-(1-pyrrolidinyl)hexyloxy]benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril, 1-{1-[4-[5-hydroxy-6- dimethylaminohexyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril, 1-{1-[4-(4-hydroxy-5-dimethylaminopentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril, 1-{1-[4-(7-hydroxy-8-diethylaminooctyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril, 1-{1-[4-(5-diethylaminopentyloxy)benzoyl]-4-piperidinyl}-3,4-dihydrocarbostyril and a
pharmaceutically acceptable salt thereof.
17. The oxytocin antagonist according to claim 3, wherein R 16 is hydrogen atom, and R17 is hydrogen atom, a halogen atom, a lower alkoxy or a lower alkyl.
18. The oxytocin antagonist according to claim 3, wherein R16 is a halogen atom, and R17 is hydrogen atom, a halogen atom, a lower alkoxy or a lower alkyl.
19. The oxytocin antagonist according to claim 3, wherein R16 is a lower alkyl, an amino having optionally a lower alkyl substituent, or a lower alkoxy, and R17 is hydrogen atom, a halogen atom, a lower alkoxy or a lower alkyl .
20. The oxytocin antagonist according to claim 3, wherein R17 is a phenyl(lower)alkoxy, hydroxy, an amino having optionally a lower alkyl substituent, a carbamoyl-substituted lower alkoxy, an amino-substituted lower alkoxy having optionally a lower alkyl substituent, or a benzoyloxy which has optionally a halogen substituent on the phenyl ring.
21. The oxytocin antagonist according to claim 17, wherein R18 is a group of the formula: -NR19R20, in which
R 19 is hydrogen atom and R20 is a group of the formula: (wherein R31 and r are the same as
defined above).
22. The oxytocin antagonist according to claim 3, wherein R18 is a group of the formula: -NR19NR20, in which
R 19 is hydrogen atom, and R20 is a phenyl-lower alkoxycarbonyl, a lower alkanoyl, a phenyl-lower alkanoyl, a cycloalkyl-lower alkanoyl, a cycloalkylcarbonyl, tricyclo[ 3.3.1.1]decanylcarbonyl, naphthylcarbonyl, pyridylcarbonyl, furoyl, thenoyl, a phenoxy-lower alkanoyl wherein the phenyl ring has optionally 1 to 3 substituents selected from a lower alkyl, a lower alkoxy and an amino having optionally a lower alkanoyl substituent, a phthalimido-substituted lower alkanoyl, a lower alkoxycarbonyl-lower alkanoyl, a carboxy-lower alkanoyl, a naphthyloxy-lower alkanoyl, a halogen-substituted lower alkanoyl, a group of the formula: (wherein R23 is hydrogen atom, a lower
alkyl, a phenyl-lower alkoxycarbonyl, a carbamoyi-lower alkyl, an amino-lower alkanoyl having optionally a lower alkyl substituent, or a lower alkanoyl), an anilinocarbonyl which has optionally a lower alkyl substituent on the phenyl ring, phenoxycarbonyl, a phenylsulfonyl which has optionall a substituent selected from a halogen atom and a lower alkyl on the phenyl ring, quinolylsulfonyl, or a group of the formula: -CO-G-(CO)S-NR24R25 (wherein G is a lower alkylene, s is 0 or an ingeger of 1, and R24 and R25 are the sarαe or different and are each hydrogen atom, a lower alkyl having optionally a hydroxy substituent, a cycloalkyl, a phenyllower alkyl, a lower alkanoyl, a lower alkenyl, a phenoxylower alkyl, a phenyl which has optionally 1 to 3
substituents selected from an amino-lower alkyl having optionally a lower alkanoyl substituent, a lower alkyl, a lower alkoxy and a halogen atom, a phthalimido-substituted lower alkyl, an amino-lower alkyl having optionally a lower alkanoyl substituent, a lower alkynyl, or an amino-lower alkyl having optionally a lower alkyl substituent, or R2 and R25 may bind together with the nitrogen atom to which they bond to form a 5- or 6-membered saturated heterocyclic group with or without being intervened with nitrogen or oxygen atom wherein the heterocylic group has optionally a substituent selected from a lower alkyl, a lower alkoxycarbonyl and piperidinyl.
23. The oxytocin antagonist according to claim 3, wherein R18 is a group of the formula: -CONR26R27 in which R26 and R27 are the same as defined above.
24. The oxytocin antagonist according to claim 3, wherein R18 is a group of the formula:-NR19R20 in which R19 is a lower alkyl, and R20 is the same as defined above.
25. The oxytocin antagonist according to claim 18, wherein R18 is a group of the formula: -NR19R20 in which R19 is hydrogen atom, and R 20 is a group of the formula: (R31 and r are the same as defined
above).
26. The oxytocin antagonist according to claim 19, wherein R18 is a group of the formula: -NR19R20 in which R19 is hydrogen atom, and R 20 is a group of the formula: (R31 and r are the same as def ined
above ) .
27. The oxytocin antagonist according to any one of claims 21, 25 and 26, wherein R 31 is a halogen atom or a lower alkyl which has optionally a substituent selected from a halogen atom and hydroxy.
28. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -(CH2)t-, in which t is 4, and the carbon atom thereof is not replaced by any oxygen atom, sulfur atom, sulfinyl, sulfonyl, or a group of the formula: -NR 28- (R28 is the same as defined above), and the group of the formula: -(CH2)t- has no substituent.
29. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -(CH2)t-, in which t is 4, and the carbon atom thereof is not replaced by any oxygen atom, sulfur atom, sulfinyl, sulfonyl, or a group of the formula: -NR28- (R28 is the same as defined above), and the group of the formula:-(CH2)t- has a substituent of the formula: -(CO)s-NR29R30 (R29 and R30 are the same as define above).
30. The oxytocin antagonist according to claim 29, wherein s is 0, R29 and R30 are the same or different and each hydrogen atom, a lower alky or a cycloalkyl.
31. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -(CH2)t- in which t is 3.
32. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -(CH2)t- in which t is 4.
33. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -(CH2)t- in which t is 5.
34. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -CH=CH-(CH2)v- in which v is 1.
35. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -CH=CH-(CH2)v- in which v is 2.
36. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -CH=CH-(CH2)v- in which v is 3.
37. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -(CH2)t- in which t is 4, and the carbon atom thereof is not replaced by any oxygen atom, sulfur atom, sulfinyl, sulfonyl, or a group of the formula:-NR 28- (R 28 is the same as defined above), and the group of the formula:- (CH2)t- has 1 to 3 substituents selected from a lower alkyl having optionally a hydroxy substituent, hydroxy, an amino-lower alkyl having optionally a substituent selected from a lower alkyl and a lower alkanoyl, an amino-lower alkanoyloxy having optionally a lower alkyl substituent, a group of the formula:
-O-F-CO-NR33R34 (F, R33 and R34 are the same as defined above).
38. The oxytocin antagonist according to claim 3, wherein W is a group of the formula: -(CH2)t- in which t is 4, and the cargon atom thereof is not replaced by any oxygen atom, sulfur atom, sulfinyl, sulfonyl, or a group of the formula:-NR 28- (R 28 is the same as defined above), and the group of the formula:-(CH2)t- has 1 to 3 substituents selected from a lower alkyl having optionally a hydroxy-substituent, and hydroxy.
39. The oxytocin antagonist according to claim 32, wherein the heterocyclic group of the formula:
is 2,3,4,5-tetrahydro-1H-benzazepine.
40. The oxytocin antagonist according to claim 3, wherein the active ingredient is a compound selected from 5-dimethylamino-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine, 7-chloro-5-hydroxy-1-[2-methyl-4- (2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzoazepine, 7-chloro-5-hydroxy-1-[2-methoxy-4-(2-methyl¬benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine, 7-fluoro-5-hydroxy-1-[2-chloro-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine, and a
pharmaceutically acceptable salt thereof.
41. A method for the protection or treatment of premature delivery, dysmenorrhea, endometritis, or for stopping labour preparatory to Caearian delivery, which comprises administering the oxytocin antagonist as set forth in claim 1 to a warm-blooded animal including a human being.
42. A method for the protection or treatment of premature delivery, dysmenorrhea, endometritis, or for stopping labour preparatory to Caearian delivery, which comprises administering the oxytocin antagonist as set forth in claim 2 to a warm-blooded animal including a human being.
43. A method for the protection or treatment of premature delivery, dysmenorrhea, endometritis, or for stopping labour preparatory to Caearian delivery, which comprises administering the oxytocin antagonist as set forth in claim 3 to a warm-blooded animal including a human being.
44. . A method for the protection or treatment of premature delivery, dysmenorrhea, endometritis, or for stopping labour preparatory to Caearian delivery, which comprises administering the oxytocin antagonist as set forth in claim 16 to a warm-blooded animal including a human being.
45. A method for the protection or treatment of premature delivery, dysmenorrhea, endometritis, or for stopping labour preparatory to Caearian delivery, which comprises administering the oxytocin antagonist as set forth in claim 40 to a warm-blooded animal including a human being.
46. A method for antagonizing oxytocin
participating in uterin smooth muscle constriction, which comprises administering the oxytocin antagonist as set forth in claim 1 to a warm-blooded animal including a human being.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17556692 | 1992-07-02 | ||
JP17556392 | 1992-07-02 | ||
JP4-175566 | 1992-07-02 | ||
JP4-175563 | 1992-07-02 | ||
PCT/JP1993/000835 WO1994001113A1 (en) | 1992-07-02 | 1993-06-22 | Oxytocin antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4356993A true AU4356993A (en) | 1994-01-31 |
AU657424B2 AU657424B2 (en) | 1995-03-09 |
Family
ID=26496804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU43569/93A Ceased AU657424B2 (en) | 1992-07-02 | 1993-06-22 | Oxytocin antagonist |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0602209A1 (en) |
CN (1) | CN1091288A (en) |
AU (1) | AU657424B2 (en) |
CA (1) | CA2116334A1 (en) |
ID (1) | ID15999A (en) |
MX (1) | MX9304015A (en) |
TW (1) | TW249201B (en) |
WO (1) | WO1994001113A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU679719B2 (en) * | 1993-04-13 | 1997-07-10 | Fujisawa Pharmaceutical Co., Ltd. | New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5356904A (en) * | 1992-10-07 | 1994-10-18 | Merck & Co., Inc. | Carbostyril oxytocin receptor antagonists |
CA2166975C (en) * | 1993-07-16 | 2005-04-05 | Mark G. Bock | Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
WO1996022775A1 (en) * | 1995-01-24 | 1996-08-01 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
TW359669B (en) * | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
US5726172A (en) * | 1996-01-16 | 1998-03-10 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
AR011913A1 (en) | 1997-03-06 | 2000-09-13 | Yamano Masaki | DERIVATIVES OF 4,4-DIFLUORO-2,3,4,5-TETRAHIDRO-1H-1-BENZOAZEPINA AND PHARMACEUTICAL COMPOSITIONS THEREOF. |
US6977254B2 (en) | 2001-04-12 | 2005-12-20 | Wyeth | Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
US7022699B2 (en) | 2001-04-12 | 2006-04-04 | Wyeth | Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
US7109193B2 (en) | 2001-04-12 | 2006-09-19 | Wyeth | Tricyclic diazepines tocolytic oxytocin receptor antagonists |
US6900200B2 (en) | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
US7202239B2 (en) | 2001-04-12 | 2007-04-10 | Wyeth | Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists |
US7064120B2 (en) | 2001-04-12 | 2006-06-20 | Wyeth | Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
US7326700B2 (en) | 2001-04-12 | 2008-02-05 | Wyeth | Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
GB0120051D0 (en) * | 2001-08-16 | 2001-10-10 | Ferring Bv | Oxytocin agonists |
US20050228016A1 (en) * | 2002-06-13 | 2005-10-13 | Enrique Michelotti | Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex |
CN1681487A (en) | 2002-07-15 | 2005-10-12 | 美瑞德生物工程公司 | Compounds, compositions, and methods for employing the same |
US7504508B2 (en) | 2002-10-04 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
BR0315041A (en) | 2002-10-04 | 2005-08-16 | Millennium Pharm Inc | Methods for inhibiting crth2 in an individual requiring crth2 inhibition; compound; and pharmaceutical composition |
JP2006512404A (en) * | 2002-10-22 | 2006-04-13 | グラクソ グループ リミテッド | Aryloxyalkylamine derivatives as H3 receptor ligands |
TW200503994A (en) * | 2003-01-24 | 2005-02-01 | Novartis Ag | Organic compounds |
TWI322689B (en) | 2003-02-24 | 2010-04-01 | Otsuka Pharma Co Ltd | Method for treating severe heart failure and medicament therefor |
KR20070114762A (en) | 2005-02-24 | 2007-12-04 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Pgd2 receptor antagonists for the treatment of inflammatory diseases |
US7671058B2 (en) | 2006-06-21 | 2010-03-02 | Institute Of Medicinal Molecular Design, Inc. | N-(3,4-disubstituted phenyl) salicylamide derivatives |
EA017249B8 (en) | 2007-05-10 | 2013-01-30 | Олбани Молекьюлар Рисерч, Инк. | Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
TWI459947B (en) * | 2007-06-26 | 2014-11-11 | Otsuka Pharma Co Ltd | Benzazepine compound and pharmaceutical preparation |
CN102030709B (en) * | 2009-09-25 | 2013-10-16 | 江苏豪森医药集团有限公司 | Benzazepines compounds serving as vasopressin receptor antagonism |
US9238658B2 (en) | 2011-12-06 | 2016-01-19 | Janssen Pharmaceutica Nv | Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors |
US9102669B2 (en) | 2011-12-06 | 2015-08-11 | Janssen Pharmaceutica Nv | Substituted piperidinyl-pyridazinyl derivatives useful as SCD 1 inhibitors |
WO2017156164A1 (en) | 2016-03-09 | 2017-09-14 | Board Of Regents, The University Of Texas System | 20-hete receptor (gpr75) antagonists and methods of use |
WO2019003433A1 (en) | 2017-06-30 | 2019-01-03 | 大塚製薬株式会社 | Benzazepine derivative |
TW202016094A (en) * | 2018-06-29 | 2020-05-01 | 美商奇奈特生物製藥公司 | Inhibitors of cyclin-dependent kinases |
EP4253367A4 (en) * | 2020-11-26 | 2024-10-23 | Shanghai Jemincare Pharmaceuticals Co Ltd | Novel benzazepine spiro derivative |
CN112851583B (en) * | 2021-01-19 | 2023-09-08 | 徐州医科大学 | Novel benzazepine compounds, compositions and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69009785T2 (en) * | 1989-02-10 | 1994-11-03 | Otsuka Pharma Co Ltd | Carbostyril derivatives. |
CA2026856A1 (en) * | 1989-10-05 | 1991-04-06 | Mark G. Bock | 3-substituted-1,4-benzodiazepines useful as oxytocin |
ES2089033T3 (en) * | 1989-10-20 | 1996-10-01 | Otsuka Pharma Co Ltd | BENZOHETEROCICLICOS COMPOUNDS. |
TW199153B (en) * | 1990-08-07 | 1993-02-01 | Dtsuka Seiyaku Kk |
-
1993
- 1993-06-22 EP EP93913553A patent/EP0602209A1/en not_active Withdrawn
- 1993-06-22 AU AU43569/93A patent/AU657424B2/en not_active Ceased
- 1993-06-22 WO PCT/JP1993/000835 patent/WO1994001113A1/en not_active Application Discontinuation
- 1993-06-22 TW TW82104913A patent/TW249201B/zh active
- 1993-06-22 CA CA 2116334 patent/CA2116334A1/en not_active Abandoned
- 1993-07-02 CN CN 93109876 patent/CN1091288A/en active Pending
- 1993-07-02 MX MX9304015A patent/MX9304015A/en unknown
-
1997
- 1997-03-11 ID IDP970772A patent/ID15999A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU679719B2 (en) * | 1993-04-13 | 1997-07-10 | Fujisawa Pharmaceutical Co., Ltd. | New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
Also Published As
Publication number | Publication date |
---|---|
TW249201B (en) | 1995-06-11 |
EP0602209A1 (en) | 1994-06-22 |
CA2116334A1 (en) | 1994-01-20 |
AU657424B2 (en) | 1995-03-09 |
MX9304015A (en) | 1994-02-28 |
CN1091288A (en) | 1994-08-31 |
ID15999A (en) | 1997-08-21 |
WO1994001113A1 (en) | 1994-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU657424B2 (en) | Oxytocin antagonist | |
WO2005080399A1 (en) | Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor | |
JP4299139B2 (en) | Heteroaryl-substituted triazole modulators of metabotropic glutamate receptor-5 | |
TWI771420B (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
JP2905909B2 (en) | Vasopressin antagonist | |
AU2016202949A1 (en) | Novel nicotinamide derivative or salt thereof | |
CZ161993A3 (en) | Peptides capable of inhibiting activity of hiv protease, their preparation and therapeutic use | |
NZ541193A (en) | Aminoindazole derivatives and use thereof as kinase inhibitors | |
NZ539193A (en) | Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same | |
WO2001047883A1 (en) | Fused-ring compounds and use thereof as drugs | |
WO2001021169A1 (en) | Mch antagonists | |
JP2005516934A (en) | Heteroaryl-substituted pyrazole modulators of metabotropic glutamate receptor-5 | |
JP2004517072A (en) | Compounds useful in treating CNS disorders | |
EP0666258A1 (en) | Indolylcycloaklanylamin- und Indolylcycloalkenylamine derivatives, their preparation and their use as anti-migraine agents | |
JP2005526081A (en) | Diaryl substituted tetrazole modulators of metabotropic glutamate-5 | |
EP3041841B1 (en) | Triazolopyridine compounds, compositions and methods of use thereof | |
JPH09505036A (en) | Novel 4-piperidinyl-substituted lactams as neurokinin 2 receptor antagonists for the treatment of asthma | |
EP3572405A1 (en) | Benzoimidazol-1,2-yl amides as kv7 channel activators | |
WO2006057270A1 (en) | Nitrogeneous tricyclic compound | |
EP4082614A1 (en) | Acylsulfamide compound and pharmaceutical use therefor | |
KR100210977B1 (en) | Oxytocin antagonist | |
TW200819455A (en) | Pyrrolizine, indolizine and quinolizine derivatives, their preparation and their therapeutic application | |
WO2018188660A1 (en) | Brd4 inhibitor, preparation and application thereof | |
CA2519733C (en) | Indazole having analgesic activity | |
JP2007084530A (en) | Pharmaceutical composition containing indanol derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |